
<html lang="en"     class="pb-page"  data-request-id="d6e3ace0-a7c4-40ac-a1c8-894017e53ee7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b00351;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Defining Structure–Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists" /></meta><meta name="dc.Creator" content="Michael&#xA;L.  Martini" /></meta><meta name="dc.Creator" content="Jing  Liu" /></meta><meta name="dc.Creator" content="Caroline  Ray" /></meta><meta name="dc.Creator" content="Xufen  Yu" /></meta><meta name="dc.Creator" content="Xi-Ping  Huang" /></meta><meta name="dc.Creator" content="Aarti  Urs" /></meta><meta name="dc.Creator" content="Nikhil  Urs" /></meta><meta name="dc.Creator" content="John D.  McCorvy" /></meta><meta name="dc.Creator" content="Marc G.  Caron" /></meta><meta name="dc.Creator" content="Bryan L.  Roth" /></meta><meta name="dc.Creator" content="Jian  Jin" /></meta><meta name="dc.Description" content="G protein-coupled receptors (GPCRs) are capable of downstream signaling through distinct noncanonical pathways such as β-arrestins in addition to the canonical G protein-dependent pathways. GPCR li..." /></meta><meta name="Description" content="G protein-coupled receptors (GPCRs) are capable of downstream signaling through distinct noncanonical pathways such as β-arrestins in addition to the canonical G protein-dependent pathways. GPCR li..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00351" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00351" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00351" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00351" /></link>
        
    
    

<title>Defining Structure–Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00351" /></meta><meta property="og:title" content="Defining Structure–Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0020.jpeg" /></meta><meta property="og:description" content="G protein-coupled receptors (GPCRs) are capable of downstream signaling through distinct noncanonical pathways such as β-arrestins in addition to the canonical G protein-dependent pathways. GPCR ligands that differentially activate the downstream signaling pathways are termed functionally selective or biased ligands. A class of novel non-catechol G protein-biased agonists of the dopamine D1 receptor (D1R) was recently disclosed. We conducted the first comprehensive structure–functional selectivity relationship study measuring GS and β-arrestin2 recruitment activities focused on four regions of this scaffold, resulting in over 50 analogs with diverse functional selectivity profiles. Some compounds became potent full agonists of β-arrestin2 recruitment, while others displayed enhanced GS bias compared to the starting compound. Pharmacokinetic testing of an analog with an altered functional selectivity profile demonstrated excellent blood–brain barrier penetration. This study provides novel tools for studying ligand bias at D1R and paves the way for developing the next generation of biased D1R ligands." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00351"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00351">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00351&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00351&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00351&amp;href=/doi/10.1021/acs.jmedchem.9b00351" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3753-3772</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00304" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00206" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Defining Structure–Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D<sub>1</sub> Receptor Agonists</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Michael L. Martini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael L. Martini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute,  Medical Scientist Training Program, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael%0AL.++Martini">Michael L. Martini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jing Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jing Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Liu">Jing Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Caroline Ray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Caroline Ray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Caroline++Ray">Caroline Ray</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xufen Yu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xufen Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xufen++Yu">Xufen Yu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xi-Ping Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xi-Ping Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xi-Ping++Huang">Xi-Ping Huang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aarti Urs</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aarti Urs</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, Florida 32610, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aarti++Urs">Aarti Urs</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nikhil Urs</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nikhil Urs</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, Florida 32610, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nikhil++Urs">Nikhil Urs</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John D. McCorvy</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John D. McCorvy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div><div class="loa-info-affiliations-info">Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#81ebece2e2eef3f7f8c1ece2f6afe4e5f4"><span class="__cf_email__" data-cfemail="1c76717f7f736e6a655c717f6b32797869">[email protected]</span></a> (J.D.M.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++McCorvy">John D. McCorvy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marc G. Caron</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marc G. Caron</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cell Biology,  Department of Medicine and Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#472a2635246924263528290723322c2269222332"><span class="__cf_email__" data-cfemail="9ef3ffecfdb0fdffecf1f0defaebf5fbb0fbfaeb">[email protected]</span></a> (M.G.C.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marc+G.++Caron">Marc G. Caron</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bryan L. Roth</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bryan L. Roth</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#a6c4d4dfc7c8f9d4c9d2cee6cbc3c288d3c8c588c3c2d3"><span class="__cf_email__" data-cfemail="ef8d9d968e81b09d809b87af828a8bc19a818cc18a8b9a">[email protected]</span></a> (B.L.R.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+L.++Roth">Bryan L. Roth</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0561-6520" title="Orcid link">http://orcid.org/0000-0002-0561-6520</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jian Jin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jian Jin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#28424149460642414668455b5b45064d4c5d"><span class="__cf_email__" data-cfemail="fd97949c93d3979493bd908e8e90d3989988">[email protected]</span></a> (J.J.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Jin">Jian Jin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2387-3862" title="Orcid link">http://orcid.org/0000-0002-2387-3862</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00351&amp;href=/doi/10.1021%2Facs.jmedchem.9b00351" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3753–3772</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 15, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 February 2019</li><li><span class="item_label"><b>Published</b> online</span>15 March 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 April 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00351" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00351</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3753%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%250AL.%2BMartini%252C%2BJing%2BLiu%252C%2BCaroline%2BRay%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D7%26contentID%3Dacs.jmedchem.9b00351%26title%3DDefining%2BStructure%25E2%2580%2593Functional%2BSelectivity%2BRelationships%2B%2528SFSR%2529%2Bfor%2Ba%2BClass%2Bof%2BNon-Catechol%2BDopamine%2BD1%2BReceptor%2BAgonists%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3772%26publicationDate%3DApril%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00351"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1579</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00351" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Defining Structure–Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael\nL.&quot;,&quot;last_name&quot;:&quot;Martini&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;Ray&quot;},{&quot;first_name&quot;:&quot;Xufen&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Xi-Ping&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Aarti&quot;,&quot;last_name&quot;:&quot;Urs&quot;},{&quot;first_name&quot;:&quot;Nikhil&quot;,&quot;last_name&quot;:&quot;Urs&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. McCorvy&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;G. Caron&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;L. Roth&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Jin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;3753-3772&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00351&quot;},&quot;abstract&quot;:&quot;G protein-coupled receptors (GPCRs) are capable of downstream signaling through distinct noncanonical pathways such as β-arrestins in addition to the canonical G protein-dependent pathways. GPCR ligands that differentially activate the downstream signaling pathways are termed functionally selective or biased ligands. A class of novel non-catechol G protein-biased agonists of the dopamine D1 receptor (D1R) was recently disclosed. We conducted the first comprehensive structure–functional selectivity relationship study measuring GS and β-arrestin2 recruitment activities focused on four regions of this scaffold, resulting in over 50 analogs with diverse functional selectivity profiles. Some compounds became potent full agonists of β-arrestin2 recruitment, while others displayed enhanced GS bias compared to the starting compound. Pharmacokinetic testing of an analog with an altered functional selectivity profile demonstrated excellent blood–brain barrier penetration. This study provides novel tools for studying li&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00351&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00351" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00351&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00351" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00351&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00351" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00351&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00351&amp;href=/doi/10.1021/acs.jmedchem.9b00351" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00351" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00351" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00351%26sid%3Dliteratum%253Aachs%26pmid%3D30875219%26genre%3Darticle%26aulast%3DMartini%26date%3D2019%26atitle%3DDefining%2BStructure%25E2%2580%2593Functional%2BSelectivity%2BRelationships%2B%2528SFSR%2529%2Bfor%2Ba%2BClass%2Bof%2BNon-Catechol%2BDopamine%2BD1%2BReceptor%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D7%26spage%3D3753%26epage%3D3772%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/jmcmar.2019.62.issue-7/20190411/jmcmar.2019.62.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">G protein-coupled receptors (GPCRs) are capable of downstream signaling through distinct noncanonical pathways such as β-arrestins in addition to the canonical G protein-dependent pathways. GPCR ligands that differentially activate the downstream signaling pathways are termed functionally selective or biased ligands. A class of novel non-catechol G protein-biased agonists of the dopamine D<sub>1</sub> receptor (D<sub>1</sub>R) was recently disclosed. We conducted the first comprehensive structure–functional selectivity relationship study measuring G<sub>S</sub> and β-arrestin2 recruitment activities focused on four regions of this scaffold, resulting in over 50 analogs with diverse functional selectivity profiles. Some compounds became potent full agonists of β-arrestin2 recruitment, while others displayed enhanced G<sub>S</sub> bias compared to the starting compound. Pharmacokinetic testing of an analog with an altered functional selectivity profile demonstrated excellent blood–brain barrier penetration. This study provides novel tools for studying ligand bias at D<sub>1</sub>R and paves the way for developing the next generation of biased D<sub>1</sub>R ligands.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As the largest superfamily of proteins in the druggable genome with functions that have been implicated in diverse biological processes, G protein-coupled receptors (GPCRs) represent an incredibly important target class in drug discovery.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> For decades, G proteins were believed to be the sole signaling effector molecules downstream of membrane-bound GPCRs. This canonical G protein-mediated signaling pathway is known to proceed upon ligand binding, which induces a conformational change in the GPCR, causing the release and dissociation of a heterotrimeric G protein that then drives downstream signaling processes within the cell.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a></div><div class="NLM_p">More recently, exciting discoveries in GPCR pharmacology have revealed that this receptor superfamily is capable of signaling through noncanonical G protein-independent pathways.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6−9)</a> This concept of “functional selectivity”, or biased signaling, now refers to the process by which a ligand with a given GPCR binding mode is capable of differentially activating distinct subsequent signaling cascades in the cell, including most notably those driven by G proteins or β-arrestins.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16">(10−16)</a> In addition, recent studies have also shown that it is possible for a compound to differentially activate various G protein subtypes, such as G<sub>S</sub>/G<sub>olf</sub>, leading to subtype-selective biased agonism.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Importantly, recent and ongoing studies on diverse classes of GPCRs have demonstrated that the direct therapeutic relevance of functional selectivity at these receptors as distinct signaling pathways can mediate divergent processes. In some cases, one downstream signaling pathway may even be responsible for the therapeutic benefit of the ligand, while the other pathway may underlie the observed adverse effects.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25">(18−25)</a> For example, at the μ-opioid receptor (MOR), cellular processes related to analgesia, antinociception, and respiratory depression have been ascribed to differential signaling downstream of the receptor.<a onclick="showRef(event, 'ref20 ref22 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref20 ref22 ref26 ref27 ref28">(20,22,26−28)</a> Similarly, at the D<sub>2</sub> receptor, biased ligands with various downstream functional activities have been shown to modulate diverse effects on motor, cognitive and antipsychotic processes.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41">(29−41)</a> These findings provide a strong rationale for the discovery and characterization of functionally selective GPCR ligands with the potential to serve as valuable chemical tools with utility in dissecting the molecular pathways implicated in various pathophysiological processes.</div><div class="NLM_p">Recently, Gray et al. reported a novel non-catechol-containing D<sub>1</sub> dopamine receptor (D<sub>1</sub>R) agonist scaffold with a putative orthosteric binding mode that differs in several important aspects from the binding mechanisms of virtually all catechol-containing agonists at aminergic GPCRs, including dopamine.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> As a direct result of this unique binding mechanism, the few reported compounds that were tested potently induced downstream cyclic adenosine monophosphate (cAMP) production, indicating stimulatory G protein (G<sub>S</sub>) pathway activation, while failing to recruit β-arrestin2.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> A subsequent study by Davoren et al. detailing the discovery of this scaffold via a high throughput screening campaign confirmed its potent induction of cAMP production, in addition to providing a detailed biophysical characterization of the atropisomerism that exists because of the locked biaryl ring system.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Results from that study suggested that this property relates to the scaffold’s D<sub>1</sub>R high binding affinity and potent ability to stimulate cAMP production. Importantly, functional selectivity and β-arrestin2 recruitment activity were not considered in the study and all of the reported analogue ligands focused around altering the atropisomerism through modification of the locked biaryl ring system. In further studies, this non-catechol scaffold was also shown to be highly selective for D<sub>1</sub>R across a panel of class A aminergic GPCRs and neurotransmitter transporters.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> In an acute rodent model of Parkinson’s disease (PD), this agonist scaffold was shown to elicit a more sustained dopaminergic response in the animals in comparison with dopamine by virtue of its inability to recruit β-arrestin2, thereby resulting in diminished desensitization and tachyphylaxis after repeated dosing.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In separate studies of downstream signaling at D<sub>1</sub>R in PD animal models, it has been suggested that the G<sub>S</sub>-mediated pathway may be responsible for the eventual development of Levodopa-induced dyskinesias (LIDs), while β-arrestin2-mediated signaling pathways may attenuate LIDs while maintaining locomotor improvements.<a onclick="showRef(event, 'ref18 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref18 ref44 ref45">(18,44,45)</a> We believe that such findings concerning D<sub>1</sub>R G<sub>S</sub>- and β-arrestin2-mediated signaling pathways make this a particularly interesting system for studying GPCR functional selectivity. As such, we saw a ripe opportunity to more completely characterize the structure-functional selectivity relationships (SFSR) of this unique scaffold and assess ligand structural determinants of D<sub>1</sub>R functional selectivity.</div><div class="NLM_p last">Herein, we report our SFSR study results that demonstrate certain robust trends in this distinctive scaffold that help confer its exquisite G protein functional selectivity at D<sub>1</sub>R. We describe the design, synthesis, and in vitro pharmacological assessment of novel derivatives that explore four regions of the scaffold represented by compound <b>1</b> (PF-6142), which was reported as a potent, highly selective, full agonist of the G<sub>S</sub> signaling pathway at D<sub>1</sub>R with minimal β-arrestin2 recruitment.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> These comprehensive SFSR studies provide critical information regarding the steric, electronic, and spatial determinants of G protein bias on this scaffold as well as an important framework for designing, characterizing, and optimizing compounds for ideal levels of functional selectivity at various GPCR targets.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Traditional catechol D<sub>1</sub>R agonists are less CNS-penetrant and may be liable for metabolism to inactive metabolites, as observed in several well-known D1-selective catechol agonists.<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46−48)</a> Non-catechol agonists, on the other hand, are more attractive for further development to avoid such extensive metabolism.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Thus, we chose to study the SFSR of the scaffold represented by <b>1</b> (PF-6142), which features a neutral heterocyclic arylphenoxyaryl core with an interlocking biaryl ring system.</div><div class="NLM_p">To determine whether modifying various structural elements of <b>1</b> could result in biased compounds favoring either cAMP or β-arrestin2 signaling, we divided the arylphenoxyaryl scaffold into four primary regions: (1) a right-hand side (RHS) aromatic heterocycle with various ring substitutions, (2) a substituted middle phenyl ring, (3) a linking heteroatom, and (4) a left-hand side (LHS) pyridine-containing heterocycle (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). We then investigated each region by making analogues with structural, spatial, and electronic changes isolated to that region and comparing their resulting potencies, efficacies, and functional selectivity profiles.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Four regions of the arylphenoxyaryl scaffold of compound <b>1</b> that were investigated for SFSR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> SFSR of the RHS Heterocycle</h3><div class="NLM_p">To determine the effects of various heteroaromatic rings on the RHS, we designed and synthesized the compounds as presented in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. We sought to create a diverse array of analogues of <b>1</b> with variously substituted bicyclic rings, including imidazopyridines, imidazopyrazines and pyrimidines, and monocyclic rings, including pyridines, to evaluate the ligand determinants of potency, efficacy, and functional selectivity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SFSR of the RHS Moiety of Compound <b>1</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0008.gif" alt="" id="GRAPHIC-d7e573-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0009.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> and <i>E</i><sub>max</sub> values are the mean of at least three independent experiments performed in triplicate with standard error of the mean (SEM) values. N.A. no activity at maximum concentration tested (10<sup>–4</sup> M), N.D. not determined, N.C. not calculable.</p></div></div><div></div></div><div class="NLM_p">All of these compounds were prepared according to the synthetic strategy depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Briefly, the designed compounds were prepared by Suzuki coupling of a known intermediate <b>3</b><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> with known<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> or commercially available brominated heterocycles.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> These syntheses employed tetrakis(triphenylphosphine)palladium(0) as a catalyst and resulted in the corresponding desired product in moderate to good yields.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds for Exploring the RHS Heterocyclic Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 125 °C, 48 h; (b) Pd(dppf)Cl<sub>2</sub>, KOAc, B<sub>2</sub>(pin)<sub>2</sub>, dioxane, 80 °C, 18 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O<sub>2</sub>, 120 °C, 25 min.</p></p></figure><div class="NLM_p">The synthesized compounds were evaluated for potency and efficacy in stimulating D<sub>1</sub>R-mediated cAMP production as measured in a D<sub>1</sub>R-G<sub>S</sub> GloSensor assay, and in activating D<sub>1</sub>R-mediated β-arrestin2 recruitment via a bioluminescence resonance energy transfer (BRET) platform-based assay, with both assays using dopamine (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) and dihydrexidine (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) as positive full agonist controls.<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51−53)</a> Of note, the D<sub>1</sub>R-G<sub>S</sub> GloSensor assay involves a signal amplification mechanism, meaning that an <i>E</i><sub>MAX</sub> may be achieved at less than full receptor occupancy, while the β-arrestin2 recruitment assay measures an unamplified, stoichiometric protein–protein interaction, meaning that an <i>E</i><sub>MAX</sub> is achieved at full receptor occupancy. We began our SFSR study with compound <b>1</b>, which was recently disclosed following an extensive HTS and optimization campaign.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> We identified <b>1</b> to be a potent partial agonist in the GloSensor assay (EC<sub>50</sub> = 0.25 nM, <i>E</i><sub>MAX</sub> = 61%) with some partial agonist activity in the β-arrestin2 recruitment BRET assay (EC<sub>50</sub> = 110 nM, <i>E</i><sub>MAX</sub> = 48%) (bias factor for cAMP accumulation: 7.7) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Full concentration–response curves for representative compounds and control compounds measured using the Glosensor assay for G<sub>S</sub> pathway activation (G<sub>S</sub>-cAMP) and the BRET assay for β-arrestin2 (β-arr2) recruitment as a percentage of the maximal dopamine (DA) response. Dopamine (A) is a potent full agonist of both signaling pathways, while dihydrexidine (B), a known D<sub>1</sub>/D<sub>5</sub> selective full agonist, displays a slight β-arrestin bias (bias factor = 7.5). Compound <b>1</b> (C) is a potent G<sub>S</sub>-biased partial agonist in both pathways, while compound <b>7</b> (D) displays relatively enhanced G<sub>S</sub> bias and full agonism in the G<sub>S</sub> pathway with minimal β-arr2 recruitment. Compound <b>17</b> (E) is a potent full agonist of both signaling pathways and possesses a functional selectivity profile similar to dopamine. Compound <b>46</b> (F) also displays relatively enhanced G<sub>S</sub> bias, with potent full agonism in the G<sub>S</sub> pathway and minimal β-arr2 recruitment. Data points represent the mean concentrations ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Through manipulation of compound <b>1</b>’s RHS with diverse heterocyclic entities, we found a wide variation among compounds in terms of their activities and functional selectivity profiles. Compound <b>4</b> was designed to feature the same imidazopyrazinyl moiety as <b>1</b> but with a different methyl substitution position and a different point of attachment to the middle phenyl ring of the scaffold. Compound <b>4</b> possessed 23-fold reduced potency in the G<sub>S</sub>-cAMP accumulation assay (EC<sub>50</sub> = 5.8 nM; <i>E</i><sub>MAX</sub> = 63%) and 22-fold reduction in potency for β-arrestin2 recruitment (EC<sub>50</sub> = 2600 nM; <i>E</i><sub>MAX</sub> = 89%) (bias factor for cAMP accumulation: 4.1) compared to <b>1</b>. Compound <b>5</b> featured an unsubstituted imidazopyridinyl group for the RHS and was found to maintain a similarly potent partial agonism toward β-arrestin2 recruitment as <b>1</b> (EC<sub>50</sub> = 180 nM; <i>E</i><sub>MAX</sub> = 63%). While potency in the G<sub>S</sub>-cAMP accumulation assay was approximately 10-fold weaker than <b>1</b>, <b>5</b> was determined to be a full agonist of the G<sub>S</sub> pathway with an EC<sub>50</sub> and <i>E</i><sub>MAX</sub> similar to dopamine (EC<sub>50</sub> = 2.7 nM; <i>E</i><sub>MAX</sub> = 95%) (bias factor for cAMP accumulation: 1.3). The RHS of <b>6</b> featured a similar imidazopyridinyl moiety as <b>5</b>, with alterations to the position of attachment and a methyl ester substitution on the ring’s 8-position. These changes resulted in a dramatically reduced potency and efficacy toward G<sub>S</sub>-cAMP accumulation (EC<sub>50</sub> = 1000 nM; <i>E</i><sub>MAX</sub> = 44%) and no detectable β-arrestin2 recruitment activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SFSR of the Middle Phenyl Ring Moiety of Compound <b>1</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0010.gif" alt="" id="GRAPHIC-d7e889-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0011.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> and <i>E</i><sub>MAX</sub> values are the mean of at least three independent experiments performed in triplicate with standard error of the mean (SEM) values. N.A. no activity at maximum concentration tested (10<sup>–4</sup> M), N.D. not determined, N.C. not calculable.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SFSR of the Linking Heteroatom Moiety of Compound <b>1</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0012.gif" alt="" id="GRAPHIC-d7e917-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0013.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> and <i>E</i><sub>MAX</sub> values are the mean of at least three independent experiments performed in triplicate with standard error of the mean (SEM) values. N.A. no activity at maximum concentration tested (10<sup>–4</sup> M), N.D. not determined, N.C. not calculable.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SFSR of the LHS Moiety of Compound <b>1</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0014.gif" alt="" id="GRAPHIC-d7e945-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0015.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> and <i>E</i><sub>MAX</sub> values are the mean of at least three independent experiments performed in triplicate with standard error of the mean (SEM) values. N.A. no activity at maximum concentration tested (10<sup>–4</sup> M), N.D. not determined, N.C. not calculable.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SFSR of the Middle Phenyl Ring Moiety of Compound <b>5</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0016.gif" alt="" id="GRAPHIC-d7e974-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0017.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> and <i>E</i><sub>MAX</sub> values are the mean of at least three independent experiments performed in triplicate with standard error of the mean (SEM) values. N.A. no activity at maximum concentration tested (10<sup>–4</sup> M), N.D. not determined, N.C. not calculable.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. SFSR of the LHS Moiety of Compound <b>41</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0018.gif" alt="" id="GRAPHIC-d7e1002-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0019.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> and <i>E</i><sub>MAX</sub> values are the mean of at least three independent experiments performed in triplicate with standard error of the mean (SEM) values. N.A. no activity at maximum concentration tested (10<sup>–4</sup> M), N.D. not determined, N.C. not calculable.</p></div></div><div></div></div><div class="NLM_p last">Switching the bicyclic imidazopyrazinyl moiety of <b>1</b> to a monocyclic aminopyrazinyl group (<b>7</b>) increased the efficacy of the ligand in G<sub>S</sub>-cAMP accumulation, however, with sacrificed potency (EC<sub>50</sub> = 22 nM; <i>E</i><sub>MAX</sub> = 91%). This modification also diminished the β-arrestin2 recruitment activity, resulting in a compound that is almost completely biased compound for G<sub>S</sub> compared to <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). Compared to <b>7</b>, a disubstituted pyrimidinyl RHS (<b>8</b>) and a substituted pyridazinyl RHS (<b>9</b>) showed similar and improved potency (<b>8</b>: EC<sub>50</sub> = 12 nM; <b>9</b>: EC<sub>50</sub> = 1 nM), respectively, but decreased efficacy in the G<sub>S</sub>-cAMP accumulation assay (<b>8</b>: E<sub>MAX</sub> = 67%; <b>9</b>: <i>E</i><sub>MAX</sub> = 61%). Similar to <b>7</b>, <b>8</b> and <b>9</b> were not active in the β-arrestin2 recruitment assay. Compound <b>10</b> is a close analogue of <b>7</b>, featuring a pyridinyl ring rather than a pyrazinyl ring. Compound <b>10</b> possessed similar potency in the G<sub>S</sub> pathway, but as a partial agonist compared to <b>7</b> (EC<sub>50</sub> = 13 nM; <i>E</i><sub>MAX</sub> = 67%). Notably, <b>10</b> was more active than <b>7</b> in the β-arrestin2 recruitment assay; however, it was still only a weak recruiter of β-arrestin2 overall (EC<sub>50</sub> = 1100 nM; <i>E</i><sub>MAX</sub> = 64%) (bias factor for cAMP accumulation: 1.2). Compounds <b>11</b>, <b>12</b>, and <b>13</b> featured different substituted pyridinyl RHS moieties and displayed different degrees of potency (<b>11</b>: EC<sub>50</sub> = 77 nM; <b>12</b>: EC<sub>50</sub> = 1300 nM; <b>13</b>: EC<sub>50</sub> > 10 000 nM) as partial agonists in the G<sub>S</sub>-cAMP accumulation assay, while all being inactive in the β-arrestin2 recruitment assay. This suggests that the positions of the nitrogen in the pyridine and the ring substitutions can have a particularly important impact on both cAMP production and β-arrestin2 recruitment activity.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> SFSR of the Middle Phenyl Ring</h3><div class="NLM_p">To determine the effects of the middle phenyl ring on functional selectivity, we designed and synthesized a set of compounds with differentially substituted phenyl rings using the synthetic route outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Various commercially available bromo phenols were substituted onto the same pyridofuran LHS group of <b>1</b>, using previously described methods.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The bromo group of the resulting intermediates was subsequently converted to a boronic ester before Suzuki coupling with the bromo imidazopyrazine RHS of <b>1</b> to afford the corresponding desired products in moderate to good yields.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds for Exploring the Middle Phenyl Ring Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 125 °C, 48 h; (b) Pd(dppf)Cl<sub>2</sub>, KOAc, B<sub>2</sub>(pin)<sub>2</sub>, dioxane, 80 °C, 18 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O<sub>2</sub>, 120 °C, 25 min.</p></p></figure><div class="NLM_p">A few interesting SFSR trends emerged from this series of analogues, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. First, changing the position of the methyl group from ortho to meta relative to the RHS, as in <b>14</b>, dramatically reduced potency in the G<sub>S</sub>-cAMP accumulation assay (EC<sub>50</sub> = 610 nM; <i>E</i><sub>MAX</sub> = 62%) and completely eliminated β-arrestin2 recruitment activity. A dimethyl ring substitution at both the ortho and meta positions were introduced in compound <b>15</b> and resulted in an intermediate activity profile. In the G<sub>S</sub>-cAMP accumulation assay, <b>15</b> was found to be more potent than <b>14</b>, but less potent than <b>1</b> (EC<sub>50</sub> = 55 nM; <i>E</i><sub>MAX</sub> = 54%). Compound <b>15</b> was also inactive in β-arrestin2 recruitment, similar to <b>14</b>. Replacing the methyl group of <b>1</b> with an amino group resulted in compound <b>16</b>, which was characterized as a potent, full agonist of the G<sub>S</sub> signaling pathway (EC<sub>50</sub> = 1.29 nM; <i>E</i><sub>MAX</sub> = 104%), while also displaying good potency and efficacy in recruiting β-arrestin2 (EC<sub>50</sub> = 209 nM; <i>E</i><sub>MAX</sub> = 81%) (bias factor for cAMP accumulation: 2.7). In compound <b>17</b>, this substitution instead featured a trifluoromethyl group. This single change resulted in potent, full agonism of both the G protein (EC<sub>50</sub> = 1.73 nM; <i>E</i><sub>MAX</sub> = 94%) and β-arrestin2 (EC<sub>50</sub> = 230 nM; <i>E</i><sub>MAX</sub> = 103%) assays (bias factor for cAMP accumulation: 1.6), comparable to dopamine (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E). The enhanced efficacy of <b>16</b> and <b>17</b> in stimulating the G protein pathway may in part be due to the amino and trifluoromethyl groups being slightly bulkier and more electronegative, possibly leading to an increased energy barrier preventing torsion in this biaryl ring system.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> When this trifluoromethyl substitution was moved over one position to be meta to the RHS (compound <b>18</b>), the resulting ligand was completely devoid of activity in both the G protein and β-arrestin2 recruitment assays. Interestingly, however, difluoro substitutions at both of the positions meta to the RHS, as in compound <b>19</b>, eliminated β-arrestin2 recruitment activity but preserved partial agonist activity in promoting G<sub>S</sub>-cAMP accumulation (EC<sub>50</sub> = 143 nM; <i>E</i><sub>MAX</sub> = 66%).</div><div class="NLM_p last">The above findings from our SFSR studies of the middle phenyl ring suggest that the substituent on the phenyl ring positioned ortho, but not meta, to the RHS is important for the observed potency and efficacy in the G<sub>S</sub> signaling pathway.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> SFSR of the Linking Heteroatom</h3><div class="NLM_p">A series of ligands were generated to explore the role of the linking heteroatom in D<sub>1</sub>R activity and functional selectivity. This series was synthesized using the protocol outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> and essentially involved replacing the linking oxygen atom with a variety of secondary and tertiary amine analogues. The commercially available bromo aniline was substituted onto the same pyridofuran group, using similar conditions above. The bromo group of the resulting intermediate was then replaced with a boronic ester before coupling with the same bromo imidazopyrazine RHS to afford compound <b>20</b>, which was then alkylated to yield compounds <b>21–25</b> in moderate to good yields.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds for Exploring the Linking Heteroatom Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 125 °C, 48 h; (b) Pd(dppf)Cl<sub>2</sub>, KOAc, B<sub>2</sub>(pin)<sub>2</sub>, dioxane, 80 °C, 18 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O<sub>2</sub>, 120 °C, 25 min; (d) NaH, DMF, 1 h, 80 °C, then 25–0 °C, R-I, 2 h.</p></p></figure><div class="NLM_p">Compound <b>20</b>, which featured an unsubstituted secondary amino group linking the middle phenyl ring and LHS moieties, was more G protein-biased than <b>1</b> as it became only minimally active in the β-arrestin2 recruitment assay but displayed moderately potent, full agonism in the G<sub>S</sub>-cAMP accumulation assay (EC<sub>50</sub> = 16 nM; <i>E</i><sub>MAX</sub> = 98%). We next sought to explore the immediate space around this amino group. We prepared several analogues (<b>21–25</b>) featuring tertiary amines alkylated with side groups of varying size as the linking heteroatom moiety. The addition of a methyl group to the secondary amine to produce <b>21</b> reduced the compound’s potency and efficacy in activating the G<sub>S</sub> pathway (EC<sub>50</sub> = 88 nM; <i>E</i><sub>MAX</sub> = 79%). Methylating this amine did not alter potency for β-arrestin2 as both <b>20</b> and <b>21</b> were completely inactive in the β-arrestin2 recruitment assay. Increasing the size of the alkyl group revealed a size tolerance limit to retain potency toward G<sub>S</sub>-cAMP accumulation. An ethyl group at this position (<b>22</b>) possessed an intermediate potency in the G<sub>S</sub>-cAMP accumulation assay (EC<sub>50</sub> = 36 nM; <i>E</i><sub>MAX</sub> = 80%). Any larger alkyl group at this position, such as isopropyl (<b>23</b>) (EC<sub>50</sub> = 100 nM; <i>E</i><sub>MAX</sub> = 67%), methylcyclopropyl (<b>24</b>) (EC<sub>50</sub> = 320 nM; <i>E</i><sub>MAX</sub> = 78%), or cyclopentyl (<b>25</b>) (EC<sub>50</sub> = 1100 nM; <i>E</i><sub>MAX</sub> = 68%), significantly reduced potency and moderately reduced efficacy toward G<sub>S</sub> activity. Compared to the ether linker in <b>1</b>, the amino group linkers in <b>20–25</b> dramatically reduced potency toward stimulating β-arrestin2 recruitment, rendering the compounds inactive for β-arrestin2 recruitment.</div><div class="NLM_p last">Our SFSR studies indicate that replacing the linking oxygen with unsubstituted and various substituted amino groups is not well-tolerated, as these changes reduced this scaffold’s potency toward G protein activation while eliminating ability to recruit β-arrestin2 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This suggests that perhaps this region is spatially confined within the D<sub>1</sub>R binding pocket, or that an electronic interaction with the heteroatom at this position is important for the binding modality of this scaffold, with an oxygen atom being the preferred entity over both a secondary and tertiary amine.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> SFSR of the LHS Heterocycle</h3><div class="NLM_p">A fourth set of compounds was synthesized to explore the SFSR of the LHS portion of the non-catechol scaffold (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). This compound set preserved the RHS, middle phenyl ring, and linking heteroatom moieties from compound <b>1</b>, while installing diverse heterocyclic entities on the LHS of the scaffold. These compounds were all synthesized from commercially available starting materials according to the synthetic routes outlined in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Various commercially available chlorinated heterocycles were reacted with 4-bromo-3-methylphenol, using previously described methods.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The bromo group of the resulting intermediates was converted to a boronic ester before Suzuki coupling with the bromo imidazopyrazine RHS of <b>1</b> to afford the desired products in moderate to good yields.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds for Exploring the LHS Heterocyclic Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 125 °C, 48 h; (b) Pd(dppf)Cl<sub>2</sub>, KOAc, B<sub>2</sub>(pin)<sub>2</sub>, dioxane, 80 °C, 18 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O<sub>2</sub>, 120 °C 25 min.</p></p></figure><div class="NLM_p last">Cyclopropyl group substitution at the 3-position on the furopyridinyl LHS (<b>26</b>) dramatically reduced potency for G<sub>S</sub>-cAMP production (EC<sub>50</sub> = 62 nM; <i>E</i><sub>MAX</sub> = 67%) and diminished β-arrestin2 recruitment activity as well. The roles of the LHS pyridine nitrogen was examined with benzofuro compound <b>27</b>. Omission of the nitrogen in <b>27</b> resulted in a reduction in potency for G<sub>S</sub>-cAMP accumulation (EC<sub>50</sub> = 79 nM; <i>E</i><sub>MAX</sub> = 69%) and inactivity for β-arrestin2 recruitment. Switching the furopyridinyl group of <b>1</b> to an isoquinolinyl moiety of <b>28</b> was also inactive for β-arrestin2 recruitment but retained more potency for G<sub>S</sub>-cAMP accumulation assay (EC<sub>50</sub> = 14 nM; <i>E</i><sub>MAX</sub> = 82%). Heteroatom placement within the bicyclic aromatic LHS ring was explored with the next set of compounds. A thienopyridinyl moiety was introduced in <b>29</b>, which was found to be a potent full agonist of the G<sub>S</sub> pathway (EC<sub>50</sub> = 0.23 nM; <i>E</i><sub>MAX</sub> = 100%) and a potent partial agonist for β-arrestin2 recruitment (EC<sub>50</sub> = 22 nM; <i>E</i><sub>MAX</sub> = 63%) (bias factor for cAMP accumulation: 1.9). When this entity was replaced with a pyrrolopyrazinyl moiety (<b>30</b>), the activity in the G<sub>S</sub>-cAMP accumulation assay was retained (EC<sub>50</sub> = 0.87 nM; <i>E</i><sub>MAX</sub> = 83%), while β-arrestin2 recruitment activity dropped (EC<sub>50</sub> = 690 nM; <i>E</i><sub>MAX</sub> = 59%) (bias factor for cAMP accumulation: 15). However, the addition of a third nitrogen to create an imidazopyrazinyl moiety in this position (<b>31</b>) was not well-tolerated as potency for the G<sub>S</sub> pathway was dramatically reduced (EC<sub>50</sub> = 260 nM; <i>E</i><sub>MAX</sub> = 85%) and β-arrestin2 recruitment was undetectable. Rearrangement of the three nitrogen atoms in this ring to generate a pyrazolopyridinyl on the LHS (<b>32</b>) almost fully restored G<sub>S</sub>-cAMP accumulation activity (EC<sub>50</sub> = 1.8 nM; <i>E</i><sub>MAX</sub> = 104%). β-arrestin2 recruitment activity, however, was not recovered, making <b>32</b> a highly G<sub>S</sub>-biased D<sub>1</sub>R agonist. Our last set of compounds in this series sought to briefly explore a few pyridinyl groups as the LHS. The unsubstituted pyridinyl group led to a moderately potent ligand <b>33</b> with near full agonism in the G<sub>S</sub>-cAMP accumulation assay (EC<sub>50</sub> = 120 nM; <i>E</i><sub>MAX</sub> = 83%) and very weak activity in the β-arrestin2 recruitment assay. The addition of a bromine substituent at the 3-position (<b>34</b>) rendered the scaffold completely inactive in both pathways. When a disubstituted 3-methyl-4-hydroxy analogue (<b>35</b>) that mimicked an opened ring version of <b>1</b> was examined, only weak partial agonist activity was observed in the G<sub>S</sub>-cAMP accumulation assay (EC<sub>50</sub> = 160 nM; <i>E</i><sub>MAX</sub> = 34%). Finally, a similar effect on G<sub>S</sub>-cAMP accumulation activity (EC<sub>50</sub> = 640 nM; <i>E</i><sub>MAX</sub> = 26%) was observed with a piperidinyl substituted pyridinyl analogue (<b>36</b>). All of these pyridinyl analogues were also inactive in β-arrestin2 recruitment assays.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Hybrid SFSR Exploration</h3><div class="NLM_p">During our SFSR campaign of the RHS portion of this non-catechol scaffold, we discovered compound <b>5</b>, a close analogue of <b>1</b> that featured an unsubstituted imidazopyridine moiety and displayed enhanced efficacy and comparable potency in both downstream pathways relative to its parent compound. Given these robust activities, we wanted to explore whether our initial SFSR trends with <b>1</b> were consistent with <b>5</b> and whether this scaffold could also be altered to display considerably different functional selectivity profiles (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).</div><div class="NLM_p">First, a set of analogues of <b>5</b> were generated by modifying the methylation pattern on the middle phenyl ring of the scaffold using the same synthetic route outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Various commercially available bromo phenols were substituted onto the same pyridofuran LHS group of <b>5</b>, using previously described methods.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The bromo group of the resulting intermediates was subsequently converted to a boronic ester before Suzuki coupling with the bromo imidazopyridine RHS of <b>5</b> to afford the desired products in moderate to good yields.</div><div class="NLM_p">Similar to before, migration of the methyl substituent on the middle phenyl ring to the meta position relative to the RHS (<b>37</b>) severely dampened G<sub>S</sub> activity (EC<sub>50</sub> = 530 nM; <i>E</i><sub>MAX</sub> = 29%) and eliminated β-arrestin2 recruitment activity. A more mild reduction in G protein activity (EC<sub>50</sub> = 110 nM; <i>E</i><sub>MAX</sub> = 30%) was observed for the substituted dimethyl analogue, <b>38</b>, while β-arrestin2 recruitment was eliminated. Interestingly, this scaffold was completely inactive when both methyl groups were moved ortho to the RHS, as in <b>39</b>.</div><div class="NLM_p">When the methyl substituent on <b>1</b> was converted to an amino group, the resulting compound <b>16</b> possessed high potency and efficacy in both signaling pathways; however, when this same conversion was implemented starting with <b>5</b>, the resulting analogue (<b>40</b>) was a G<sub>S</sub>-biased compound with full agonistic activity toward G<sub>S</sub>-cAMP accumulation (EC<sub>50</sub> = 10 nM; <i>E</i><sub>MAX</sub> = 91%) and relatively weak β-arrestin2 recruitment activity (EC<sub>50</sub> = 790 nM; <i>E</i><sub>MAX</sub> = 54%) (bias factor for cAMP accumulation: 1.7). Conversely, converting the methyl substituent on the middle phenyl ring of <b>5</b> into a trifluoromethyl group (compound <b>41</b>) closely recapitulated the functional selectivity profile of the analogue <b>17</b> in both pathways (bias factor for cAMP accumulation: 1.5). When this trifluoromethyl substitution was moved meta to the RHS (compound <b>42</b>), the resulting ligand was inactive in both G protein and β-arrestin2 recruitment assays. Difluoro substitutions at both of the positions meta to the RHS (compound <b>43</b>) showed moderate partial agonist activity in the G<sub>S</sub>-cAMP accumulation assay with an EC<sub>50</sub> = 190 nM and <i>E</i><sub>MAX</sub> = 57%, and minimal β-arrestin2 recruitment.</div><div class="NLM_p">Because the goal of this SFSR study was to explore the structural determinants of the non-catechol scaffold’s potency and efficacy in both the G<sub>S</sub> and β-arrestin2 pathways at D<sub>1</sub>R, we wanted to use one of the more balanced ligands we developed with potent full agonism in both pathways to further explore this topic. We decided to use <b>41</b> for this purpose because it featured slight structural modifications on the RHS and middle phenyl moieties that led to potent full agonism of both the G<sub>S</sub> and β-arrestin2 pathways. The compound set derived from <b>41</b> preserved the RHS, middle phenyl ring, and linking heteroatom moieties from compound <b>41</b>, while making diverse modifications to the heterocyclic entities on the LHS portion of the scaffold (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Compounds in this set were all synthesized from commercially available starting materials using the synthetic routes similar to the ones outlined in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Various commercially available chlorinated heterocycles were reacted with 4-bromo-3-trifluoromethylphenol, using previously described methods.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The bromo group of the resulting intermediate was converted to a boronic ester before Suzuki coupling with the bromo imidazopyridine RHS of <b>41</b> to afford the desired products in moderate to good yields.</div><div class="NLM_p">Substitution on the 3-position of the LHS pyridofuran moiety with a cyclopropyl group (<b>44</b>) abolished β-arrestin2 recruitment and dramatically hindered G<sub>S</sub> pathway activation (EC<sub>50</sub> = 770 nM; <i>E</i><sub>MAX</sub> = 83%), suggesting spatial constraints in this binding region. G protein activity was only mildly reduced (EC<sub>50</sub> = 67 nM; <i>E</i><sub>MAX</sub> = 61%) and β-arrestin2 recruitment still eliminated for compound <b>45</b> in which the furan moiety was replaced with a phenyl group on the LHS bicycle, suggesting that spatial or electronic properties on this portion of the LHS may be important for binding.</div><div class="NLM_p">When heteroatom substitutions and rearrangements were made within the LHS core of <b>41</b>, the scaffold tended to become more G<sub>S</sub>-biased. When a thienopyridine analogue was installed on the LHS (<b>46</b>), G<sub>S</sub>-cAMP accumulation activity showed mild attenuation (EC<sub>50</sub> = 2.2 nM; <i>E</i><sub>MAX</sub> = 93%), while β-arrestin2 recruitment activity was greatly weakened (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>F). A similar profile was also observed for the pyrrolopyrazine-containing analogue <b>47</b>. Compound <b>47</b> retained full agonism toward G<sub>S</sub>-cAMP accumulation with a slight reduction in potency (EC<sub>50</sub> = 7.8 nM; <i>E</i><sub>MAX</sub> = 78%), while β-arrestin2 recruitment activity was completely abrogated. Only moderate partial agonist activity was observed in the G<sub>S</sub>-cAMP accumulation assay for <b>48</b>, which featured an imidazopyrazine moiety on the LHS (EC<sub>50</sub> = 180 nM; <i>E</i><sub>MAX</sub> = 54%). The pyridine-containing analogue <b>49</b> displayed modest partial agonist activity in the G<sub>S</sub> pathway (EC<sub>50</sub> = 270 nM; <i>E</i><sub>MAX</sub> = 65%) and no activity in the β-arrestin2 pathway. Finally, the substituted pyridine analogue <b>50</b> was determined to be inactive in both the G<sub>S</sub> and β-arrestin2 pathways. Together, these findings suggest that the electronic and spatial properties of <b>41</b>’s LHS moiety are critical for maintaining its potent β-arrestin2 recruitment activity, as many rearrangements and substitutions disproportionately impacted β-arrestin2 recruitment over G<sub>S</sub>-cAMP accumulation activity.</div><div class="NLM_p last">In light of the fact that our SFSR campaign resulted in numerous compounds with varying functional selectivity profiles, an open question remains as to what degree of bias measured in vitro is sufficient to observe significant change in the biological activity of this ligand class at D<sub>1</sub>R in vivo. An excellent example of this is G protein-biased agonism at the MOR, which has shown the potential for improving therapeutic on-target effects for anti-nociception with reduced constipation and respiratory depression effects.<a onclick="showRef(event, 'ref20 ref22 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref20 ref22 ref26 ref27 ref28">(20,22,26−28)</a> Among the most clinically advanced MOR G protein-biased agonists includes TRV130, a potent G protein-biased ligand that recently completed phase 3 clinical studies for the treatment of acute pain. In in vitro studies, TRV130 demonstrated nanomolar activation of G protein signaling (pEC<sub>50</sub> = 8.1; <i>E</i><sub>MAX</sub> = 84%) and diminished activity in recruiting β-arrestin (pEC<sub>50</sub> = 7.3; <i>E</i><sub>MAX</sub> = 15%).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Several other examples of MOR G protein-biased agonists show a correlation between their in vitro profile and reduced side effects.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> While the novel biological effects of TRV130 and other MOR G protein-biased agonists are attributed to their G protein bias at MOR, it is unclear about the degree of bias threshold necessary to produce these significant effects in vivo, especially for other GPCRs. Future studies using sets of tool compounds with a variety of bias profiles, both toward either G protein or β-arrestin, could help provide further insight into the degree of in vitro bias necessary for therapeutic effects.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Binding Affinity and Selectivity</h3><div class="NLM_p">A selection of analogue compounds with interesting SFSR were selected for assessing their selectivity across a broad panel of over 30 class A aminergic GPCRs, ion channels, and neurotransmitter transporters using a validated radioligand binding affinity assay.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> We determined the selectivity and binding affinity of 4 ligands with diverse functional selectivity profiles generated through our SFSR studies on this non-catechol scaffold. The results, detailed in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>, demonstrate the remarkable selectivity of this scaffold for the D<sub>1</sub>-like class of dopamine receptors, D<sub>1</sub>R and D<sub>5</sub>R. This trend was evident across all the ligands tested, regardless of whether they only displayed G<sub>S</sub> bias (<b>1</b>, <b>46</b>) or potent full agonism in both pathways (<b>17</b>, <b>41</b>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Radioligand Binding Affinities of Compounds <b>1</b>, <b>17</b>, <b>41</b>, and <b>46</b> at Select GPCRs, Ion Channels, and Transporters<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">binding affinity <i>K</i><sub><i>i</i></sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">receptor</th><th class="colsep0 rowsep0" align="center">compound <b>1</b></th><th class="colsep0 rowsep0" align="center">compound <b>17</b></th><th class="colsep0 rowsep0" align="center">compound <b>41</b></th><th class="colsep0 rowsep0" align="center">compound <b>46</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>1</sub></td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8300</td><td class="colsep0 rowsep0" align="left">9600</td><td class="colsep0 rowsep0" align="left">7600</td><td class="colsep0 rowsep0" align="left">8700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>3</sub></td><td class="colsep0 rowsep0" align="left">7900</td><td class="colsep0 rowsep0" align="left">8100</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">6200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>4</sub></td><td class="colsep0 rowsep0" align="left">4500</td><td class="colsep0 rowsep0" align="left">6900</td><td class="colsep0 rowsep0" align="left">6900</td><td class="colsep0 rowsep0" align="left">4900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>5</sub></td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">1200</td><td class="colsep0 rowsep0" align="left">6900</td><td class="colsep0 rowsep0" align="left">2500</td><td class="colsep0 rowsep0" align="left">3700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1B</sub></td><td class="colsep0 rowsep0" align="left">9300</td><td class="colsep0 rowsep0" align="left">8800</td><td class="colsep0 rowsep0" align="left">9300</td><td class="colsep0 rowsep0" align="left">9900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1D</sub></td><td class="colsep0 rowsep0" align="left">9300</td><td class="colsep0 rowsep0" align="left">8100</td><td class="colsep0 rowsep0" align="left">8900</td><td class="colsep0 rowsep0" align="left">4100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1E</sub></td><td class="colsep0 rowsep0" align="left">9800</td><td class="colsep0 rowsep0" align="left">8900</td><td class="colsep0 rowsep0" align="left">9900</td><td class="colsep0 rowsep0" align="left">7800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">4900</td><td class="colsep0 rowsep0" align="left">8700</td><td class="colsep0 rowsep0" align="left">4300</td><td class="colsep0 rowsep0" align="left">3400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2B</sub></td><td class="colsep0 rowsep0" align="left">4100</td><td class="colsep0 rowsep0" align="left">6700</td><td class="colsep0 rowsep0" align="left">830</td><td class="colsep0 rowsep0" align="left">1100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>3</sub></td><td class="colsep0 rowsep0" align="left">7900</td><td class="colsep0 rowsep0" align="left">9100</td><td class="colsep0 rowsep0" align="left">9300</td><td class="colsep0 rowsep0" align="left">7600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>4</sub></td><td class="colsep0 rowsep0" align="left">9100</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">3700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>5A</sub></td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">9500</td><td class="colsep0 rowsep0" align="left">7400</td><td class="colsep0 rowsep0" align="left">6200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>6</sub></td><td class="colsep0 rowsep0" align="left">8100</td><td class="colsep0 rowsep0" align="left">7900</td><td class="colsep0 rowsep0" align="left">6900</td><td class="colsep0 rowsep0" align="left">7200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>7A</sub></td><td class="colsep0 rowsep0" align="left">7800</td><td class="colsep0 rowsep0" align="left">8100</td><td class="colsep0 rowsep0" align="left">4100</td><td class="colsep0 rowsep0" align="left">3800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">alpha<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">3400</td><td class="colsep0 rowsep0" align="left">8700</td><td class="colsep0 rowsep0" align="left">7000</td><td class="colsep0 rowsep0" align="left">2900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">alpha<sub>1B</sub></td><td class="colsep0 rowsep0" align="left">9200</td><td class="colsep0 rowsep0" align="left">8800</td><td class="colsep0 rowsep0" align="left">7400</td><td class="colsep0 rowsep0" align="left">4800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">alpha<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">3400</td><td class="colsep0 rowsep0" align="left">6800</td><td class="colsep0 rowsep0" align="left">5100</td><td class="colsep0 rowsep0" align="left">2600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">beta<sub>1</sub></td><td class="colsep0 rowsep0" align="left">7600</td><td class="colsep0 rowsep0" align="left">9600</td><td class="colsep0 rowsep0" align="left">8500</td><td class="colsep0 rowsep0" align="left">8500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">beta<sub>2</sub></td><td class="colsep0 rowsep0" align="left">9300</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">8600</td><td class="colsep0 rowsep0" align="left">5900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MOR</td><td class="colsep0 rowsep0" align="left">8200</td><td class="colsep0 rowsep0" align="left">9400</td><td class="colsep0 rowsep0" align="left">4400</td><td class="colsep0 rowsep0" align="left">2100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KOR</td><td class="colsep0 rowsep0" align="left">3100</td><td class="colsep0 rowsep0" align="left">7200</td><td class="colsep0 rowsep0" align="left">1500</td><td class="colsep0 rowsep0" align="left">3200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M<sub>1</sub></td><td class="colsep0 rowsep0" align="left">8800</td><td class="colsep0 rowsep0" align="left">8500</td><td class="colsep0 rowsep0" align="left">9000</td><td class="colsep0 rowsep0" align="left">6600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7700</td><td class="colsep0 rowsep0" align="left">7300</td><td class="colsep0 rowsep0" align="left">8100</td><td class="colsep0 rowsep0" align="left">1700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">9200</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">2700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sigma<sub>1</sub></td><td class="colsep0 rowsep0" align="left">8200</td><td class="colsep0 rowsep0" align="left">8000</td><td class="colsep0 rowsep0" align="left">6900</td><td class="colsep0 rowsep0" align="left">8800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H<sub>1</sub></td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">9800</td><td class="colsep0 rowsep0" align="left">2600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8000</td><td class="colsep0 rowsep0" align="left">8200</td><td class="colsep0 rowsep0" align="left">6700</td><td class="colsep0 rowsep0" align="left">2500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DAT</td><td class="colsep0 rowsep0" align="left">8300</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">9100</td><td class="colsep0 rowsep0" align="left">4500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SERT</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">9700</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last"><i>K</i><sub><i>i</i></sub> values represent the average of at least three triplicate experiments. SEM <±20%.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Mouse Pharmacokinetic Studies and Blood–Brain Barrier Penetrance</h3><div class="NLM_p">Given the favorable in vivo profile of our starting compound <b>1</b>, as reported by Gray et al.,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> we sought to examine whether or not the modifications we introduced into this scaffold during our SFSR campaign altered in vivo pharmacokinetic properties and blood–brain barrier (BBB) penetrance of this scaffold. We selected compound <b>40</b> for these studies because it represented a structure to which sufficient chemical modifications were made resulting in further diminished β-arrestin2 recruitment potency compared to <b>1</b> with potency in the G<sub>S</sub> pathway mostly retained. Compound <b>40</b> was administered to mice at 50 mg/kg via intraperitoneal injection and drug concentrations in the plasma and brain were assessed at four time points. These results, obtained in biological triplicates, clearly indicate that this scaffold retains high exposure in plasma and excellent BBB penetrance. At this dose, compound <b>40</b> reached a peak concentration of approximately 100 μM in the brain and plasma. The exposure levels of this drug were found to persist in both the plasma and the brain even up to 4 h after injection (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Further, even with a high plasma and brain exposure of <b>40</b>, it was well tolerated and no clinical signs were observed in the tested animals. During the course of this study, the mean brain-to-plasma ratio typically ranged around 1.2–1.6, indicating excellent BBB penetration. Taken together, these data suggest that <b>40</b> and other ligands in this series may serve as valuable chemical tools for in vivo investigations of functional selectivity and G<sub>S</sub> protein signaling at D<sub>1</sub>R.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mouse pharmacokinetic profile of compound <b>40</b> in the plasma and brain. Compound <b>40</b> was injected into the peritoneum at 50 mg/kg, and concentrations were quantitatively assessed at 0.5, 1, 2, and 4 h after administration. Experiments were carried out in biological triplicates. Data points represent the mean concentrations ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we conducted a comprehensive SFSR campaign on four regions of compound <b>1</b>, a non-catechol D<sub>1</sub>R agonist scaffold. By design, synthesis, and biological characterization of approximately 50 novel derivatives, we found a number of interesting SFSR trends for this scaffold. Our SFSR studies culminated in the discovery of compounds with high degrees of structural similarity but differences in their abilities to activate the G protein and β-arrestin2 signaling pathways. Some compounds, such as <b>16</b>, <b>17</b>, and <b>41</b>, are potent full agonists of β-arrestin2 recruitment, which represents a striking result for this initially G<sub>S</sub>-biased scaffold. Conversely, other compounds, such as <b>7</b>, <b>32</b>, <b>46</b>, and <b>47</b>, displayed enhanced G<sub>S</sub> bias profiles compared to <b>1</b>. Several of these compounds exhibited remarkable selectivity for the D<sub>1</sub>-like class of dopamine receptors, D<sub>1</sub>R and D<sub>5</sub>R, over a broad panel of aminergic GPCRs, ion channels, and transporters. Further characterization revealed that, despite making certain structural alterations to the scaffold, this scaffold can still possess high exposure levels in the plasma and excellent BBB permeability, as demonstrated with <b>40</b>. These ligands could therefore be potential chemical tools for dissecting the downstream effects of biased signaling at D<sub>1</sub>R. Furthermore, the results described here are valuable for the research community to develop the next generation of D<sub>1</sub>R biased ligands, and biased ligands for other GPCRs.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36568" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36568" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Chemistry General Procedures</h3><div class="NLM_p">All reagents were commercial grade and were used without additional purification. All dry solvents were purchased from Sigma-Aldrich and were assured to be of anhydrous quality. A Discover SP microwave system with an Explorer 12 Hybrid Autosampler by CEM (Buckingham, UK) was used for procedures that required microwave heating. All microwave reactions were carried out at 125 °C for 25 min using 250 W of power and a pressure less than 300 psi. EMD Millipore 210–270 μm 60-F254 silica gel plates were used for analytical thin-layer chromatography, with visualization using 254 μm UV light. A Teledyne (Thousand Oaks, CA) ISCO CombiFlash Rf+ system was utilized for flash column chromatography along with normal phase RediSep Rf silica columns. This system was equipped with a UV detector and a fraction collector apparatus. All final compounds were purified using a preparative high-performance liquid chromatography (HPLC) system. Preparative HPLC was performed using an Agilent Prep 1200 series with a Phenomenex Luna 750 mm × 30 mm, 5 μm, C<sub>18</sub> column. Samples were injected into the column at room temperature. The solvent flow rate was set to 40 mL/min, and the UV detector was set to 254 nm. A linear gradient was implemented with 10% [or 50% MeOH (A) in H<sub>2</sub>0] (with 0.1% TFA) (B) to 100% MeOH (A). The purities of all target compounds were established using HPLC. All biologically evaluated compounds had >95% purity after purification via the HPLC methods described below. All compounds were characterized using a liquid chromatography–mass spectrometer (LC–MS). Key compounds were further examined by liquid chromatography–high resolution mass spectrometry (LC–HRMS) as follows. HPLC spectra were obtained for all compounds using an Agilent 1200 series system with a DAD detector. A 2.1 mm × 150 mm Zorbax 300SB-C<sub>18</sub> 5 μm column was used for chromatography. Solvent A included water containing 0.1% formic acid and solvent B included acetonitrile containing 0.1% formic acid. The flow rate was set at 0.4 mL/min and the gradient program was as follows: 1% B (0–1 min), 1–99% B (1–4 min), and 99% B (4–8 min). These spectra were used for the HPLC retention times reported below for each compound. HRMS data was obtained for each compound. Samples were ionized by electrospray ionization (ESI) in positive mode. A G1969A high-resolution API-TOF mass spectrometer by Agilent Technologies, attached to the 1200 HPLC system described above, was used to conduct the HRMS analysis reported below for each compound. Each compound was also characterized using nuclear magnetic resonance (NMR) spectroscopy. A Bruker (Billerica, MA) DRX-600 spectrometer was used to obtain NMR spectra, with shifts given in parts per million (ppm, δ) relative to residual solvent peaks (CD<sub>3</sub>OD, <sup>1</sup>H: 3.31 ppm; CDCl<sub>3</sub>, <sup>1</sup>H: 7.26 ppm). Data from <sup>1</sup>H NMR spectra are provided in the form of: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, m = multiplet, app = apparent), coupling constant, and integration.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-(3-Methyl-4-(2-methylimidazo[1,2-<i>a</i>]pyrazin-3-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>4</b>)</h4><div class="NLM_p last">To an oven dried microwavable tube were added a stir bar, tetrakis(triphenylphosphine)palladium(0) (30 mg, 0.026 mmol), potassium carbonate (36 mg, 0.26 mmol), 3-bromo-2-methylimidazo[1,2-<i>a</i>]pyrazine (30 mg, 0.14 mmol), and intermediate 4-(3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>3</b>) (46 mg, 0.14 mmol) in dioxane (1 mL), and water (0.2 mL). The mixture was subjected to microwave heating for 25 min as described in the <a class="ref internalNav" href="#sec4_1" aria-label="General Chemistry Procedures">General Chemistry Procedures</a> section. The resulting mixture was filtered through Celite. The filter was then washed with ethyl acetate. The organic filtrate was then diluted with water and extracted three times with ethyl acetate. The combined organic layers were then washed with brine and saturated NaHCO<sub>3</sub>, dried over anhydrous MgSO<sub>4</sub>, and concentrated in vacuo. The resulting residue was taken up in 2 mL of methanol and purified by HPLC under the conditions described above to give compound <b>4</b> as a beige residue (20.3 mg, 44%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.37 (d, <i>J</i> = 1.3 Hz, 1H), 8.33–8.28 (m, 2H), 8.01 (d, <i>J</i> = 5.9 Hz, 1H), 7.96 (d, <i>J</i> = 2.3 Hz, 1H), 7.52 (d, <i>J</i> = 8.3 Hz, 1H), 7.44 (dd, <i>J</i> = 5.9, 1.0 Hz, 1H), 7.41 (d, <i>J</i> = 2.5 Hz, 1H), 7.31 (dd, <i>J</i> = 8.3, 2.5 Hz, 1H), 7.06–7.04 (m, 1H), 2.57 (s, 3H), 2.17 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.471 min. MS (ESI) <i>m</i>/<i>z</i>: 357.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(4-(Imidazo[1,2-<i>a</i>]pyridin-5-yl)-3-methylphenoxy)furo[3,2-<i>c</i>]pyridine (<b>5</b>)</h4><div class="NLM_p last">Compound <b>5</b> was prepared as a light yellow oil using the same procedure as preparing <b>4</b> starting with compound <b>3</b> and 5-bromoimidazo[1,2-<i>a</i>]pyridine, yield 94%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.15–8.08 (m, 2H), 8.07–7.98 (m, 2H), 7.95 (d, <i>J</i> = 2.2 Hz, 1H), 7.87 (d, <i>J</i> = 2.2 Hz, 1H), 7.54 (dd, <i>J</i> = 23.7, 7.7 Hz, 2H), 7.43 (d, <i>J</i> = 5.9 Hz, 1H), 7.38 (d, <i>J</i> = 2.3 Hz, 1H), 7.31 (dd, <i>J</i> = 8.3, 2.4 Hz, 1H), 7.08–7.05 (m, 1H), 2.18 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.079 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calculated for C<sub>21</sub>H<sub>16</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>, 342.1237; found, 342.1259.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl-3-(4-(furo[3,2-<i>c</i>]pyridin-4-yloxy)-2-methylphenyl)imidazo[1,2-<i>a</i>]pyridine-8-carboxylate (<b>6</b>)</h4><div class="NLM_p last">Compound <b>6</b> was prepared using the same procedure as preparing <b>4</b> starting with compound <b>3</b> and methyl 3-bromoimidazo[1,2-<i>a</i>]pyridine-8-carboxylate. The title compound was obtained as a beige residue, yield 60%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.26 (dd, <i>J</i> = 6.8, 1.3 Hz, 1H), 8.13 (dd, <i>J</i> = 7.1, 1.3 Hz, 1H), 8.00 (d, <i>J</i> = 5.9 Hz, 1H), 7.93 (d, <i>J</i> = 2.3 Hz, 1H), 7.74 (s, 1H), 7.48 (d, <i>J</i> = 8.3 Hz, 1H), 7.41 (dt, <i>J</i> = 5.8, 0.6 Hz, 1H), 7.31 (d, <i>J</i> = 2.5 Hz, 1H), 7.22 (dd, <i>J</i> = 8.3, 2.5 Hz, 1H), 7.10 (t, <i>J</i> = 7.0 Hz, 1H), 7.01–7.00 (m, 1H), 4.05 (s, 3H), 2.16 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.210 min. MS (ESI) <i>m</i>/<i>z</i>: 400.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-(4-(Furo[3,2-<i>c</i>]pyridin-4-yloxy)-2-methylphenyl)-5-methylpyrazin-2-amine (<b>7</b>)</h4><div class="NLM_p last">Compound <b>7</b> was prepared using the same procedure as preparing <b>4</b> starting with compound <b>3</b> and 6-bromo-5-methylpyrazin-2-amine. The title compound was obtained as a tan oil, yield 52%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.39 (s, 1H), 8.27 (d, <i>J</i> = 6.3 Hz, 1H), 7.67 (d, <i>J</i> = 2.3 Hz, 1H), 7.47–7.44 (m, 1H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.27–7.26 (m, 1H), 7.21 (dd, <i>J</i> = 8.4, 2.5 Hz, 1H), 6.54–6.38 (m, 1H), 2.35 (s, 3H), 2.22 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.394 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calculated for C<sub>19</sub>H<sub>17</sub>N<sub>4</sub>O<sub>2</sub><sup>+</sup>, 333.1346; found, 333.1356.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-(4-(4-Ethoxy-6-methylpyrimidin-5-yl)-3-methylphenoxy)furo[3,2-<i>c</i>]pyridine (<b>8</b>)</h4><div class="NLM_p last">Compound <b>8</b> was prepared as a clear oil using the same procedure as preparing <b>4</b> starting with compound <b>3</b> and 5-bromo-4-ethoxy-6-methylpyrimidine, yield 66%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.09–9.07 (m, 1H), 8.02 (d, <i>J</i> = 5.9 Hz, 1H), 7.93 (d, <i>J</i> = 2.3 Hz, 1H), 7.44 (dd, <i>J</i> = 6.0, 1.0 Hz, 1H), 7.27–7.26 (m, 1H), 7.25 (s, 1H), 7.19 (dd, <i>J</i> = 8.3, 2.5 Hz, 1H), 6.91–6.88 (m, 1H), 4.67 (ddq, <i>J</i> = 52.6, 10.8, 7.0 Hz, 2H), 2.43 (s, 3H), 2.15 (s, 3H), 1.38 (t, <i>J</i> = 7.1 Hz, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.946 min. MS (ESI) <i>m</i>/<i>z</i>: 362.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-(4-(3,5-Dimethylpyridazin-4-yl)-3-methylphenoxy)furo[3,2-<i>c</i>]pyridine (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> was prepared using the same procedure as preparing <b>4</b> starting with compound <b>3</b> and 4-chloro-3,5-dimethylpyridazine. The title compound was obtained as a golden oil, yield 55%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.04 (s, 1H), 7.99 (d, <i>J</i> = 5.9 Hz, 1H), 7.90 (d, <i>J</i> = 2.2 Hz, 1H), 7.41–7.38 (m, 1H), 7.26 (d, <i>J</i> = 2.3 Hz, 1H), 7.19 (dd, <i>J</i> = 8.2, 2.4 Hz, 1H), 7.16 (d, <i>J</i> = 8.3 Hz, 1H), 6.95–6.93 (m, 1H), 2.41 (s, 3H), 2.15 (s, 3H), 2.03 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.381 min. MS (ESI) <i>m</i>/<i>z</i>: 332.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 5-(4-(Furo[3,2-<i>c</i>]pyridin-4-yloxy)-2-methylphenyl)-6-methylpyridin-3-amine (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was prepared as a tan oil using the same procedure as preparing <b>4</b> starting with compound <b>3</b> and 5-bromo-6-methylpyridin-3-amine, yield 59%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.99 (d, <i>J</i> = 5.8 Hz, 1H), 7.92 (dd, <i>J</i> = 4.2, 2.5 Hz, 2H), 7.55 (d, <i>J</i> = 2.7 Hz, 1H), 7.41 (dd, <i>J</i> = 5.9, 1.0 Hz, 1H), 7.30–7.23 (m, 2H), 7.18 (dd, <i>J</i> = 8.3, 2.5 Hz, 1H), 6.97 (q, <i>J</i> = 1.2 Hz, 1H), 2.37 (s, 3H), 2.17 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.117 min. MS (ESI) <i>m</i>/<i>z</i>: 332.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-(4-(6-Methoxy-2-methylpyridin-3-yl)-3-methylphenoxy)furo[3,2-<i>c</i>]pyridine (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was prepared as a clear oil using the same procedure as preparing <b>4</b> starting with compound <b>3</b> and 3-bromo-6-methoxy-2-methylpyridine, yield 44%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.98 (d, <i>J</i> = 5.9 Hz, 1H), 7.89 (d, <i>J</i> = 2.2 Hz, 1H), 7.44 (d, <i>J</i> = 8.3 Hz, 1H), 7.38 (dd, <i>J</i> = 5.9, 1.0 Hz, 1H), 7.18–7.15 (m, 2H), 7.08 (dd, <i>J</i> = 8.2, 2.5 Hz, 1H), 6.89 (dd, <i>J</i> = 2.5, 0.9 Hz, 1H), 6.72 (d, <i>J</i> = 8.3 Hz, 1H), 3.96 (s, 3H), 2.26 (s, 3H), 2.10 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 5.393 min. MS (ESI) <i>m</i>/<i>z</i>: 347.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-(4-(Furo[3,2-<i>c</i>]pyridin-4-yloxy)-2-methylphenyl)nicotinamide (<b>12</b>)</h4><div class="NLM_p last">Compound <b>12</b> was prepared as a clear oil using the same procedure as preparing <b>4</b> starting with compound <b>3</b> and 5-bromonicotinamide, yield 34%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.15 (d, <i>J</i> = 2.0 Hz, 1H), 8.89 (d, <i>J</i> = 2.0 Hz, 1H), 8.61 (d, <i>J</i> = 1.9 Hz, 1H), 8.01 (d, <i>J</i> = 5.9 Hz, 1H), 7.92 (d, <i>J</i> = 2.2 Hz, 1H), 7.43 (dd, <i>J</i> = 7.7, 2.5 Hz, 2H), 7.27 (d, <i>J</i> = 2.5 Hz, 1H), 7.21 (dd, <i>J</i> = 8.3, 2.5 Hz, 1H), 6.91–6.89 (m, 1H), 2.36 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.244 min. MS (ESI) <i>m</i>/<i>z</i>: 346.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 6-(4-(Furo[3,2-<i>c</i>]pyridin-4-yloxy)-2-methylphenyl)nicotinonitrile (<b>13</b>)</h4><div class="NLM_p last">Compound <b>13</b> was prepared using the same procedure as preparing <b>4</b> starting with compound <b>3</b> and 6-bromonicotinonitrile. The title compound was obtained as an off-white residue, yield 15%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.00 (s, 1H), 8.05 (t, <i>J</i> = 7.7 Hz, 2H), 7.68 (s, 1H), 7.61 (d, <i>J</i> = 8.2 Hz, 1H), 7.52 (d, <i>J</i> = 8.1 Hz, 1H), 7.26 (d, <i>J</i> = 6.0 Hz, 1H), 7.20 (d, <i>J</i> = 9.4 Hz, 2H), 6.94 (s, 1H), 2.45 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 328.1 min. MS (ESI) <i>m</i>/<i>z</i>: 4.925 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-(2-Methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>14</b>)</h4><div class="NLM_p last">Starting from 4-chlorofuro[3,2-<i>c</i>]pyridine (123 mg, 0.80 mmol) and 4-bromo-2-methylphenol (150 mg, 0.80 mmol), the intermediate 4-(4-bromo-2-methylphenoxy)furo[3,2-<i>c</i>]pyridine was prepared (80 mg, 0.26 mmol, 33%) in an analogous fashion with identical reaction conditions as compound <b>2</b>, described by Gray et al.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The entirety of 4-(4-bromo-2-methylphenoxy)furo[3,2-<i>c</i>]pyridine was then converted to the boronic ester intermediate 4-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (63 mg, 0.18 mmol, 68%) with the same conditions described by Gray, et al. for the synthesis of compound <b>3</b>. Compound <b>14</b> was prepared using the same procedure as preparing compound <b>4</b> starting with 4-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (30 mg, 0.085 mmol). The title compound was obtained as a beige residue, yield 79%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.31 (s, 1H), 8.14 (d, <i>J</i> = 1.7 Hz, 1H), 8.01 (d, <i>J</i> = 1.7 Hz, 1H), 7.98–7.96 (m, 2H), 7.61 (d, <i>J</i> = 2.1 Hz, 1H), 7.52 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 7.46 (d, <i>J</i> = 8.2 Hz, 1H), 7.43–7.41 (m, 1H), 7.13–7.11 (m, 1H), 2.58 (s, 3H), 2.31 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 5.052 min. MS (ESI) <i>m</i>/<i>z</i>: 357.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-(2,3-Dimethyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>15</b>)</h4><div class="NLM_p last">Starting from 4-chlorofuro[3,2-<i>c</i>]pyridine and 4-bromo-2,3-dimethylphenol, compound <b>15</b> was prepared as a white solid according to the same procedures and synthetic route as <b>14</b>. The title compound was obtained as a brown residue, yield 99%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.38 (s, 1H), 8.18 (t, <i>J</i> = 1.4 Hz, 1H), 7.98–7.94 (m, 2H), 7.90 (d, <i>J</i> = 1.7 Hz, 1H), 7.41 (dd, <i>J</i> = 6.0, 1.0 Hz, 1H), 7.35 (d, <i>J</i> = 8.3 Hz, 1H), 7.29 (d, <i>J</i> = 8.3 Hz, 1H), 7.12–7.10 (m, 1H), 2.51 (s, 3H), 2.26 (s, 3H), 2.10 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.515 min. MS (ESI) <i>m</i>/<i>z</i>: 371.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-(Furo[3,2-<i>c</i>]pyridin-4-yloxy)-2-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)aniline (<b>16</b>)</h4><div class="NLM_p last">Starting from 4-chlorofuro[3,2-<i>c</i>]pyridine and 3-amino-4-bromophenol, compound <b>16</b> was prepared as a white solid according to the same procedures and synthetic route as <b>14</b>. The title compound was obtained as a beige residue, yield 43%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.37 (s, 1H), 8.21 (s, 1H), 8.03 (d, <i>J</i> = 5.9 Hz, 1H), 7.99 (d, <i>J</i> = 1.8 Hz, 1H), 7.95 (d, <i>J</i> = 2.2 Hz, 1H), 7.44 (dd, <i>J</i> = 6.0, 1.0 Hz, 1H), 7.28 (d, <i>J</i> = 8.4 Hz, 1H), 7.02 (d, <i>J</i> = 2.2 Hz, 1H), 6.80 (d, <i>J</i> = 2.3 Hz, 1H), 6.67 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 2.61 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.081 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calculated for C<sub>20</sub>H<sub>16</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, 358.1299; found, 358.1303.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 4-(4-(6-Methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)-3-(trifluoromethyl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>17</b>)</h4><div class="NLM_p last">Starting from 4-chlorofuro[3,2-<i>c</i>]pyridine and 4-bromo-3-(trifluoromethyl)phenol, compound <b>17</b> was prepared as a white solid according to the same procedures and synthetic route as <b>14</b>. The title compound was obtained as a clear oil, yield 42%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.31 (t, <i>J</i> = 1.4 Hz, 1H), 8.07 (t, <i>J</i> = 1.6 Hz, 1H), 8.05 (d, <i>J</i> = 5.8 Hz, 1H), 8.00–7.97 (m, 2H), 7.85–7.81 (m, 1H), 7.76–7.73 (m, 2H), 7.52 (d, <i>J</i> = 7.5 Hz, 1H), 7.15 (q, <i>J</i> = 1.2 Hz, 1H), 2.43 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.514 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calculated for C<sub>21</sub>H<sub>14</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub><sup>+</sup>, 411.1063; found, 411.1065.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 4-(4-(6-Methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)-2-(trifluoromethyl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>18</b>)</h4><div class="NLM_p last">Starting from 4-chlorofuro[3,2-<i>c</i>]pyridine and 4-bromo-2-(trifluoromethyl)phenol, compound <b>18</b> was prepared as a white solid according to the same procedures and synthetic route as <b>14</b>. The title compound was obtained as a clear oil, yield 85%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.28 (d, <i>J</i> = 1.7 Hz, 1H), 8.43 (d, <i>J</i> = 2.3 Hz, 1H), 8.28 (d, <i>J</i> = 2.1 Hz, 1H), 8.22 (d, <i>J</i> = 2.3 Hz, 1H), 8.10 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 8.07 (dd, <i>J</i> = 2.9, 1.5 Hz, 1H), 7.96 (d, <i>J</i> = 8.4 Hz, 1H), 7.86 (s, 1H), 7.81 (d, <i>J</i> = 8.9 Hz, 1H), 7.08 (d, <i>J</i> = 7.9 Hz, 1H), 2.53 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 3.646 min. MS (ESI) <i>m</i>/<i>z</i>: 411.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 4-(2,6-Difluoro-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>19</b>)</h4><div class="NLM_p last">Starting from 4-chlorofuro[3,2-<i>c</i>]pyridine and 4-bromo-2,6-difluorophenol, compound <b>19</b> was prepared as a white solid according to the same procedures and synthetic route as <b>14</b>. The title compound was obtained as a tan residue, yield 59%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.28 (s, 1H), 8.09 (d, <i>J</i> = 1.4 Hz, 1H), 8.00 (d, <i>J</i> = 2.2 Hz, 1H), 7.98 (d, <i>J</i> = 1.6 Hz, 1H), 7.67–7.65 (m, 1H), 7.59–7.56 (m, 1H), 7.52 (d, <i>J</i> = 7.5 Hz, 1H), 7.48–7.46 (m, 1H), 7.20–7.18 (m, 1H), 2.57 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.624 min. MS (ESI) <i>m</i>/<i>z</i>: 379.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(3-Methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenyl)furo[3,2-<i>c</i>]pyridin-4-amine (<b>20</b>)</h4><div class="NLM_p last">Starting from 4-chlorofuro[3,2-<i>c</i>]pyridine (1.66 g, 10.8 mmol) and 4-bromo-3-methylaniline (2.0 g, 10.8 mmol), the intermediate <i>N</i>-(4-bromo-3-methylphenyl)furo[3,2-<i>c</i>]pyridin-4-amine was prepared (851 mg, 2.81 mmol, 26%) in an analogous fashion with identical reaction conditions as compound <b>2</b>, described by Gray et al. <i>N</i>-(4-bromo-3-methylphenyl)furo[3,2-<i>c</i>]pyridin-4-amine (97 mg, 0.32 mmol) was then converted to the boronic ester intermediate <i>N</i>-(3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)furo[3,2-<i>c</i>]pyridin-4-amine (106 mg, 0.30 mmol, 94%) with the same conditions described by Gray, et al. for the synthesis of compound <b>3</b>. Compound <b>20</b> was prepared using the same procedure as preparing compound <b>4</b> starting with <i>N</i>-(3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)furo[3,2-<i>c</i>]pyridin-4-amine (52 mg, 0.148 mmol). The title compound was obtained as a light yellow oil, yield 99%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.25 (d, <i>J</i> = 2.7 Hz, 1H), 8.17–8.15 (m, 1H), 8.04–8.02 (m, 1H), 7.89 (d, <i>J</i> = 6.9 Hz, 1H), 7.71 (s, 1H), 7.63–7.61 (m, 2H), 7.52 (s, 1H), 7.48 (d, <i>J</i> = 7.1 Hz, 1H), 7.34 (d, <i>J</i> = 2.4 Hz, 1H), 2.46 (d, <i>J</i> = 2.4 Hz, 3H), 2.18 (d, <i>J</i> = 2.5 Hz, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.159 min. MS (ESI) <i>m</i>/<i>z</i>: 356.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-Methyl-<i>N</i>-(3-methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenyl)furo[3,2-<i>c</i>]pyridin-4-amine (<b>21</b>)</h4><div class="NLM_p last">To an oven-dried flask was added a stir bar, compound <b>20</b> (20 mg, 0.056 mmol), sodium hydride (2.0 mg, 0.084 mmol), and anhydrous <i>N</i>,<i>N</i>-dimethylformamide (0.5 mL). The reaction was allowed to stir under N<sub>2</sub> for 1 h. The mixture was then cooled to 0 °C and methyl iodide (8.8 mg, 0.062 mmol) was added dropwise. The reaction was then stirred for 2 h, allowing the temperature to slowly rise to room temperature. The reaction was quenched with saturated sodium bicarbonate, extracted three times with ethyl acetate, dried over anhydrous sodium sulfate, concentrated in vacuo, and purified by HPLC to give compound <b>21</b> as a clear oil. (7.8 mg, 43%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.16 (s, 1H), 8.01 (d, <i>J</i> = 7.0 Hz, 1H), 7.94 (d, <i>J</i> = 2.3 Hz, 2H), 7.74 (d, <i>J</i> = 2.2 Hz, 1H), 7.67 (d, <i>J</i> = 8.1 Hz, 1H), 7.64 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 7.50 (s, 1H), 7.48–7.46 (m, 1H), 5.89–5.86 (m, 1H), 3.86 (s, 3H), 2.44 (s, 3H), 2.16 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 3.481 min. MS (ESI) <i>m</i>/<i>z</i>: 370.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-Ethyl-<i>N</i>-(3-methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenyl)furo[3,2-<i>c</i>]pyridin-4-amine (<b>22</b>)</h4><div class="NLM_p last">Using the same procedure as <b>21</b>, an oven-dried flask was charged with a stir bar, compound <b>20</b>, sodium hydride, and anhydrous <i>N</i>,<i>N</i>-dimethylformamide. The reaction was allowed to stir under N<sub>2</sub> for 1 h. The mixture was then cooled to 0 °C and ethyl iodide was added dropwise. The reaction was then stirred for 2 h, allowing the temperature to slowly rise to room temperature. The reaction was quenched with saturated sodium bicarbonate, extracted three times with ethyl acetate, dried over anhydrous sodium sulfate, concentrated in vacuo, and purified by HPLC to give compound <b>22</b> as a clear oil. (Yield: 29%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.03 (s, 1H), 8.13–8.10 (m, 1H), 7.83 (s, 1H), 7.61–7.58 (m, 1H), 7.43–7.38 (m, 2H), 7.36 (s, 1H), 7.29 (d, <i>J</i> = 8.2 Hz, 1H), 7.11 (d, <i>J</i> = 5.9 Hz, 1H), 5.74 (s, 1H), 4.27–4.21 (m, 2H), 2.41 (dd, <i>J</i> = 3.5, 1.7 Hz, 3H), 2.05 (d, <i>J</i> = 2.8 Hz, 3H), 1.36 (ddd, <i>J</i> = 7.0, 4.5, 2.7 Hz, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.160 min. MS (ESI) <i>m</i>/<i>z</i>: 384.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-Isopropyl-<i>N</i>-(3-methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenyl)furo[3,2-<i>c</i>]pyridin-4-amine (<b>23</b>)</h4><div class="NLM_p last">Using the same procedure as <b>21</b>, an oven-dried flask was charged with a stir bar, compound <b>20</b>, sodium hydride, and anhydrous <i>N</i>,<i>N</i>-dimethylformamide. The reaction was allowed to stir under N<sub>2</sub> for 1 h. The mixture was then cooled to 0 °C and isopropyl iodide was added dropwise. The reaction was then stirred for 2 h, allowing the temperature to slowly rise to room temperature. The reaction was quenched with saturated sodium bicarbonate, extracted three times with ethyl acetate, dried over anhydrous sodium sulfate, concentrated in vacuo, and purified by HPLC to give compound <b>23</b> as a light yellow oil. (Yield: 36%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.06 (s, 1H), 8.06 (dd, <i>J</i> = 6.6, 2.2 Hz, 1H), 7.85 (s, 1H), 7.51 (d, <i>J</i> = 8.1 Hz, 1H), 7.48 (t, <i>J</i> = 2.6 Hz, 1H), 7.40 (s, 1H), 7.35 (s, 2H), 7.00 (d, <i>J</i> = 5.9 Hz, 1H), 5.33 (dd, <i>J</i> = 13.4, 6.8 Hz, 1H), 5.29 (d, <i>J</i> = 3.0 Hz, 1H), 2.42 (d, <i>J</i> = 2.7 Hz, 3H), 2.09 (d, <i>J</i> = 2.8 Hz, 3H), 1.33 (d, <i>J</i> = 2.2 Hz, 3H), 1.31 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.173 min. MS (ESI) <i>m</i>/<i>z</i>: 398.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(Cyclopropylmethyl)-<i>N</i>-(3-methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenyl)furo[3,2-<i>c</i>]pyridin-4-amine (<b>24</b>)</h4><div class="NLM_p last">Using the same procedure as <b>21</b>, an oven-dried flask was charged with a stir bar, compound <b>20</b>, sodium hydride, and anhydrous <i>N</i>,<i>N</i>-dimethylformamide. The reaction was allowed to stir under N<sub>2</sub> for 1 h. The mixture was then cooled to 0 °C and (iodomethyl)cyclopropane was added dropwise. The reaction was then stirred for 2 h, allowing the temperature to slowly rise to room temperature. The reaction was quenched with saturated sodium bicarbonate, extracted three times with ethyl acetate, dried over anhydrous sodium sulfate, concentrated in vacuo, and purified by HPLC to give compound <b>24</b> as a light yellow oil. (Yield: 35%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.03 (s, 1H), 8.11 (dd, <i>J</i> = 5.5, 1.9 Hz, 1H), 7.83 (s, 1H), 7.60–7.57 (m, 1H), 7.43–7.38 (m, 2H), 7.38–7.32 (m, 2H), 7.10 (d, <i>J</i> = 5.9 Hz, 1H), 5.74 (s, 1H), 4.10–4.04 (m, 2H), 2.40 (d, <i>J</i> = 1.9 Hz, 3H), 2.07–2.03 (m, 3H), 1.31 (s, 1H), 0.52–0.47 (m, 2H), 0.22 (d, <i>J</i> = 4.9 Hz, 2H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.217 min. MS (ESI) <i>m</i>/<i>z</i>: 410.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-Cyclopentyl-<i>N</i>-(3-methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenyl)furo[3,2-<i>c</i>]pyridin-4-amine (<b>25</b>)</h4><div class="NLM_p last">Using the same procedure as <b>21</b>, an oven-dried flask was charged with a stir bar, compound <b>20</b>, sodium hydride, and anhydrous <i>N</i>,<i>N</i>-dimethylformamide. The reaction was allowed to stir under N<sub>2</sub> for 1 h. The mixture was then cooled to 0 °C and iodocyclopentane was added dropwise. The reaction was then stirred for 2 h, allowing the temperature to slowly rise to room temperature. The reaction was quenched with saturated sodium bicarbonate, extracted three times with ethyl acetate, dried over anhydrous sodium sulfate, concentrated in vacuo, and purified by HPLC to give compound <b>25</b> as a light yellow oil. (Yield: 17%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.05 (s, 1H), 8.09–8.06 (m, 1H), 7.84 (s, 1H), 7.50 (s, 2H), 7.38 (s, 1H), 7.33 (d, <i>J</i> = 10.1 Hz, 2H), 7.03 (s, 1H), 5.36 (s, 1H), 2.42–2.40 (m, 3H), 2.08 (d, <i>J</i> = 2.5 Hz, 3H), 1.71 (s, 5H), 1.63 (d, <i>J</i> = 12.0 Hz, 4H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.458 min. MS (ESI) <i>m</i>/<i>z</i>: 424.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-Cyclopropyl-4-(3-methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>26</b>)</h4><div class="NLM_p last">To a flame dried microwavable vessel were added a stir bar, tetrakis(triphenylphosphine)palladium(0) (81 mg, 0.07 mmol), potassium carbonate (99 mg, 0.72 mmol), 3-bromo-4-chlorofuro[3,2-<i>c</i>]pyridine (100 mg, 0.43 mmol), and cyclopropylboronic acid (31 mg, 0.36 mmol) in dioxane (2 mL) and water (0.3 mL). The mixture was subjected to microwave heating for 25 minutes as described in the <a class="ref internalNav" href="#sec4_1" aria-label="General Chemistry Procedures">General Chemistry Procedures</a> section. The resulting mixture was filtered through Celite. The filter was then washed with ethyl acetate. The organic filtrate was then diluted with water and extracted three times with ethyl acetate. The combined organic layers were then washed with brine and saturated NaHCO<sub>3</sub>, dried over anhydrous MgSO<sub>4</sub>, and concentrated in vacuo. The resulting crude product, 4-chloro-3-cyclopropylfuro[3,2-<i>c</i>]pyridine (177 mg, 0.91 mmol), was obtained as a brown residue and used directly in the next step. The intermediate 4-(4-bromo-3-methylphenoxy)-3-cyclopropylfuro[3,2-<i>c</i>]pyridine (28 mg, 0.08 mmol) was prepared using 4-bromo-3-methylphenol (94 mg, 0.50 mmol) and the crude 4-chloro-3-cyclopropylfuro[3,2-<i>c</i>]pyridine (88 mg, 0.45 mmol) obtained from the previous step in an analogous fashion with identical reaction conditions as compound <b>2</b>, described by Gray et al. 4-(4-bromo-3-methylphenoxy)-3-cyclopropylfuro[3,2-<i>c</i>]pyridine (28 mg, 0.08 mmol) was then converted to the boronic ester intermediate 3-cyclopropyl-4-(3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (11 mg, 0.03 mmol, 35%) with the same conditions described by Gray, et al. for the synthesis of compound <b>3</b>. Compound <b>26</b> was prepared using the same procedure as preparing compound <b>4</b> starting with 3-cyclopropyl-4-(3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (11 mg, 0.03 mmol). The title compound was obtained as a clear oil, yield 58%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.23 (s, 1H), 8.05–7.96 (m, 2H), 7.70 (s, 1H), 7.62 (s, 1H), 7.48 (d, <i>J</i> = 8.5 Hz, 1H), 7.42–7.29 (m, 3H), 2.46 (d, <i>J</i> = 2.3 Hz, 3H), 2.11 (d, <i>J</i> = 3.1 Hz, 3H), 1.01 (d, <i>J</i> = 8.2 Hz, 2H), 0.93 (s, 1H), 0.79 (s, 2H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.827 min. MS (ESI) <i>m</i>/<i>z</i>: 397.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-(4-(Benzofuran-4-yloxy)-2-methylphenyl)-6-methylimidazo[1,2-<i>a</i>]pyrazine (<b>27</b>)</h4><div class="NLM_p last">Starting from 4-chlorobenzofuran and 4-bromo-3-methylphenol, compound <b>27</b> was prepared as a white solid according to the same procedures and synthetic route as <b>26</b>. The title compound was obtained as a beige residue, yield 69%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.49 (s, 1H), 7.95 (s, 1H), 7.65 (d, <i>J</i> = 2.1 Hz, 1H), 7.44 (d, <i>J</i> = 8.3 Hz, 1H), 7.35 (t, <i>J</i> = 8.2 Hz, 1H), 7.24 (d, <i>J</i> = 7.6 Hz, 2H), 7.13 (d, <i>J</i> = 2.5 Hz, 1H), 7.09–7.05 (m, 1H), 7.00 (d, <i>J</i> = 7.9 Hz, 1H), 6.73 (s, 1H), 2.47 (s, 3H), 2.03 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.860 min. MS (ESI) <i>m</i>/<i>z</i>: 356.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-(3-Methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenoxy)isoquinoline (<b>28</b>)</h4><div class="NLM_p last">Starting from 1-chloroisoquinoline and 4-bromo-3-methylphenol, compound <b>28</b> was prepared as a white solid according to the same procedures and synthetic route as <b>26</b>. The title compound was obtained as a yellow oil, yield 95%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.30 (s, 1H), 8.50 (d, <i>J</i> = 8.4 Hz, 1H), 8.11 (s, 1H), 7.98 (d, <i>J</i> = 8.0 Hz, 1H), 7.95 (d, <i>J</i> = 5.4 Hz, 1H), 7.88 (t, <i>J</i> = 7.6 Hz, 1H), 7.81 (s, 1H), 7.79–7.75 (m, 1H), 7.56 (d, <i>J</i> = 6.1 Hz, 1H), 7.52 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (s, 1H), 7.39 (d, <i>J</i> = 8.2 Hz, 1H), 2.50 (d, <i>J</i> = 2.2 Hz, 3H), 2.14 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.813 min. MS (ESI) <i>m</i>/<i>z</i>: 367.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 7-(3-Methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenoxy)thieno[2,3-<i>c</i>]pyridine (<b>29</b>)</h4><div class="NLM_p last">Starting from 7-chlorothieno[2,3-<i>c</i>]pyridine and 4-bromo-3-methylphenol, compound <b>29</b> was prepared as a white solid according to the same procedures and synthetic route as <b>26</b>. The title compound was obtained as a clear oil, yield 99%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.33 (s, 1H), 8.13 (d, <i>J</i> = 2.1 Hz, 1H), 8.07–8.00 (m, 2H), 7.79 (s, 1H), 7.66 (dd, <i>J</i> = 5.6, 3.1 Hz, 1H), 7.59 (dd, <i>J</i> = 6.0, 2.4 Hz, 1H), 7.51 (dd, <i>J</i> = 8.4, 2.6 Hz, 1H), 7.45 (d, <i>J</i> = 2.8 Hz, 1H), 7.37 (d, <i>J</i> = 8.0 Hz, 1H), 2.50 (d, <i>J</i> = 2.8 Hz, 3H), 2.14 (d, <i>J</i> = 2.8 Hz, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.679 min. MS (ESI) <i>m</i>/<i>z</i>: 373.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 6-Methyl-5-(2-methyl-4-(pyrrolo[1,2-<i>a</i>]pyrazin-1-yloxy)phenyl)imidazo[1,2-<i>a</i>]pyrazine (<b>30</b>)</h4><div class="NLM_p last">Starting from 1-chloropyrrolo[1,2-<i>a</i>]pyrazine and 4-bromo-3-methylphenol, compound <b>30</b> was prepared as a white solid according to the same procedures and synthetic route as <b>26</b>. The title compound was obtained as a light brown residue, yield 99%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.58 (d, <i>J</i> = 2.6 Hz, 1H), 8.01 (s, 1H), 7.73–7.67 (m, 1H), 7.57–7.55 (m, 1H), 7.53 (d, <i>J</i> = 7.6 Hz, 1H), 7.45 (s, 1H), 7.39 (dd, <i>J</i> = 11.1, 6.5 Hz, 2H), 7.16 (dd, <i>J</i> = 5.0, 2.5 Hz, 1H), 7.10 (s, 1H), 6.94 (d, <i>J</i> = 3.0 Hz, 1H), 2.51 (d, <i>J</i> = 2.7 Hz, 3H), 2.11 (d, <i>J</i> = 2.7 Hz, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.512 min. MS (ESI) <i>m</i>/<i>z</i>: 356.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 5-(4-(Imidazo[1,2-<i>a</i>]pyrazin-8-yloxy)-2-methylphenyl)-6-methylimidazo[1,2-<i>a</i>]pyrazine (<b>31</b>)</h4><div class="NLM_p last">Starting from 8-chloroimidazo[1,2-<i>a</i>]pyrazine and 4-bromo-3-methylphenol, compound <b>31</b> was prepared as a white solid according to the same procedures and synthetic route as <b>26</b>. The title compound was obtained as a light brown residue, yield 96%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.57 (d, <i>J</i> = 2.7 Hz, 1H), 8.05–7.96 (m, 3H), 7.85 (dd, <i>J</i> = 2.9, 1.4 Hz, 1H), 7.59 (dd, <i>J</i> = 4.6, 2.6 Hz, 1H), 7.55–7.49 (m, 2H), 7.43–7.39 (m, 1H), 7.33 (s, 1H), 2.52 (d, <i>J</i> = 2.7 Hz, 3H), 2.13 (d, <i>J</i> = 2.7 Hz, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.202 min. MS (ESI) <i>m</i>/<i>z</i>: 357.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-(3-Methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenoxy)-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine (<b>32</b>)</h4><div class="NLM_p last">Starting from 4-chloro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine and 4-bromo-3-methylphenol, compound <b>32</b> was prepared as a white solid according to the same procedures and synthetic route as <b>26</b>. The title compound was obtained as a clear oil, yield 10%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.21 (s, 1H), 8.00 (s, 1H), 7.96 (s, 1H), 7.71 (d, <i>J</i> = 6.4 Hz, 1H), 7.49 (d, <i>J</i> = 8.1 Hz, 1H), 7.44 (s, 1H), 7.36 (d, <i>J</i> = 8.4 Hz, 1H), 7.06 (s, 1H), 7.01 (s, 1H), 6.92 (s, 1H), 2.47–2.45 (m, 3H), 2.12 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.527 min. MS (ESI) <i>m</i>/<i>z</i>: 356.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 6-Methyl-5-(2-methyl-4-(pyridin-2-yloxy)phenyl)imidazo[1,2-<i>a</i>]pyrazine (<b>33</b>)</h4><div class="NLM_p last">Starting from 2-chloropyridine and 4-bromo-3-methylphenol, compound <b>33</b> was prepared as a white solid according to the same procedures and synthetic route as <b>26</b>. The title compound was obtained as a clear oil, yield 31%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.21 (s, 1H), 8.21 (s, 1H), 8.01 (s, 1H), 7.94 (t, <i>J</i> = 7.8 Hz, 1H), 7.64 (s, 1H), 7.45 (d, <i>J</i> = 8.2 Hz, 1H), 7.32 (s, 1H), 7.23 (d, <i>J</i> = 8.8 Hz, 2H), 7.16 (d, <i>J</i> = 8.5 Hz, 1H), 2.44 (d, <i>J</i> = 3.1 Hz, 3H), 2.10 (d, <i>J</i> = 2.8 Hz, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.398 min. MS (ESI) <i>m</i>/<i>z</i>: 317.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 5-(4-((3-bromopyridin-2-yl)oxy)-2-methylphenyl)-6-methylimidazo[1,2-<i>a</i>]pyrazine (<b>34</b>)</h4><div class="NLM_p last">Starting from 3-bromo-2-chloropyridine and 4-bromo-3-methylphenol, compound <b>34</b> was prepared as a white solid according to the same procedures and synthetic route as <b>26</b>. The title compound was obtained as a beige residue, yield 23%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.21 (s, 1H), 8.42 (d, <i>J</i> = 4.5 Hz, 1H), 8.31 (s, 1H), 8.11 (d, <i>J</i> = 7.4 Hz, 1H), 8.04 (s, 1H), 7.86 (s, 1H), 7.76 (s, 1H), 7.02 (s, 1H), 6.82 (d, <i>J</i> = 8.6 Hz, 1H), 2.54–2.51 (m, 3H), 2.35 (d, <i>J</i> = 3.1 Hz, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.736 min. MS (ESI) <i>m</i>/<i>z</i>: 395.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 3-Methyl-2-(3-methyl-4-(6-methylimidazo[1,2-<i>a</i>]pyrazin-5-yl)phenoxy)pyridin-4-ol (<b>35</b>)</h4><div class="NLM_p last">Starting from 2-chloro-3-methylpyridin-4-ol and 4-bromo-3-methylphenol, compound <b>35</b> was prepared as a white solid according to the same procedures and synthetic route as <b>26</b>. The title compound was obtained as a light yellow residue, yield 88%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.27 (s, 1H), 8.08–8.04 (m, 1H), 7.52 (d, <i>J</i> = 3.2 Hz, 1H), 7.33–7.29 (m, 1H), 6.99 (d, <i>J</i> = 3.2 Hz, 1H), 6.91 (ddt, <i>J</i> = 8.3, 6.4, 2.5 Hz, 2H), 6.77 (d, <i>J</i> = 3.2 Hz, 1H), 6.73–6.68 (m, 1H), 2.44–2.41 (m, 3H), 2.16 (d, <i>J</i> = 3.2 Hz, 3H), 2.03 (d, <i>J</i> = 3.2 Hz, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.455 min. MS (ESI) <i>m</i>/<i>z</i>: 346.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 6-Methyl-5-(2-methyl-4-((4-(piperidin-1-yl)pyridin-2-yl)oxy)phenyl)imidazo[1,2-<i>a</i>]pyrazine (<b>36</b>)</h4><div class="NLM_p last">Starting from 2-chloro-4-(piperidin-1-yl)pyridine and 4-bromo-3-methylphenol, compound <b>36</b> was prepared as a white solid according to the same procedures and synthetic route as <b>26</b>. The title compound was obtained as a light brown oil, yield 91%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.20 (s, 1H), 7.97 (s, 1H), 7.92 (d, <i>J</i> = 7.4 Hz, 1H), 7.58 (d, <i>J</i> = 8.4 Hz, 1H), 7.50 (d, <i>J</i> = 7.3 Hz, 2H), 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 7.01 (d, <i>J</i> = 7.6 Hz, 1H), 6.41 (d, <i>J</i> = 2.7 Hz, 1H), 3.66 (d, <i>J</i> = 6.1 Hz, 4H), 2.43–2.39 (m, 3H), 2.14 (s, 3H), 1.79 (s, 2H), 1.72 (s, 4H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.101 min. MS (ESI) <i>m</i>/<i>z</i>: 400.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-(4-(Imidazo[1,2-<i>a</i>]pyridin-5-yl)-2-methylphenoxy)furo[3,2-<i>c</i>]pyridine (<b>37</b>)</h4><div class="NLM_p last">Compound <b>37</b> was prepared starting from 5-bromoimidazo[1,2-<i>a</i>]pyridine and the boronic ester intermediate 4-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)furo[3,2-<i>c</i>]pyridine that was initially prepared for the synthesis of <b>14</b>. This synthesis followed the same procedure as was used for the conversion of the boronic ester intermediate <b>3</b> into compound <b>4</b>. Compound <b>37</b> was obtained as a light brown residue, yield 99%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.25 (d, <i>J</i> = 2.2 Hz, 1H), 8.12–8.08 (m, 2H), 8.00–7.94 (m, 3H), 7.75 (d, <i>J</i> = 2.2 Hz, 1H), 7.67 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.56–7.53 (m, 1H), 7.44–7.40 (m, 2H), 7.11–7.09 (m, 1H), 2.32 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.835 min. MS (ESI) <i>m</i>/<i>z</i>: 342.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-(4-(Imidazo[1,2-<i>a</i>]pyridin-5-yl)-2,3-dimethylphenoxy)furo[3,2-<i>c</i>]pyridine (<b>38</b>)</h4><div class="NLM_p last">Compound <b>38</b> was prepared starting from 5-bromoimidazo[1,2-<i>a</i>]pyridine and the boronic ester intermediate 4-(2,3-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)furo[3,2-<i>c</i>]pyridine that was initially prepared for the synthesis of <b>15</b>. This synthesis followed the same procedure as was described compound <b>4</b>. Compound <b>38</b> was obtained as a light brown residue, yield 93%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.14–8.09 (m, 2H), 8.04 (d, <i>J</i> = 9.0 Hz, 1H), 7.96 (t, <i>J</i> = 1.9 Hz, 1H), 7.94 (d, <i>J</i> = 5.9 Hz, 1H), 7.91 (d, <i>J</i> = 2.2 Hz, 1H), 7.53–7.51 (m, 1H), 7.40 (ddd, <i>J</i> = 8.2, 4.5, 3.1 Hz, 2H), 7.25 (d, <i>J</i> = 8.1 Hz, 1H), 7.11 (d, <i>J</i> = 2.7 Hz, 1H), 2.25 (s, 3H), 2.11 (s, 3H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.351 min. MS (ESI) <i>m</i>/<i>z</i>: 356.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(4-(Imidazo[1,2-<i>a</i>]pyridin-5-yl)-3,5-dimethylphenoxy)furo[3,2-<i>c</i>]pyridine (<b>39</b>)</h4><div class="NLM_p last">Starting from 4-chlorofuro[3,2-<i>c</i>]pyridine (154 mg, 1.0 mmol) and 4-bromo-3,5-dimethylphenol (221 mg, 1.1 mmol), the intermediate 4-(4-bromo-3,5-dimethylphenoxy)furo[3,2-<i>c</i>]pyridine was prepared (195 mg, 0.61 mmol, 61%) in an analogous fashion with identical reaction conditions as compound <b>2</b>, described by Gray et al. 4-(4-bromo-3,5-dimethylphenoxy)furo[3,2-<i>c</i>]pyridine (92 mg, 0.29 mmol) was then converted to the boronic ester intermediate 4-(3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (67 mg, 0.18 mmol, 63%) with the same conditions described by Gray, et al. for the synthesis of compound <b>3</b>. Compound <b>39</b> was prepared using the same procedure as preparing compound <b>4</b> starting with 4-(3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)furo[3,2-<i>c</i>]pyridine and 5-bromoimidazo[1,2-<i>a</i>]pyridine. The title compound was obtained as a clear oil, yield 33%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.42 (q, <i>J</i> = 3.6, 2.9 Hz, 1H), 8.15 (ddt, <i>J</i> = 14.1, 4.6, 2.2 Hz, 2H), 8.10 (d, <i>J</i> = 8.9 Hz, 1H), 8.02–7.97 (m, 1H), 7.71 (dd, <i>J</i> = 6.0, 3.7 Hz, 2H), 7.57–7.53 (m, 1H), 7.42 (d, <i>J</i> = 4.4 Hz, 2H), 6.89 (dt, <i>J</i> = 9.5, 3.1 Hz, 1H), 2.13–2.10 (m, 6H). HPLC 99% pure, <i>t</i><sub>R</sub> = 3.238 min. MS (ESI) <i>m</i>/<i>z</i>: 355.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 5-(Furo[3,2-<i>c</i>]pyridin-4-yloxy)-2-(imidazo[1,2-<i>a</i>]pyridin-5-yl)aniline (<b>40</b>)</h4><div class="NLM_p last">Compound <b>40</b> was prepared starting from 5-bromoimidazo[1,2-<i>a</i>]pyridine and intermediate 5-(furo[3,2-<i>c</i>]pyridin-4-yloxy)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline that was initially prepared for the synthesis of <b>16</b>. This synthesis followed the same procedure as was used for the conversion of the boronic ester intermediate <b>3</b> into compound <b>4</b>. Compound <b>40</b> was obtained as a brown oil, yield 29%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.09–8.07 (m, 1H), 8.06 (d, <i>J</i> = 2.1 Hz, 1H), 8.02 (d, <i>J</i> = 5.9 Hz, 1H), 7.98–7.96 (m, 1H), 7.94 (d, <i>J</i> = 2.2 Hz, 1H), 7.91 (d, <i>J</i> = 2.2 Hz, 1H), 7.54 (dd, <i>J</i> = 7.2, 1.1 Hz, 1H), 7.43 (dd, <i>J</i> = 6.0, 1.0 Hz, 1H), 7.33 (d, <i>J</i> = 8.3 Hz, 1H), 7.00–6.99 (m, 1H), 6.77 (d, <i>J</i> = 2.3 Hz, 1H), 6.64 (d, <i>J</i> = 2.3 Hz, 1H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.061 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calculated for C<sub>20</sub>H<sub>15</sub>N<sub>4</sub>O<sub>2</sub><sup>+</sup>, 343.1190; found, 343.1195.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-(4-(Imidazo[1,2-<i>a</i>]pyridin-5-yl)-3-(trifluoromethyl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>41</b>)</h4><div class="NLM_p last">Compound <b>41</b> was prepared starting from 5-bromoimidazo[1,2-<i>a</i>]pyridine and the intermediate 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)phenoxy)furo[3,2-<i>c</i>]pyridine that was initially prepared for the synthesis of <b>17</b>. This synthesis followed the same procedure as was used for the conversion of the boronic ester intermediate <b>3</b> into compound <b>4</b>. Compound <b>41</b> was obtained as a clear oil, yield 89%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.16–8.13 (m, 1H), 8.13–8.10 (m, 2H), 8.04–8.02 (m, 1H), 7.99 (d, <i>J</i> = 2.3 Hz, 1H), 7.95 (d, <i>J</i> = 2.3 Hz, 1H), 7.89 (d, <i>J</i> = 2.3 Hz, 1H), 7.83 (d, <i>J</i> = 8.3 Hz, 1H), 7.80 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 7.59 (dd, <i>J</i> = 6.9, 1.4 Hz, 1H), 7.48 (dd, <i>J</i> = 5.9, 1.1 Hz, 1H), 7.15–7.14 (m, 1H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.081 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calculated for C<sub>21</sub>H<sub>13</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>, 396.0954; found, 396.0971.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-(4-(Imidazo[1,2-<i>a</i>]pyridin-5-yl)-2-(trifluoromethyl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>42</b>)</h4><div class="NLM_p last">Compound <b>42</b> was prepared starting from 5-bromoimidazo[1,2-<i>a</i>]pyridine and the intermediate 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)phenoxy)furo[3,2-<i>c</i>]pyridine that was initially prepared for the synthesis of <b>18</b>. This synthesis followed the same procedure as was used for the conversion of the boronic ester intermediate <b>3</b> into compound <b>4</b>. Compound <b>42</b> was obtained as a clear oil, yield 71%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.42–8.37 (m, 2H), 8.23–8.20 (m, 2H), 8.15 (dq, <i>J</i> = 2.5, 1.3 Hz, 1H), 8.13 (s, 1H), 8.09–8.06 (m, 1H), 8.04 (ddd, <i>J</i> = 9.0, 7.7, 1.2 Hz, 1H), 7.94 (d, <i>J</i> = 8.5 Hz, 1H), 7.81 (d, <i>J</i> = 8.9 Hz, 1H), 7.65–7.62 (m, 1H), 7.02 (d, <i>J</i> = 7.9 Hz, 1H). HPLC 99% pure, <i>t</i><sub>R</sub> = 3.256 min. MS (ESI) <i>m</i>/<i>z</i>: 395.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(2,6-Difluoro-4-(imidazo[1,2-<i>a</i>]pyridin-5-yl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>43</b>)</h4><div class="NLM_p last">Compound <b>43</b> was prepared starting from 5-bromoimidazo[1,2-<i>a</i>]pyridine and boronic ester intermediate 4-(2,6-difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)furo[3,2-<i>c</i>]pyridine that was initially prepared for the synthesis of <b>19</b>. This synthesis followed the same procedure as was used for the conversion of the boronic ester intermediate <b>3</b> into compound <b>4</b>. Compound <b>43</b> was obtained as a clear oil, yield 65%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.29 (d, <i>J</i> = 2.3 Hz, 1H), 8.14–8.11 (m, 1H), 8.11–8.09 (m, 1H), 8.05 (d, <i>J</i> = 9.0 Hz, 1H), 7.99 (d, <i>J</i> = 2.3 Hz, 1H), 7.95 (d, <i>J</i> = 5.8 Hz, 1H), 7.69–7.64 (m, 2H), 7.61 (dd, <i>J</i> = 7.1, 1.2 Hz, 1H), 7.45 (dd, <i>J</i> = 5.9, 1.1 Hz, 1H), 7.18–7.17 (m, 1H). HPLC 99% pure, <i>t</i><sub>R</sub> = 3.894 min. MS (ESI) <i>m</i>/<i>z</i>: 364.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 3-Cyclopropyl-4-(4-(imidazo[1,2-<i>a</i>]pyridin-5-yl)-3-(trifluoromethyl)phenoxy)furo[3,2-<i>c</i>]pyridine (<b>44</b>)</h4><div class="NLM_p last">Starting from 4-chloro-3-cyclopropylfuro[3,2-<i>c</i>]pyridine (88 mg, 0.45 mmol), which was previously prepared and described for compound <b>26</b>, and 4-bromo-3-(trifluoromethyl)phenol (120 mg, 0.50 mmol), the intermediate 4-(4-bromo-3-(trifluoromethyl)phenoxy)-3-cyclopropylfuro[3,2-<i>c</i>]pyridine was prepared (26 mg, 0.065 mmol, 13%) in an analogous fashion with identical reaction conditions as compound <b>2</b>, described by Gray et al. 4-(4-bromo-3-(trifluoromethyl)phenoxy)-3-cyclopropylfuro[3,2-<i>c</i>]pyridine (26 mg, 0.065 mmol) was then converted to the boronic ester intermediate 3-cyclopropyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)phenoxy)furo[3,2-<i>c</i>]pyridine (5.8 mg, 0.013 mmol, 20%) with the same conditions described by Gray, et al. for the synthesis of compound <b>3</b>. Compound <b>44</b> was prepared using the same procedure as preparing compound <b>4</b> starting with 3-cyclopropyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)phenoxy)furo[3,2-<i>c</i>]pyridine. The title compound was obtained as a beige residue, yield 30%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.09 (s, 1H), 8.01 (d, <i>J</i> = 5.9 Hz, 1H), 7.92 (s, 1H), 7.83 (s, 2H), 7.78 (d, <i>J</i> = 8.3 Hz, 1H), 7.70 (d, <i>J</i> = 8.5 Hz, 1H), 7.64 (s, 1H), 7.49 (s, 2H), 7.40 (d, <i>J</i> = 5.9 Hz, 1H), 1.01 (d, <i>J</i> = 8.2 Hz, 2H), 0.92 (s, 1H), 0.78 (s, 2H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.931 min. MS (ESI) <i>m</i>/<i>z</i>: 436.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 1-(4-(Imidazo[1,2-<i>a</i>]pyridin-5-yl)-3-(trifluoromethyl)phenoxy)isoquinoline (<b>45</b>)</h4><div class="NLM_p last">Starting from 1-chloroisoquinoline and 4-bromo-3-(trifluoromethyl)phenol, compound <b>45</b> was prepared in an analogous fashion with identical conditions as compound <b>44</b>. The title compound was obtained as a clear oil, yield 99%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.46 (d, <i>J</i> = 8.6 Hz, 2H), 8.04 (dd, <i>J</i> = 5.9, 2.8 Hz, 1H), 7.91 (s, 2H), 7.85 (t, <i>J</i> = 7.6 Hz, 1H), 7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.75 (d, <i>J</i> = 7.8 Hz, 1H), 7.69 (t, <i>J</i> = 10.0 Hz, 1H), 7.60 (d, <i>J</i> = 8.2 Hz, 1H), 7.52 (d, <i>J</i> = 6.2 Hz, 2H), 7.33 (d, <i>J</i> = 6.0 Hz, 2H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.237 min. MS (ESI) <i>m</i>/<i>z</i>: 406.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 7-(4-(Imidazo[1,2-<i>a</i>]pyridin-5-yl)-3-(trifluoromethyl)phenoxy)thieno[2,3-<i>c</i>]pyridine (<b>46</b>)</h4><div class="NLM_p last">Starting from 7-chlorothieno[2,3-<i>c</i>]pyridine and 4-bromo-3-(trifluoromethyl)phenol, compound <b>46</b> was prepared in an analogous fashion with identical conditions as compound <b>44</b>. The title compound was obtained as a light yellow oil, yield 97%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.14–8.10 (m, 2H), 8.07 (d, <i>J</i> = 5.4 Hz, 1H), 8.03 (t, <i>J</i> = 5.0 Hz, 1H), 7.98 (t, <i>J</i> = 3.3 Hz, 1H), 7.91–7.87 (m, 1H), 7.85–7.81 (m, 2H), 7.70 (t, <i>J</i> = 5.6 Hz, 1H), 7.68–7.65 (m, 1H), 7.60 (q, <i>J</i> = 6.6, 5.8 Hz, 2H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.234 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calculated for C<sub>21</sub>H<sub>12</sub>F<sub>3</sub>N<sub>3</sub>OS<sup>+</sup>, 412.0726; found, 412.0738.</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 5-(4-(Pyrrolo[1,2-<i>a</i>]pyrazin-1-yloxy)-2-(trifluoromethyl)phenyl)imidazo[1,2-<i>a</i>]pyridine (<b>47</b>)</h4><div class="NLM_p last">Starting from 1-chloropyrrolo[1,2-<i>a</i>]pyrazine and 4-bromo-3-(trifluoromethyl)phenol, compound <b>47</b> was prepared in an analogous fashion with identical conditions as compound <b>44</b>. The title compound was obtained as a beige residue, yield 95%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.44 (d, <i>J</i> = 9.1 Hz, 1H), 7.93 (s, 3H), 7.79 (dd, <i>J</i> = 8.7, 2.7 Hz, 1H), 7.72 (d, <i>J</i> = 4.7 Hz, 1H), 7.59 (d, <i>J</i> = 8.4 Hz, 1H), 7.56 (d, <i>J</i> = 2.9 Hz, 1H), 7.34–7.29 (m, 2H), 7.12 (dd, <i>J</i> = 5.0, 2.8 Hz, 1H), 7.07 (d, <i>J</i> = 4.0 Hz, 1H), 6.96–6.92 (m, 1H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.057 min. MS (ESI) <i>m</i>/<i>z</i>: 395.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 8-(4-(Imidazo[1,2-<i>a</i>]pyridin-5-yl)-3-(trifluoromethyl)phenoxy)imidazo[1,2-<i>a</i>]pyrazine (<b>48</b>)</h4><div class="NLM_p last">Starting from 8-chloroimidazo[1,2-<i>a</i>]pyrazine and 4-bromo-3-(trifluoromethyl)phenol, compound <b>48</b> was prepared in an analogous fashion with identical conditions as compound <b>44</b>. The title compound was obtained as a beige residue, yield 89%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.45 (d, <i>J</i> = 9.2 Hz, 1H), 8.05–8.01 (m, 2H), 7.96 (s, 1H), 7.94–7.91 (m, 2H), 7.89 (s, 1H), 7.87–7.85 (m, 1H), 7.63 (d, <i>J</i> = 8.4 Hz, 1H), 7.54 (d, <i>J</i> = 4.5 Hz, 1H), 7.35 (d, <i>J</i> = 7.2 Hz, 1H), 7.32–7.29 (m, 1H). HPLC 99% pure, <i>t</i><sub>R</sub> = 3.431 min. MS (ESI) <i>m</i>/<i>z</i>: 396.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 5-(4-(Pyridin-2-yloxy)-2-(trifluoromethyl)phenyl)imidazo[1,2-<i>a</i>]pyridine (<b>49</b>)</h4><div class="NLM_p last">Starting from 2-chloropyridine and 4-bromo-3-(trifluoromethyl)phenol, compound <b>49</b> was prepared in an analogous fashion with identical conditions as compound <b>44</b>. The title compound was obtained as a light brown oil, yield 79%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.22 (d, <i>J</i> = 4.4 Hz, 1H), 8.10 (td, <i>J</i> = 15.3, 14.7, 8.6 Hz, 3H), 8.01–7.97 (m, 1H), 7.86–7.81 (m, 2H), 7.78 (d, <i>J</i> = 8.4 Hz, 1H), 7.69 (d, <i>J</i> = 7.3 Hz, 1H), 7.57 (d, <i>J</i> = 7.4 Hz, 1H), 7.26 (dd, <i>J</i> = 12.5, 7.9 Hz, 2H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.134 min. MS (ESI) <i>m</i>/<i>z</i>: 356.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 5-(4-((4-(Piperidin-1-yl)pyridin-2-yl)oxy)-2-(trifluoromethyl)phenyl)imidazo[1,2-<i>a</i>]pyridine (<b>50</b>)</h4><div class="NLM_p last">Starting from 2-chloro-4-(piperidin-1-yl)pyridine and 4-bromo-3-(trifluoromethyl)phenol, compound <b>50</b> was prepared in an analogous fashion with identical conditions as compound <b>44</b>. The title compound was obtained as a brown residue, yield 96%. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.12 (d, <i>J</i> = 11.3 Hz, 3H), 7.95–7.90 (m, 2H), 7.85 (d, <i>J</i> = 8.4 Hz, 1H), 7.80 (s, 1H), 7.77 (d, <i>J</i> = 8.3 Hz, 1H), 7.56 (d, <i>J</i> = 6.8 Hz, 1H), 6.95 (d, <i>J</i> = 7.2 Hz, 1H), 6.56 (s, 1H), 3.63 (t, <i>J</i> = 5.4 Hz, 4H), 1.80–1.76 (m, 2H), 1.72 (s, 4H). HPLC 99% pure, <i>t</i><sub>R</sub> = 4.249 min. MS (ESI) <i>m</i>/<i>z</i>: 439.2 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Experimental Procedures for in Vitro Pharmacology Assays</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> General Procedures</h4><div class="NLM_p last">Protocols of the cAMP biosensor and bioluminescent resonance energy transfer (BRET) assays are detailed below.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> D<sub>1</sub>R G<sub>S</sub>-mediated G<sub>S</sub>-cAMP Accumulation Assay</h4><div class="NLM_p last">D<sub>1</sub>R G<sub>S</sub>-mediated G<sub>S</sub>-cAMP accumulation assays with HEK293T cells co-expressing human D<sub>1</sub> and the cAMP biosensor GloSensor-22F (Promega) were performed. Cells were seeded (15 000 cells/40 μL/well) into white 384 clear-bottom, tissue culture plates in DMEM containing 1% dialyzed fetal bovine serum (FBS). Next day, drug dilutions were diluted in HBSS, 20 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (HEPES), 0.1% bovine serum albumin (BSA), 0.01% ascorbic acid, pH 7.4. Next, media was decanted from 384 well plates and 20 μL of drug buffer (HBSS, 20 mM HEPES, pH 7.4) containing GloSensor reagent was added per well and allowed to equilibrate for at least 15 min room temperature. To start the assay, cells were treated with 10 μL per well of 3× drug diluted in HBSS, 20 mM HEPES, 0.1% BSA, 0.01% ascorbic acid, pH 7.4 using a FLIPR (molecular devices). After 15 min, G<sub>S</sub>-cAMP accumulation was read on a TriLux Microbeta (PerkinElmer) plate counter. Data were normalized to maximum G<sub>S</sub>-cAMP accumulation by dopamine (100%). Data were analyzed using the sigmoidal dose–response function built into GraphPad Prism 5.0.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> BRET β-Arrestin2 Assay</h4><div class="NLM_p last">To measure D1R-mediated β-arrestin2 recruitment, HEK293T cells were co-transfected in a 1:15 ratio with human D<sub>1</sub> containing a C-terminal renilla luciferase (RLuc8), and Venus-tagged N-terminal β-arrestin2. Next day, transfected cells were plated in polylysine coated 96-well white clear bottom cell culture plates in plating media (DMEM + 1% dialyzed FBS) at a density of 25–40 000 cells in 200 μL per well and incubated overnight. Next day, media was decanted and cells were washed twice with 60 μL of drug buffer (1× HBSS, 20 mM HEPES, 0.1% BSA, 0.01% ascorbic acid, pH 7.4). Then, 60 μL of drug buffer, 30 μL of drug (3×), and 10 μL (10×) of RLuc substrate, coelenterazine h (Promega, 5 μM final concentration) 15 min was added per well before reading. Plates were read for both luminescence at 485 nm and fluorescent eYFP emission at 530 nm for 1 s per well using a Mithras LB940. The ratio of eYFP/RLuc was calculated per well, and the net BRET ratio was calculated by subtracting the eYFP/RLuc per well from the eYFP/RLuc ratio in wells without Venus-β-arrestin2 present. The net BRET ratio was plotted as a function of drug concentration using Graphpad Prism 5 (Graphpad Software Inc., San Diego, CA). Data were normalized to % dopamine stimulation and analyzed using nonlinear regression log(agonist) versus response.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Bias Calculation</h3><div class="NLM_p">Transduction coefficients [log(τ/<i>K</i><sub>A</sub>)] were calculated using the Black and Leff operational model in Graphpad Prism 5.0, where τ is agonist efficacy and <i>K</i><sub>A</sub> is the equilibrium dissociation constant. Using dopamine as the full agonist reference, transduction coefficients for G<sub>S</sub> activity and β-arrestin2 recruitment were calculated and averaged across experiments. Calculation of bias factors utilized the method by Kenakin et al., where the Δlog(τ/<i>K</i><sub>A</sub>) was calculated relative to the reference and the ΔΔlog(τ/<i>K</i><sub>A</sub>) was calculated by subtracting the G<sub>S</sub> from β-arrestin2 transduction coefficient.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Radioligand Binding Affinity Assay</h4><div class="NLM_p last">Assays were performed exactly as described in previous publications.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Further information regarding the assay protocols can be found online in greater detail at <a href="https://pdspdb.unc.edu/pdspWeb/?site=assays" class="extLink">https://pdspdb.unc.edu/pdspWeb/?site=assays</a>.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Experimental Procedures for in Vivo Pharmacokinetic Studies</h3><div class="NLM_p last">Compound <b>40</b> was taken up in 5% NMP, 5% Solutol HS-15, and 90% normal saline for formulation. Nine male Swiss Albino mice were administered intraperitoneally with the formulated solution of compound <b>40</b> at 50 mg/kg dose. Blood samples (approximately 60 μL) were collected from a set of three mice at 0.5, 1.5, and 4 h under light isoflurane anesthesia. Plasma was harvested by centrifugation of blood and stored at −70 ± 10 °C until analysis. Brain samples were collected from a set of three mice at each time point at 0.5, 1.5 and 4 h immediately after blood collection. Brain samples were homogenized using ice-cooled phosphate buffer saline (pH 7.4) in a ratio of 2 (buffer):1 (brain). Homogenates were stored below −70 ± 10 °C until analysis. Total homogenate volume was three times the brain weight. The plasma and brain concentration–time data of compound <b>40</b> was used for the pharmacokinetic analysis. Pharmacokinetic analysis was performed using the NCA module of Phoenix WinNonlin (Version 7.0). Plasma and brain samples were quantified by fit-for-purpose LCMS–MS method (LLOQ: 1.01 ng/mL for plasma and 3.03 ng/g for brain).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00351" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00351" class="ext-link">10.1021/acs.jmedchem.9b00351</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H NMR spectra of compounds <b>40</b> and <b>41</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00351/suppl_file/jm9b00351_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00351/suppl_file/jm9b00351_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00351/suppl_file/jm9b00351_si_001.pdf">jm9b00351_si_001.pdf (212.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00351/suppl_file/jm9b00351_si_002.csv">jm9b00351_si_002.csv (4.77 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00351" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. McCorvy</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and National Institute of Mental Health Psychoactive
Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#81ebece2e2eef3f7f8c1ece2f6afe4e5f4"><span class="__cf_email__" data-cfemail="d3b9beb0b0bca1a5aa93beb0a4fdb6b7a6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc G. Caron</span> - <span class="hlFld-Affiliation affiliation">Department of Cell Biology, 
    Department of Medicine
and Neurobiology, 
     and , Duke University Medical
Center, Durham, North Carolina 27710, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#65080417064b0604170a0b2501100e004b000110"><span class="__cf_email__" data-cfemail="6a070b180944090b1805042a0e1f010f440f0e1f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan L. Roth</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and National Institute of Mental Health Psychoactive
Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0561-6520" title="Orcid link">http://orcid.org/0000-0002-0561-6520</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f290808b939cad809d869ab29f9796dc879c91dc979687"><span class="__cf_email__" data-cfemail="dfbdada6beb180adb0abb79fb2babbf1aab1bcf1babbaa">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Jin</span> - <span class="hlFld-Affiliation affiliation">Mount
Sinai Center for Therapeutics Discovery, Departments of Pharmacological
Sciences and Oncological Sciences, Tisch Cancer Institute and , Icahn School of Medicine
at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2387-3862" title="Orcid link">http://orcid.org/0000-0002-2387-3862</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#39535058571753505779544a4a54175c5d4c"><span class="__cf_email__" data-cfemail="bdd7d4dcd393d7d4d3fdd0ceced093d8d9c8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael
L. Martini</span> - <span class="hlFld-Affiliation affiliation">Mount
Sinai Center for Therapeutics Discovery, Departments of Pharmacological
Sciences and Oncological Sciences, Tisch Cancer Institute, 
    Medical Scientist
Training Program, 
     and , Icahn School of Medicine
at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Liu</span> - <span class="hlFld-Affiliation affiliation">Mount
Sinai Center for Therapeutics Discovery, Departments of Pharmacological
Sciences and Oncological Sciences, Tisch Cancer Institute and , Icahn School of Medicine
at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline Ray</span> - <span class="hlFld-Affiliation affiliation">Department of Cell Biology and , Duke University Medical
Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xufen Yu</span> - <span class="hlFld-Affiliation affiliation">Mount
Sinai Center for Therapeutics Discovery, Departments of Pharmacological
Sciences and Oncological Sciences, Tisch Cancer Institute and , Icahn School of Medicine
at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xi-Ping Huang</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and National Institute of Mental Health Psychoactive
Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aarti Urs</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, Florida 32610, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikhil Urs</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, Florida 32610, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28734" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28734" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the grant R01NS100930 (to M.G.C., J.J. and N.U.) from the U.S. National Institutes of Health. J.J. and B.L.R. acknowledge the support by the grant U24DK116195 from the U.S. National Institutes of Health. M.L.M. acknowledges the support by the NIGMS-funded Integrated Pharmacological Sciences Training Program T32 GM062754 and the MSTP training grants at the Icahn School of Mount Sinai (NIH T32 GM007280). The authors acknowledge Drs. H. Ümit Kaniskan and Yudao Shen for their critical review of this manuscript and advice in experimental planning and manuscript preparation.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">SFSR</td><td class="NLM_def"><p class="first last">structure–functional selectivity relationship</p></td></tr><tr><td class="NLM_term">D<sub>1</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>1</sub> receptor</p></td></tr><tr><td class="NLM_term">G<sub>S</sub></td><td class="NLM_def"><p class="first last">stimulatory G protein</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">RHS</td><td class="NLM_def"><p class="first last">right-hand side</p></td></tr><tr><td class="NLM_term">LHS</td><td class="NLM_def"><p class="first last">left-hand side</p></td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">D<sub>2</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>2</sub> receptor</p></td></tr><tr><td class="NLM_term">D<sub>3</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>3</sub> receptor</p></td></tr><tr><td class="NLM_term">D<sub>4</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>4</sub> receptor</p></td></tr><tr><td class="NLM_term">D<sub>5</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>5</sub> receptor</p></td></tr><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine</p></td></tr><tr><td class="NLM_term">H1</td><td class="NLM_def"><p class="first last">histamine receptor 1</p></td></tr><tr><td class="NLM_term">H2</td><td class="NLM_def"><p class="first last">histamine receptor 2</p></td></tr><tr><td class="NLM_term">M1</td><td class="NLM_def"><p class="first last">muscarinic receptor 1</p></td></tr><tr><td class="NLM_term">M2</td><td class="NLM_def"><p class="first last">muscarinic receptor 2</p></td></tr><tr><td class="NLM_term">M3</td><td class="NLM_def"><p class="first last">muscarinic receptor 3</p></td></tr><tr><td class="NLM_term">MOR</td><td class="NLM_def"><p class="first last">μ opioid receptor</p></td></tr><tr><td class="NLM_term">KOR</td><td class="NLM_def"><p class="first last">kappa opioid receptor</p></td></tr><tr><td class="NLM_term">SERT</td><td class="NLM_def"><p class="first last">serotonin transporter</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rask-Andersen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almén, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiöth, H. B.</span></span> <span> </span><span class="NLM_article-title">Trends in the exploitation of novel drug targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1038/nrd3478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnrd3478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=21804595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFKqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=579-590&author=M.+Rask-Andersenauthor=M.+S.+Alm%C3%A9nauthor=H.+B.+Schi%C3%B6th&title=Trends+in+the+exploitation+of+novel+drug+targets&doi=10.1038%2Fnrd3478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in the exploitation of novel drug targets</span></div><div class="casAuthors">Rask-Andersen, Mathias; Almen, Markus Saellman; Schioeth, Helgi B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">579-590</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery and exploitation of new drug targets is a key focus for both the pharmaceutical industry and academic biomedical research.  To provide an insight into trends in the exploitation of new drug targets, we have analyzed the drugs that were approved by the US Food and Drug Administration during the past three decades and examd. the interactions of these drugs with therapeutic targets that are encoded by the human genome, using the DrugBank database and extensive manual curation.  We have identified 435 effect-mediating drug targets in the human genome, which are modulated by 989 unique drugs, through 2,242 drug-target interactions.  We also analyze trends in the introduction of drugs that modulate previously unexploited targets, and discuss the network pharmacol. of the drugs in our data set.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo19FXXFB-PsLVg90H21EOLACvtfcHk0lhUJ9GuhzHfDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFKqsLc%253D&md5=9255431a28f2c07759b0f36975711f84</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3478%26sid%3Dliteratum%253Aachs%26aulast%3DRask-Andersen%26aufirst%3DM.%26aulast%3DAlm%25C3%25A9n%26aufirst%3DM.%2BS.%26aulast%3DSchi%25C3%25B6th%26aufirst%3DH.%2BB.%26atitle%3DTrends%2520in%2520the%2520exploitation%2520of%2520novel%2520drug%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D579%26epage%3D590%26doi%3D10.1038%2Fnrd3478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">How Ligands Illuminate GPCR Molecular Pharmacology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.cell.2017.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=28753422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GisLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2017&pages=414-427&author=D.+Wackerauthor=R.+C.+Stevensauthor=B.+L.+Roth&title=How+Ligands+Illuminate+GPCR+Molecular+Pharmacology&doi=10.1016%2Fj.cell.2017.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">How ligands illuminate GPCR molecular pharmacology</span></div><div class="casAuthors">Wacker, Daniel; Stevens, Raymond C.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">414-427</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs), which are modulated by a variety of endogenous and synthetic ligands, represent the largest family of druggable targets in the human genome.  Recent structural and mol. studies have both transformed and expanded classical concepts of receptor pharmacol. and have begun to illuminate the distinct mechanisms by which structurally, chem., and functionally diverse ligands modulate GPCR function.  These mol. insights into ligand engagement and action have enabled new computational methods and accelerated the discovery of novel ligands and tool compds., esp. for understudied and orphan GPCRs.  These advances promise to streamline the development of GPCR-targeted medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCNWK2Zg6HebVg90H21EOLACvtfcHk0lgmbalI0MpvLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GisLvF&md5=d4f7f48d757cf3d13a980d2f7f1be138</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DHow%2520Ligands%2520Illuminate%2520GPCR%2520Molecular%2520Pharmacology%26jtitle%3DCell%26date%3D2017%26volume%3D170%26spage%3D414%26epage%3D427%26doi%3D10.1016%2Fj.cell.2017.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span> <span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1124/pr.110.002642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.-M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors&doi=10.1124%2Fpr.110.002642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0lgmbalI0MpvLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.-M.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217%26doi%3D10.1124%2Fpr.110.002642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spano, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabucchi, M.</span></span> <span> </span><span class="NLM_article-title">Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system</span>. <i>Adv. Biochem. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=358777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaE1cXmtV2gsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1978&pages=155-165&author=P.+F.+Spanoauthor=S.+Govoniauthor=M.+Trabucchi&title=Studies+on+the+pharmacological+properties+of+dopamine+receptors+in+various+areas+of+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system</span></div><div class="casAuthors">Spano, P. F.; Govoni, S.; Trabucchi, M.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biochemical Psychopharmacology</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">Dopamine</span>),
    <span class="NLM_cas:pages">155-65</span>CODEN:
                <span class="NLM_cas:coden">ABPYBL</span>;
        ISSN:<span class="NLM_cas:issn">0065-2229</span>.
    </div><div class="casAbstract">A review with 4 refs. of studies on the pharmacol. properties of dopamine (I)  [51-61-6] receptors in various areas of the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC0TSNtsLbfLVg90H21EOLACvtfcHk0lgmbalI0MpvLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXmtV2gsr0%253D&md5=1dc94041ad8f5201f508d9736220c142</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpano%26aufirst%3DP.%2BF.%26aulast%3DGovoni%26aufirst%3DS.%26aulast%3DTrabucchi%26aufirst%3DM.%26atitle%3DStudies%2520on%2520the%2520pharmacological%2520properties%2520of%2520dopamine%2520receptors%2520in%2520various%2520areas%2520of%2520the%2520central%2520nervous%2520system%26jtitle%3DAdv.%2520Biochem.%2520Psychopharmacol.%26date%3D1978%26volume%3D19%26spage%3D155%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greengard, P.</span></span> <span> </span><span class="NLM_article-title">The neurobiology of dopamine signaling</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1023/a:1013205230142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1023%2Fa%3A1013205230142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=11892993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFSmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=247-269&author=P.+Greengard&title=The+neurobiology+of+dopamine+signaling&doi=10.1023%2Fa%3A1013205230142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The neurobiology of dopamine signaling</span></div><div class="casAuthors">Greengard, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Bioscience Reports</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-269</span>CODEN:
                <span class="NLM_cas:coden">BRPTDT</span>;
        ISSN:<span class="NLM_cas:issn">0144-8463</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">A review with refs.  The biochem. of synaptic transmission, esp. the neurobiol. of dopamine signaling, is discussed.  The elucidation of the principles underlying slow synaptic transmission and the discovery of numerous components of the underlying intracellular signaling pathways have provided a no. of novel therapeutic targets for the treatment of neurol. and psychiatric illnesses assocd. with abnormalities of dopamine signaling.  Levodopa is effective in most patients with Parkinson's disease.  It is converted to dopamine, which then activates dopamine receptors and alleviates the disease symptoms.  Unfortunately, within a short time, many Parkinson's patients become refractory to Levodopa treatment.  This refractoriness is probably the result in part of down-regulation of dopamine receptors.  It should be possible, through the new-found knowledge of the intracellular signaling pathways by which dopamine produces its physiol. effects, to develop various therapeutic substances that activate or inhibit these various intracellular components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK48-i-tJZe7Vg90H21EOLACvtfcHk0lgmbalI0MpvLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFSmtLo%253D&md5=1a899c5801216bc46e6d99928f3a1f09</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1023%2Fa%3A1013205230142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252Fa%253A1013205230142%26sid%3Dliteratum%253Aachs%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DThe%2520neurobiology%2520of%2520dopamine%2520signaling%26jtitle%3DBiosci.%2520Rep.%26date%3D2001%26volume%3D21%26spage%3D247%26epage%3D269%26doi%3D10.1023%2Fa%3A1013205230142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotnikova, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marion, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2005.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.cell.2005.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=16051150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFGjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2005&pages=261-273&author=J.-M.+Beaulieuauthor=T.+D.+Sotnikovaauthor=S.+Marionauthor=R.+J.+Lefkowitzauthor=R.+R.+Gainetdinovauthor=M.+G.+Caron&title=An+Akt%2F%CE%B2-Arrestin+2%2FPP2A+Signaling+Complex+Mediates+Dopaminergic+Neurotransmission+and+Behavior&doi=10.1016%2Fj.cell.2005.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Sotnikova, Tatyana D.; Marion, Sebastien; Lefkowitz, Robert J.; Gainetdinov, Raul R.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Dopamine plays an important role in the etiol. of schizophrenia, and D2 class dopamine receptors are the best-established target of antipsychotic drugs.  Here we show that D2 class-receptor-mediated Akt regulation involves the formation of signaling complexes contg. β-arrestin 2, PP2A, and Akt.  β-Arrestin 2 deficiency in mice results in redn. of dopamine-dependent behaviors, loss of Akt regulation by dopamine in the striatum, and disruption of the dopamine-dependent interaction of Akt with its neg. regulator, protein phosphatase 2A.  Importantly, canonical cAMP-mediated dopamine-receptor signaling is not inhibited in the absence of β-arrestin 2.  These results demonstrate that, apart from its classical function in receptor desensitization, β-arrestin 2 also acts as a signaling intermediate through a kinase/phosphatase scaffold.  Furthermore, this function of β-arrestin 2 is important for the expression of dopamine-assocd. behaviors, thus implicating β-arrestin 2 as a pos. mediator of dopaminergic synaptic transmission and a potential pharmacol. target for dopamine-related psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC2L_HMvsJuLVg90H21EOLACvtfcHk0lhJmwum271oYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFGjsLw%253D&md5=841fbd1ab433f4795631118d9de65e4b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.-M.%26aulast%3DSotnikova%26aufirst%3DT.%2BD.%26aulast%3DMarion%26aufirst%3DS.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DAn%2520Akt%252F%25CE%25B2-Arrestin%25202%252FPP2A%2520Signaling%2520Complex%2520Mediates%2520Dopaminergic%2520Neurotransmission%2520and%2520Behavior%26jtitle%3DCell%26date%3D2005%26volume%3D122%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fj.cell.2005.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urs, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigle, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">A Dopamine D1 Receptor-Dependent β-Arrestin Signaling Complex Potentially Regulates Morphine-Induced Psychomotor Activation but not Reward in Mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1038/npp.2010.186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnpp.2010.186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=20980993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=551-558&author=N.+M.+Ursauthor=T.+L.+Daigleauthor=M.+G.+Caron&title=A+Dopamine+D1+Receptor-Dependent+%CE%B2-Arrestin+Signaling+Complex+Potentially+Regulates+Morphine-Induced+Psychomotor+Activation+but+not+Reward+in+Mice&doi=10.1038%2Fnpp.2010.186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A Dopamine D1 Receptor-Dependent β-Arrestin Signaling Complex Potentially Regulates Morphine-Induced Psychomotor Activation but not Reward in Mice</span></div><div class="casAuthors">Urs, Nikhil M.; Daigle, Tanya L.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">551-558</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Morphine is a widely used analgesic in humans that is assocd. with multiple untoward effects, such as addiction and phys. dependence.  In rodent models, morphine also induces locomotor activity.  These effects likely involve functionally selective mechanisms.  Indeed, G protein-coupled receptor desensitization and adaptor protein β-arrestin 2 (βarr2) through its interaction with the μ-opioid receptor regulates the analgesic but not the rewarding properties of morphine.  However, βarr2 is also required for morphine-induced locomotor activity in mice, but the exact cellular and mol. mechanisms that mediate this arrestin-dependent behavior are not understood.  In this study, we show that βarr2 is required for morphine-induced locomotor activity in a dopamine D1 receptor (D1R)-dependent manner and that a βarr2/phospho-ERK (βarr2/pERK) signaling complex may mediate this behavior.  Systemic administration of SL327, an MEK inhibitor, inhibits morphine-induced locomotion in wild-type mice in a dose-dependent manner.  Acute morphine administration to mice promotes the formation of a βarr2/pERK signaling complex.  Morphine-induced locomotor activity and formation of the βarr2/pERK signaling complex is blunted in D1R knockout (D1-KO) mice and is presumably independent of D2 dopamine receptors.  However, D1Rs are not required for morphine-induced reward as D1-KO mice show the same conditioned place preference for morphine as do control mice.  Taken together, these results suggest a potential role for a D1R-dependent βarr2/pERK signaling complex in selectively mediating the locomotor-stimulating but not the rewarding properties of morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEqpxpdYvWw7Vg90H21EOLACvtfcHk0lhJmwum271oYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtQ%253D%253D&md5=54a307ae3ad0968f15c8f23bf3da166d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2010.186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2010.186%26sid%3Dliteratum%253Aachs%26aulast%3DUrs%26aufirst%3DN.%2BM.%26aulast%3DDaigle%26aufirst%3DT.%2BL.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DA%2520Dopamine%2520D1%2520Receptor-Dependent%2520%25CE%25B2-Arrestin%2520Signaling%2520Complex%2520Potentially%2520Regulates%2520Morphine-Induced%2520Psychomotor%2520Activation%2520but%2520not%2520Reward%2520in%2520Mice%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D551%26epage%3D558%26doi%3D10.1038%2Fnpp.2010.186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenoy, S. K.</span></span> <span> </span><span class="NLM_article-title">Transduction of Receptor Signals by -Arrestins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>308</i></span>,  <span class="NLM_fpage">512</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1126/science.1109237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1126%2Fscience.1109237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=15845844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlOjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2005&pages=512-517&author=R.+J.+Lefkowitzauthor=S.+K.+Shenoy&title=Transduction+of+Receptor+Signals+by+-Arrestins&doi=10.1126%2Fscience.1109237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Transduction of Receptor Signals by β-Arrestins</span></div><div class="casAuthors">Lefkowitz, Robert J.; Shenoy, Sudha K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">5721</span>),
    <span class="NLM_cas:pages">512-517</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  The transmission of extracellular signals to the interior of the cell is a function of plasma membrane receptors, of which the seven transmembrane receptor family is by far the largest and most versatile.  Classically, these receptors stimulate heterotrimeric G proteins, which control rates of generation of diffusible second messengers and entry of ions at the plasma membrane.  Recent evidence, however, indicates another previously unappreciated strategy used by the receptors to regulate intracellular signaling pathways.  They direct the recruitment, activation, and scaffolding of cytoplasmic signaling complexes via two multifunctional adaptor and transducer mols., β-arrestins 1 and 2.  This mechanism regulates aspects of cell motility, chemotaxis, apoptosis, and likely other cellular functions through a rapidly expanding list of signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk2fXdqgYhC7Vg90H21EOLACvtfcHk0lhJmwum271oYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlOjtLs%253D&md5=ed070237312d050e5d5ec437b3adc76c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1109237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1109237%26sid%3Dliteratum%253Aachs%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DShenoy%26aufirst%3DS.%2BK.%26atitle%3DTransduction%2520of%2520Receptor%2520Signals%2520by%2520-Arrestins%26jtitle%3DScience%26date%3D2005%26volume%3D308%26spage%3D512%26epage%3D517%26doi%3D10.1126%2Fscience.1109237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Attramadal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arriza, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwatra, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">17882</span>– <span class="NLM_lpage">17890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1517224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaK3sXisV2qt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=17882-17890&author=H.+Attramadalauthor=J.+L.+Arrizaauthor=C.+Aokiauthor=T.+M.+Dawsonauthor=J.+Codinaauthor=M.+M.+Kwatraauthor=S.+H.+Snyderauthor=M.+G.+Caronauthor=R.+J.+Lefkowitz&title=Beta-arrestin2%2C+a+novel+member+of+the+arrestin%2Fbeta-arrestin+gene+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">β-Arrestin2, a novel member of the arrestin/β-arrestin gene family</span></div><div class="casAuthors">Attramadal, Havard; Arriza, Jeffrey L.; Aoki, Chiye; Dawson, Ted M.; Codina, Juan; Kwatra, Madan M.; Snyder, Solomon H.; Caron, Marc G.; Lefkowitz, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">17882-90</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Homologs or agonist-specific desensitization of β-adrenergic receptors (β2AR) is mediated by the β-adrenergic receptor kinase (βARK) which specifically phosphorylates the agonist-occupied form of the receptor.  However, the capacity of βARK-phosphorylated β2AR to stimulate Gs in a reconstituted system is only minimally impaired.  Recently, a protein termed β-arrestin, was cloned from a bovine brain cDNA library and found to quench phosphorylated β2AR-coupling to Gs.  Utilizing a low stringency hybridization technique to screen a rat brain cDNA library, cDNA clones representing two distinct β-arrestin-like genes were isolated.  One of the cDNAs is the rat homolog of bovine β-arrestin (β-arrestin1).  In addn., a cDNA clone encoding a novel, β-arrestin-related protein was isolated which was termed β-arrestin2.  Overall, β-arrestin2 exhibits 78% amino acid identity with β-arrestin1.  The primary structure of these proteins delineates a family of proteins that regulates receptor coupling to G proteins.  The capacity of purified β-arrestin1, β-arrestin2, and arrestin to inhibit the coupling of phosphorylated receptors to their resp. G proteins were assessed in a reconstituted β2AR-Gs system and in a reconstituted rhodopsin-GT system.  β-Arrestin2 was equipotent to β-arrestin1 and specifically inhibited β2AR function.  Conversely, arrestin inhibited rhodopsin coupling to GT, whereas β-arrestin1 and β-arrestin2 were at least 20-fold less potent in this system.  β-Arrestin1 and β-arrestin2 are predominantly localized in neuronal tissues and in the spleen.  However, low mRNA levels can be detected in most peripheral tissues.  In the central nervous system, β-arrestin2 appears to be even more abundant than β-arrestin1.  Immunohistochem. anal. of the tissue distribution of β-arrestin1 and β-arrestin2 in rat brain shows extensive, but heterogeneous, neuronal labeling of the two proteins.  They are found in several neuronal pathways suggesting that they have relatively broad receptor specificity regulating many G protein-coupled receptors.  Furthermore, immunoelectron microscopy shows that the β-arrestins are appropriately situated at postsynaptic sites to act in concert with βARK to regulate G protein-coupled neurotransmitter receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOAuYQ15wDkbVg90H21EOLACvtfcHk0limcasYNB8CSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXisV2qt7w%253D&md5=b6847e8bdbaacd4928da1d5b970af31f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAttramadal%26aufirst%3DH.%26aulast%3DArriza%26aufirst%3DJ.%2BL.%26aulast%3DAoki%26aufirst%3DC.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DCodina%26aufirst%3DJ.%26aulast%3DKwatra%26aufirst%3DM.%2BM.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DBeta-arrestin2%252C%2520a%2520novel%2520member%2520of%2520the%2520arrestin%252Fbeta-arrestin%2520gene%2520family%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D17882%26epage%3D17890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roudabush, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choy, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">Activation and targeting of extracellular signal-regulated kinases by -arrestin scaffolds</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">2449</span>– <span class="NLM_lpage">2454</span>, <span class="refDoi"> DOI: 10.1073/pnas.041604898</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1073%2Fpnas.041604898" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=2449-2454&author=L.+M.+Luttrellauthor=F.+L.+Roudabushauthor=E.+W.+Choyauthor=W.+E.+Millerauthor=M.+E.+Fieldauthor=K.+L.+Pierceauthor=R.+J.+Lefkowitz&title=Activation+and+targeting+of+extracellular+signal-regulated+kinases+by+-arrestin+scaffolds&doi=10.1073%2Fpnas.041604898"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.041604898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.041604898%26sid%3Dliteratum%253Aachs%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26aulast%3DRoudabush%26aufirst%3DF.%2BL.%26aulast%3DChoy%26aufirst%3DE.%2BW.%26aulast%3DMiller%26aufirst%3DW.%2BE.%26aulast%3DField%26aufirst%3DM.%2BE.%26aulast%3DPierce%26aufirst%3DK.%2BL.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DActivation%2520and%2520targeting%2520of%2520extracellular%2520signal-regulated%2520kinases%2520by%2520-arrestin%2520scaffolds%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D2449%26epage%3D2454%26doi%3D10.1073%2Fpnas.041604898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeFea, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalevsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Déry, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N. W.</span></span> <span> </span><span class="NLM_article-title">β-Arrestin-Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">1267</span>– <span class="NLM_lpage">1282</span>, <span class="refDoi"> DOI: 10.1083/jcb.148.6.1267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1083%2Fjcb.148.6.1267" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2000&pages=1267-1282&author=K.+A.+DeFeaauthor=J.+Zalevskyauthor=M.+S.+Thomaauthor=O.+D%C3%A9ryauthor=R.+D.+Mullinsauthor=N.+W.+Bunnett&title=%CE%B2-Arrestin-Dependent+Endocytosis+of+Proteinase-Activated+Receptor+2+Is+Required+for+Intracellular+Targeting+of+Activated+Erk1%2F2&doi=10.1083%2Fjcb.148.6.1267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1083%2Fjcb.148.6.1267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.148.6.1267%26sid%3Dliteratum%253Aachs%26aulast%3DDeFea%26aufirst%3DK.%2BA.%26aulast%3DZalevsky%26aufirst%3DJ.%26aulast%3DThoma%26aufirst%3DM.%2BS.%26aulast%3DD%25C3%25A9ry%26aufirst%3DO.%26aulast%3DMullins%26aufirst%3DR.%2BD.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26atitle%3D%25CE%25B2-Arrestin-Dependent%2520Endocytosis%2520of%2520Proteinase-Activated%2520Receptor%25202%2520Is%2520Required%2520for%2520Intracellular%2520Targeting%2520of%2520Activated%2520Erk1%252F2%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2000%26volume%3D148%26spage%3D1267%26epage%3D1282%26doi%3D10.1083%2Fjcb.148.6.1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laporte, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">beta -Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">1574</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1126/science.290.5496.1574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1126%2Fscience.290.5496.1574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=11090355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotl2ks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=1574-1577&author=P.+H.+McDonaldauthor=C.-W.+Chowauthor=W.+E.+Millerauthor=S.+A.+Laporteauthor=M.+E.+Fieldauthor=F.-T.+Linauthor=R.+J.+Davisauthor=R.+J.+Lefkowitz&title=beta+-Arrestin+2%3A+A+Receptor-Regulated+MAPK+Scaffold+for+the+Activation+of+JNK3&doi=10.1126%2Fscience.290.5496.1574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">β-Arrestin 2: A receptor-regulated MAPK scaffold for the activation of JNK3</span></div><div class="casAuthors">McDonald, Patricia H.; Chow, Chi-Wing; Miller, William E.; Laporte, Stephane A.; Field, Michael E.; Lin, Fang-Tsyr; Davis, Roger J.; Lefkowitz, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">5496</span>),
    <span class="NLM_cas:pages">1574-1577</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">β-Arrestins, originally discovered in the context of heterotrimeric guanine nucleotide binding protein-coupled receptor (GPCR) desensitization, also function in internalization and signaling of these receptors.  We identified c-Jun amino-terminal kinase 3 (JNK3) as a binding partner of β-arrestin 2 using a yeast two-hybrid screen and by coimmunopptn. from mouse brain exts. or cotransfected COS-7 cells.  The upstream JNK activators apoptosis signal-regulating kinase 1 (ASK1) and mitogen-activated protein kinase (MAPK) kinase 4 were also found in complex with β-arrestin 2.  Cellular transfection of β-arrestin 2 caused cytosolic retention of JNK3 and enhanced JNK3 phosphorylation stimulated by ASK1.  Moreover, stimulation of the angiotensin II type 1A receptor activated JNK3 and triggered the colocalization of β-arrestin 2 and active JNK3 to intracellular vesicles.  Thus, β-arrestin 2 acts as a scaffold protein, which brings the spatial distribution and activity of this MAPK module under the control of a GPCR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd3_ayCtQ7gbVg90H21EOLACvtfcHk0limcasYNB8CSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotl2ks7w%253D&md5=1f4b206ba2b12681d75792a8841b7533</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.290.5496.1574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.290.5496.1574%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DP.%2BH.%26aulast%3DChow%26aufirst%3DC.-W.%26aulast%3DMiller%26aufirst%3DW.%2BE.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26aulast%3DField%26aufirst%3DM.%2BE.%26aulast%3DLin%26aufirst%3DF.-T.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3Dbeta%2520-Arrestin%25202%253A%2520A%2520Receptor-Regulated%2520MAPK%2520Scaffold%2520for%2520the%2520Activation%2520of%2520JNK3%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D1574%26epage%3D1577%26doi%3D10.1126%2Fscience.290.5496.1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tohgo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choy, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesty-Palmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laporte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oakley, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span> <span> </span><span class="NLM_article-title">The Stability of the G Protein-coupled Receptor-β-Arrestin Interaction Determines the Mechanism and Functional Consequence of ERK Activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">6258</span>– <span class="NLM_lpage">6267</span>, <span class="refDoi"> DOI: 10.1074/jbc.m212231200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1074%2Fjbc.m212231200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=6258-6267&author=A.+Tohgoauthor=E.+W.+Choyauthor=D.+Gesty-Palmerauthor=K.+L.+Pierceauthor=S.+Laporteauthor=R.+H.+Oakleyauthor=M.+G.+Caronauthor=R.+J.+Lefkowitzauthor=L.+M.+Luttrell&title=The+Stability+of+the+G+Protein-coupled+Receptor-%CE%B2-Arrestin+Interaction+Determines+the+Mechanism+and+Functional+Consequence+of+ERK+Activation&doi=10.1074%2Fjbc.m212231200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m212231200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m212231200%26sid%3Dliteratum%253Aachs%26aulast%3DTohgo%26aufirst%3DA.%26aulast%3DChoy%26aufirst%3DE.%2BW.%26aulast%3DGesty-Palmer%26aufirst%3DD.%26aulast%3DPierce%26aufirst%3DK.%2BL.%26aulast%3DLaporte%26aufirst%3DS.%26aulast%3DOakley%26aufirst%3DR.%2BH.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26atitle%3DThe%2520Stability%2520of%2520the%2520G%2520Protein-coupled%2520Receptor-%25CE%25B2-Arrestin%2520Interaction%2520Determines%2520the%2520Mechanism%2520and%2520Functional%2520Consequence%2520of%2520ERK%2520Activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D6258%26epage%3D6267%26doi%3D10.1074%2Fjbc.m212231200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usui, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olefsky, J. M.</span></span> <span> </span><span class="NLM_article-title">β-Arrestin-mediated Recruitment of the Src Family Kinase Yes Mediates Endothelin-1-stimulated Glucose Transport</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">43663</span>– <span class="NLM_lpage">43667</span>, <span class="refDoi"> DOI: 10.1074/jbc.m105364200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1074%2Fjbc.m105364200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=43663-43667&author=T.+Imamuraauthor=J.+Huangauthor=S.+Dalleauthor=S.+Ugiauthor=I.+Usuiauthor=L.+M.+Luttrellauthor=W.+E.+Millerauthor=R.+J.+Lefkowitzauthor=J.+M.+Olefsky&title=%CE%B2-Arrestin-mediated+Recruitment+of+the+Src+Family+Kinase+Yes+Mediates+Endothelin-1-stimulated+Glucose+Transport&doi=10.1074%2Fjbc.m105364200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m105364200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m105364200%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DDalle%26aufirst%3DS.%26aulast%3DUgi%26aufirst%3DS.%26aulast%3DUsui%26aufirst%3DI.%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26aulast%3DMiller%26aufirst%3DW.%2BE.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26atitle%3D%25CE%25B2-Arrestin-mediated%2520Recruitment%2520of%2520the%2520Src%2520Family%2520Kinase%2520Yes%2520Mediates%2520Endothelin-1-stimulated%2520Glucose%2520Transport%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D43663%26epage%3D43667%26doi%3D10.1074%2Fjbc.m105364200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barlic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelvin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosinger, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVries, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobransky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, S. S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelvin, D. J.</span></span> <span> </span><span class="NLM_article-title">Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCR1</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/79767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2F79767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10973280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVyiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=227-233&author=J.+Barlicauthor=J.+D.+Andrewsauthor=A.+A.+Kelvinauthor=S.+E.+Bosingerauthor=M.+E.+DeVriesauthor=L.+Xuauthor=T.+Dobranskyauthor=R.+D.+Feldmanauthor=S.+S.+G.+Fergusonauthor=D.+J.+Kelvin&title=Regulation+of+tyrosine+kinase+activation+and+granule+release+through+%CE%B2-arrestin+by+CXCR1&doi=10.1038%2F79767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCR1</span></div><div class="casAuthors">Barlic, Jana; Andrews, Joseph D.; Kelvin, Alyson A.; Bosinger, Steven E.; DeVries, Mark E.; Xu, Luoling; Dobransky, Tomas; Feldman, Ross D.; Ferguson, Stephen S. G.; Kelvin, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-233</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Chemoattractant-stimulated granule release from neutrophils, basophils, and eosinophils is crit. for the innate immune response against infectious bacteria.  Interleukin 8 (IL-8) activation of the chemokine receptor CXCR1 was found to stimulate rapid formation of β-arrestin complexes with Hck or c-Fgr.  Formation of β-arrestin-Hck complexes led to Hck activation and trafficking of the complexes to granule-rich regions.  Granulocytes expressing a dominant-neg. β-arrestin-mutant did not release granules or activate tyrosine kinases after IL-8 stimulation.  Thus, β-arrestins regulate chemokine-induced granule exocytosis, indicating a broader role for β-arrestins in the regulation of cellular functions than was previously suspected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqxNWGyd4lArVg90H21EOLACvtfcHk0ljevnweqqerPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVyiur0%253D&md5=b8d91d977678631c028bb3dc9a343e64</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F79767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F79767%26sid%3Dliteratum%253Aachs%26aulast%3DBarlic%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DJ.%2BD.%26aulast%3DKelvin%26aufirst%3DA.%2BA.%26aulast%3DBosinger%26aufirst%3DS.%2BE.%26aulast%3DDeVries%26aufirst%3DM.%2BE.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DDobransky%26aufirst%3DT.%26aulast%3DFeldman%26aufirst%3DR.%2BD.%26aulast%3DFerguson%26aufirst%3DS.%2BS.%2BG.%26aulast%3DKelvin%26aufirst%3DD.%2BJ.%26atitle%3DRegulation%2520of%2520tyrosine%2520kinase%2520activation%2520and%2520granule%2520release%2520through%2520%25CE%25B2-arrestin%2520by%2520CXCR1%26jtitle%3DNat.%2520Immunol.%26date%3D2000%26volume%3D1%26spage%3D227%26epage%3D233%26doi%3D10.1038%2F79767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, S. S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maudsley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Rocca, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakatsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">β-Arrestin-Dependent Formation of β2Adrenergic Receptor-Src Protein Kinase Complexes</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1126/science.283.5402.655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1126%2Fscience.283.5402.655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=9924018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaK1MXot1Kmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1999&pages=655-661&author=L.+M.+Luttrellauthor=S.+S.+G.+Fergusonauthor=Y.+Daakaauthor=W.+E.+Millerauthor=S.+Maudsleyauthor=G.+J.+Della+Roccaauthor=F.-T.+Linauthor=H.+Kawakatsuauthor=K.+Owadaauthor=D.+K.+Luttrellauthor=M.+G.+Caronauthor=R.+J.+Lefkowitz&title=%CE%B2-Arrestin-Dependent+Formation+of+%CE%B22Adrenergic+Receptor-Src+Protein+Kinase+Complexes&doi=10.1126%2Fscience.283.5402.655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">β-Arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes</span></div><div class="casAuthors">Luttrell, L. M.; Ferguson, S. S. G.; Daaka, Y.; Miller, W. E.; Maudsley, S.; Rocca, G. J. Della; Lin, F.-T.; Kawakatsu, H.; Owada, K.; Luttrell, D. K.; Caron, M. G.; Lefkowitz, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">5402</span>),
    <span class="NLM_cas:pages">655-661</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The Ras-dependent activation of mitogen-activated protein (MAP) kinase pathways by many receptors coupled to heterotrimeric guanine nucleotide binding proteins (G proteins) requires the activation of Src family tyrosine kinases.  Stimulation of β2 adrenergic receptors resulted in the assembly of a protein complex contg. activated c-Src and the receptor.  Src recruitment was mediated by β-arrestin, which functions as an adapter protein, binding both c-Src and the agonist-occupied receptor.  β-Arrestin 1 mutants, impaired either in c-Src binding or in the ability to target receptors to clathrin-coated pits, acted as dominant neg. inhibitors of β2 adrenergic receptor-mediated activation of the MAP kinases Erk1 and Erk2.  These data suggest that β-arrestin binding, which terminates receptor-G protein coupling, also initiates a second wave of signal transduction in which the "desensitized" receptor functions as a crit. structural component of a mitogenic signaling complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_2hPyTs99rbVg90H21EOLACvtfcHk0ljevnweqqerPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXot1Kmug%253D%253D&md5=3fc55fc9a12ae32562bf0693a0050803</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.283.5402.655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.283.5402.655%26sid%3Dliteratum%253Aachs%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26aulast%3DFerguson%26aufirst%3DS.%2BS.%2BG.%26aulast%3DDaaka%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DW.%2BE.%26aulast%3DMaudsley%26aufirst%3DS.%26aulast%3DDella%2BRocca%26aufirst%3DG.%2BJ.%26aulast%3DLin%26aufirst%3DF.-T.%26aulast%3DKawakatsu%26aufirst%3DH.%26aulast%3DOwada%26aufirst%3DK.%26aulast%3DLuttrell%26aufirst%3DD.%2BK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3D%25CE%25B2-Arrestin-Dependent%2520Formation%2520of%2520%25CE%25B22Adrenergic%2520Receptor-Src%2520Protein%2520Kinase%2520Complexes%26jtitle%3DScience%26date%3D1999%26volume%3D283%26spage%3D655%26epage%3D661%26doi%3D10.1126%2Fscience.283.5402.655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, N.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rea, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, S.</span></span> <span> </span><span class="NLM_article-title">Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">486</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02606-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fs41467-017-02606-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29402888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A280%3ADC%252BC1MvnsFyntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=486&author=H.+Yanoauthor=N.-S.+Caiauthor=M.+Xuauthor=R.+K.+Vermaauthor=W.+Reaauthor=A.+F.+Hoffmanauthor=L.+Shiauthor=J.+A.+Javitchauthor=A.+Bonciauthor=S.+Ferre&title=Gs-+versus+Golf-dependent+functional+selectivity+mediated+by+the+dopamine+D1+receptor&doi=10.1038%2Fs41467-017-02606-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor</span></div><div class="casAuthors">Yano Hideaki; Cai Ning-Sheng; Xu Min; Verma Ravi Kumar; Rea William; Hoffman Alexander F; Shi Lei; Bonci Antonello; Ferre Sergi; Javitch Jonathan A; Javitch Jonathan A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">486</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The two highly homologous subtypes of stimulatory G proteins Gαs (Gs) and Gαolf (Golf) display contrasting expression patterns in the brain.  Golf is predominant in the striatum, while Gs is predominant in the cortex.  Yet, little is known about their functional distinctions.  The dopamine D1 receptor (D1R) couples to Gs/olf and is highly expressed in cortical and striatal areas, making it an important therapeutic target for neuropsychiatric disorders.  Using novel drug screening methods that allow analysis of specific G-protein subtype coupling, we found that, relative to dopamine, dihydrexidine and N-propyl-apomorphine behave as full D1R agonists when coupled to Gs, but as partial D1R agonists when coupled to Golf.  The Gs/Golf-dependent biased agonism by dihydrexidine was consistently observed at the levels of cellular signaling, neuronal function, and behavior.  Our findings of Gs/Golf-dependent functional selectivity in D1R ligands open a new avenue for the treatment of cortex-specific or striatum-specific neuropsychiatric dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMzpsIkzpxmdHxxy173TfNfW6udTcc2ebHCiyAe1V2x7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvnsFyntw%253D%253D&md5=4661a051d063c010fd4908a100849bfe</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02606-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02606-w%26sid%3Dliteratum%253Aachs%26aulast%3DYano%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DN.-S.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DVerma%26aufirst%3DR.%2BK.%26aulast%3DRea%26aufirst%3DW.%26aulast%3DHoffman%26aufirst%3DA.%2BF.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DBonci%26aufirst%3DA.%26aulast%3DFerre%26aufirst%3DS.%26atitle%3DGs-%2520versus%2520Golf-dependent%2520functional%2520selectivity%2520mediated%2520by%2520the%2520dopamine%2520D1%2520receptor%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D486%26doi%3D10.1038%2Fs41467-017-02606-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urs, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bido, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigle, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bass, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Targeting β-arrestin2 in the treatment of l-DOPA-induced dyskinesia in Parkinson’s disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E2517</span>– <span class="NLM_lpage">E2526</span>, <span class="refDoi"> DOI: 10.1073/pnas.1502740112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1073%2Fpnas.1502740112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=25918399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFCitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E2517-E2526&author=N.+M.+Ursauthor=S.+Bidoauthor=S.+M.+Petersonauthor=T.+L.+Daigleauthor=C.+E.+Bassauthor=R.+R.+Gainetdinovauthor=E.+Bezardauthor=M.+G.+Caron&title=Targeting+%CE%B2-arrestin2+in+the+treatment+of+l-DOPA-induced+dyskinesia+in+Parkinson%E2%80%99s+disease&doi=10.1073%2Fpnas.1502740112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease</span></div><div class="casAuthors">Urs, Nikhil M.; Bido, Simone; Peterson, Sean M.; Daigle, Tanya L.; Bass, Caroline E.; Gainetdinov, Raul R.; Bezard, Erwan; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">E2517-E2526</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is characterized by severe locomotor deficits and is commonly treated with the dopamine (DA) precursor l-3,4-dihydroxyphenylalanine (l-DOPA), but its prolonged use causes dyskinesias referred to as l-DOPA-induced dyskinesias (LIDs).  Recent studies in animal models of PD have suggested that dyskinesias are assocd. with the overactivation of G protein-mediated signaling through DA receptors.  β-Arrestins desensitize G protein signaling at DA receptors (D1R and D2R) in addn. to activating their own G protein-independent signaling events, which have been shown to mediate locomotion.  Therefore, targeting β-arrestins in PD l-DOPA therapy might prove to be a desirable approach.  Here we show in a bilateral DA-depletion mouse model of Parkinson's symptoms that genetic deletion of β-arrestin2 significantly limits the beneficial locomotor effects while markedly enhancing the dyskinesia-like effects of acute or chronic l-DOPA treatment.  Viral rescue or overexpression of β-arrestin2 in knockout or control mice either reverses or protects against LIDs and its key biochem. markers.  In other more conventional animal models of DA neuron loss and PD, such as 6-hydroxydopamine-treated mice or rats and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated nonhuman primates, β-arrestin2 overexpression significantly reduced dyskinesias while maintaining the therapeutic effect of l-DOPA.  Considerable efforts are being spent in the pharmaceutical industry to identify therapeutic approaches to block LIDs in patients with PD.  Our results point to a potential therapeutic approach, whereby development of either a genetic or pharmacol. intervention to enhance β-arrestin2- or limit G protein-dependent D1/D2R signaling could represent a more mechanistically informed strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0JS5BaOtvPLVg90H21EOLACvtfcHk0lgVagwx1CquCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFCitro%253D&md5=427748219d0f90165241156fcdc3122e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1502740112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1502740112%26sid%3Dliteratum%253Aachs%26aulast%3DUrs%26aufirst%3DN.%2BM.%26aulast%3DBido%26aufirst%3DS.%26aulast%3DPeterson%26aufirst%3DS.%2BM.%26aulast%3DDaigle%26aufirst%3DT.%2BL.%26aulast%3DBass%26aufirst%3DC.%2BE.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DTargeting%2520%25CE%25B2-arrestin2%2520in%2520the%2520treatment%2520of%2520l-DOPA-induced%2520dyskinesia%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3DE2517%26epage%3DE2526%26doi%3D10.1073%2Fpnas.1502740112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span> <span> </span><span class="NLM_article-title">Biased ligands of G protein-coupled receptors (GPCRs): structure-functional selectivity relationships (SFSRs) and therapeutic potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9841</span>– <span class="NLM_lpage">9878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00435</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9841-9878&author=L.+Tanauthor=W.+Yanauthor=J.+D.+McCorvyauthor=J.+Cheng&title=Biased+ligands+of+G+protein-coupled+receptors+%28GPCRs%29%3A+structure-functional+selectivity+relationships+%28SFSRs%29+and+therapeutic+potential&doi=10.1021%2Facs.jmedchem.8b00435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential</span></div><div class="casAuthors">Tan, Liang; Yan, Wenzhong; McCorvy, John D.; Cheng, Jianjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9841-9878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) signal through both G-protein-dependent and G-protein-independent pathways, and β-arrestin recruitment is the most recognized one of the latter.  Biased ligands selective for either pathway are expected to regulate biol. functions of GPCRs in a more precise way, therefore providing new drug mols. with superior efficacy and/or reduced side effects.  During the past decade, biased ligands have been discovered and developed for many GPCRs, such as the μ opioid receptor, the angiotensin II receptor type 1, the dopamine D2 receptor, and many others.  In this Perspective, recent advances in this field are reviewed by discussing the structure-functional selectivity relationships (SFSRs) of GPCR biased ligands and the therapeutic potential of these mols.  Further understanding of the biol. functions assocd. with each signaling pathway and structural basis for biased signaling will facilitate future drug design in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFjkAvar29LVg90H21EOLACvtfcHk0lgVagwx1CquCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N&md5=a7bd605b82666357f5a0a209002225e5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DCheng%26aufirst%3DJ.%26atitle%3DBiased%2520ligands%2520of%2520G%2520protein-coupled%2520receptors%2520%2528GPCRs%2529%253A%2520structure-functional%2520selectivity%2520relationships%2520%2528SFSRs%2529%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9841%26epage%3D9878%26doi%3D10.1021%2Facs.jmedchem.8b00435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeWire, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rominger, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graczyk, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitis, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotchev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lark, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span> <span> </span><span class="NLM_article-title">A G Protein-Biased Ligand at the -Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1124/jpet.112.201616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1124%2Fjpet.112.201616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=23300227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVaisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=708-717&author=S.+M.+DeWireauthor=D.+S.+Yamashitaauthor=D.+H.+Romingerauthor=G.+Liuauthor=C.+L.+Cowanauthor=T.+M.+Graczykauthor=X.-T.+Chenauthor=P.+M.+Pitisauthor=D.+Gotchevauthor=C.+Yuanauthor=M.+Koblishauthor=M.+W.+Larkauthor=J.+D.+Violin&title=A+G+Protein-Biased+Ligand+at+the+-Opioid+Receptor+Is+Potently+Analgesic+with+Reduced+Gastrointestinal+and+Respiratory+Dysfunction+Compared+with+Morphine&doi=10.1124%2Fjpet.112.201616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine</span></div><div class="casAuthors">DeWire, Scott M.; Yamashita, Dennis S.; Rominger, David H.; Liu, Guodong; Cowan, Conrad L.; Graczyk, Thomas M.; Chen, Xiao-Tao; Pitis, Philip M.; Gotchev, Dimitar; Yuan, Catherine; Koblish, Michael; Lark, Michael W.; Violin, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">708-717</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The concept of ligand bias at G protein-coupled receptors broadens the possibilities for agonist activities and provides the opportunity to develop safer, more selective therapeutics.  Morphine pharmacol. in β-arrestin-2 knockout mice suggested that a ligand that promotes coupling of the μ-opioid receptor (MOR) to G proteins, but not β-arrestins, would result in higher analgesic efficacy, less gastrointestinal dysfunction, and less respiratory suppression than morphine.  Here we report the discovery of TRV130 ([(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine), a novel MOR G protein-biased ligand.  In cell-based assays, TRV130 elicits robust G protein signaling, with potency and efficacy similar to morphine, but with far less β-arrestin recruitment and receptor internalization.  In mice and rats, TRV130 is potently analgesic while causing less gastrointestinal dysfunction and respiratory suppression than morphine at equianalgesic doses.  TRV130 successfully translates evidence that analgesic and adverse MOR signaling pathways are distinct into a biased ligand with differentiated pharmacol.  These preclin. data suggest that TRV130 may be a safer and more tolerable therapeutic for treating severe pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps3tTP2BOOKrVg90H21EOLACvtfcHk0lhtUVoHt8LTRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVaisro%253D&md5=33a685cd1952dd9cb1fb82afe78452af</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.201616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.201616%26sid%3Dliteratum%253Aachs%26aulast%3DDeWire%26aufirst%3DS.%2BM.%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DRominger%26aufirst%3DD.%2BH.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DCowan%26aufirst%3DC.%2BL.%26aulast%3DGraczyk%26aufirst%3DT.%2BM.%26aulast%3DChen%26aufirst%3DX.-T.%26aulast%3DPitis%26aufirst%3DP.%2BM.%26aulast%3DGotchev%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DKoblish%26aufirst%3DM.%26aulast%3DLark%26aufirst%3DM.%2BW.%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26atitle%3DA%2520G%2520Protein-Biased%2520Ligand%2520at%2520the%2520-Opioid%2520Receptor%2520Is%2520Potently%2520Analgesic%2520with%2520Reduced%2520Gastrointestinal%2520and%2520Respiratory%2520Dysfunction%2520Compared%2520with%2520Morphine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D708%26epage%3D717%26doi%3D10.1124%2Fjpet.112.201616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crombie, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soergel, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lark, M. W.</span></span> <span> </span><span class="NLM_article-title">Biased ligands at G-protein-coupled receptors: promise and progress</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.tips.2014.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=24878326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosl2htr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=308-316&author=J.+D.+Violinauthor=A.+L.+Crombieauthor=D.+G.+Soergelauthor=M.+W.+Lark&title=Biased+ligands+at+G-protein-coupled+receptors%3A+promise+and+progress&doi=10.1016%2Fj.tips.2014.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Biased ligands at G-protein-coupled receptors: promise and progress</span></div><div class="casAuthors">Violin, Jonathan D.; Crombie, Aimee L.; Soergel, David G.; Lark, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">308-316</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug discovery targeting G protein-coupled receptors (GPCRs) is no longer limited to seeking agonists or antagonists to stimulate or block cellular responses assocd. with a particular receptor.  GPCRs are now known to support a diversity of pharmacol. profiles, a concept broadly referred to as functional selectivity.  In particular, the concept of ligand bias, whereby a ligand stabilizes subsets of receptor conformations to engender novel pharmacol. profiles, has recently gained increasing prominence.  This review discusses how biased ligands may deliver safer, better tolerated, and more efficacious drugs, and highlights several biased ligands that are in clin. development.  Biased ligands targeting the angiotensin II type 1 receptor and the μ opioid receptor illustrate the translation of the biased ligand concept from basic biol. to clin. drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBma1S1zZ0-7Vg90H21EOLACvtfcHk0lhtUVoHt8LTRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosl2htr4%253D&md5=768953e7aa5726d1a47ecbdb068469d8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26aulast%3DCrombie%26aufirst%3DA.%2BL.%26aulast%3DSoergel%26aufirst%3DD.%2BG.%26aulast%3DLark%26aufirst%3DM.%2BW.%26atitle%3DBiased%2520ligands%2520at%2520G-protein-coupled%2520receptors%253A%2520promise%2520and%2520progress%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D308%26epage%3D316%26doi%3D10.1016%2Fj.tips.2014.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.-T.</span></span> <span> </span><span class="NLM_article-title">Enhanced Morphine Analgesia in Mice Lacking -Arrestin 2 </span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">2495</span>– <span class="NLM_lpage">2498</span>, <span class="refDoi"> DOI: 10.1126/science.286.5449.2495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1126%2Fscience.286.5449.2495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10617462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVKg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=2495-2498&author=L.+M.+Bohnauthor=R.+J.+Lefkowitzauthor=R.+R.+Gainetdinovauthor=K.+Peppelauthor=M.+G.+Caronauthor=F.-T.+Lin&title=Enhanced+Morphine+Analgesia+in+Mice+Lacking+-Arrestin+2%E2%80%89&doi=10.1126%2Fscience.286.5449.2495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced morphine analgesia in mice lacking β-arrestin 2</span></div><div class="casAuthors">Bohn, Laura M.; Lefkowitz, Robert J.; Gainetdinov, Raul R.; Peppel, Karsten; Caron, Marc G.; Lin, Fang-Tsyr</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5449</span>),
    <span class="NLM_cas:pages">2495-2498</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ability of morphine to alleviate pain is mediated through a heterotrimeric guanine nucleotide binding protein (G protein)-coupled heptahelical receptor (GPCR), the μ opioid receptor (μOR).  The efficiency of GPCR signaling is tightly regulated and ultimately limited by the coordinated phosphorylation of the receptors by specific GPCR kinases and the subsequent interaction of the phosphorylated receptors with β-arrestin 1 and β-arrestin 2.  Functional deletion of the β-arrestin 2 gene in mice resulted in remarkable potentiation and prolongation of the analgesic effect of morphine, suggesting that μOR desensitization was impaired.  These results provide evidence in vivo for the physiol. importance of β-arrestin 2 in regulating the function of a specific GPCR, the μOR.  Moreover, they suggest that inhibition of β-arrestin 2 function might lead to enhanced analgesic effectiveness of morphine and provide potential new avenues for the study and treatment of pain, narcotic tolerance, and dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSeiDXvYdnz7Vg90H21EOLACvtfcHk0lg1v1mGz1k8RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVKg&md5=95f67b133e86422f385d1a7f8165d772</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5449.2495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5449.2495%26sid%3Dliteratum%253Aachs%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DPeppel%26aufirst%3DK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLin%26aufirst%3DF.-T.%26atitle%3DEnhanced%2520Morphine%2520Analgesia%2520in%2520Mice%2520Lacking%2520-Arrestin%25202%25E2%2580%2589%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D2495%26epage%3D2498%26doi%3D10.1126%2Fscience.286.5449.2495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgenweck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span> <span> </span><span class="NLM_article-title">Bias factor and therapeutic window correlate to predict safer opioid analgesics</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">1165</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.10.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.cell.2017.10.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29149605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOhs7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2017&pages=1165-1175&author=C.+L.+Schmidauthor=N.+M.+Kennedyauthor=N.+C.+Rossauthor=K.+M.+Lovellauthor=Z.+Yueauthor=J.+Morgenweckauthor=M.+D.+Cameronauthor=T.+D.+Bannisterauthor=L.+M.+Bohn&title=Bias+factor+and+therapeutic+window+correlate+to+predict+safer+opioid+analgesics&doi=10.1016%2Fj.cell.2017.10.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics</span></div><div class="casAuthors">Schmid, Cullen L.; Kennedy, Nicole M.; Ross, Nicolette C.; Lovell, Kimberly M.; Yue, Zhizhou; Morgenweck, Jenny; Cameron, Michael D.; Bannister, Thomas D.; Bohn, Laura M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1165-1175.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Biased agonism has been proposed as a means to sep. desirable and adverse drug responses downstream of G protein-coupled receptor (GPCR) targets.  Herein, we describe structural features of a series of mu-opioid-receptor (MOR)-selective agonists that preferentially activate receptors to couple to G proteins or to recruit βarrestin proteins.  By comparing relative bias for MOR-mediated signaling in each pathway, we demonstrate a strong correlation between the respiratory suppression/antinociception therapeutic window in a series of compds. spanning a wide range of signaling bias.  We find that β-arrestin-biased compds., such as fentanyl, are more likely to induce respiratory suppression at weak analgesic doses, while G protein signaling bias broadens the therapeutic window, allowing for antinociception in the absence of respiratory suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfthQaadgklLVg90H21EOLACvtfcHk0lg1v1mGz1k8RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOhs7vE&md5=6d3f21c03fb40bc83adbe62c3ea331fc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.10.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.10.035%26sid%3Dliteratum%253Aachs%26aulast%3DSchmid%26aufirst%3DC.%2BL.%26aulast%3DKennedy%26aufirst%3DN.%2BM.%26aulast%3DRoss%26aufirst%3DN.%2BC.%26aulast%3DLovell%26aufirst%3DK.%2BM.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3DMorgenweck%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DBannister%26aufirst%3DT.%2BD.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26atitle%3DBias%2520factor%2520and%2520therapeutic%2520window%2520correlate%2520to%2520predict%2520safer%2520opioid%2520analgesics%26jtitle%3DCell%26date%3D2017%26volume%3D171%26spage%3D1165%26epage%3D1175%26doi%3D10.1016%2Fj.cell.2017.10.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiBerto, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polepally, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zjawiony, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malanga, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">The G protein-biased kappa-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.216820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1124%2Fjpet.114.216820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=25320048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOlu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2015&pages=98-109&author=K.+L.+Whiteauthor=J.+E.+Robinsonauthor=H.+Zhuauthor=J.+F.+DiBertoauthor=P.+R.+Polepallyauthor=J.+K.+Zjawionyauthor=D.+E.+Nicholsauthor=C.+J.+Malangaauthor=B.+L.+Roth&title=The+G+protein-biased+kappa-opioid+receptor+agonist+RB-64+is+analgesic+with+a+unique+spectrum+of+activities+in+vivo&doi=10.1124%2Fjpet.114.216820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo</span></div><div class="casAuthors">White, Kate L.; Robinson, J. Elliott; Zhu, Hu; DiBerto, Jeffrey F.; Polepally, Prabhakar R.; Zjawiony, Jordan K.; Nichols, David E.; Malanga, C. J.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-109, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The hypothesis that functionally selective G protein-coupled receptor (GPCR) agonists may have enhanced therapeutic benefits has revitalized interest for many GPCR targets.  In particular, although κ-opioid receptor (KOR) agonists are analgesic with a low risk of dependence and abuse, their use is limited by a propensity to induce sedation, motor incoordination, hallucinations, and dysphoria-like states.  Several labs. have produced a body of work suggesting that G protein-biased KOR agonists might be analgesic with fewer side effects.  Although that has been an intriguing hypothesis, suitable KOR-selective and G protein-biased agonists have not been available to test this idea.  Here we provide data using a G protein-biased agonist, RB-64 (22-thiocyanatosalvinorin A), which suggests that KOR-mediated G protein signaling induces analgesia and aversion, whereas β-arrestin-2 signaling may be assocd. with motor incoordination.  Addnl., unlike unbiased KOR agonists, the G protein-biased ligand RB-64 does not induce sedation and does not have anhedonia-like actions, suggesting that a mechanism other than G protein signaling mediates these effects.  Our findings provide the first evidence for a highly selective and G protein-biased tool compd. for which many, but not all, of the neg. side effects of KOR agonists can be minimized by creating G protein-biased KOR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGporsYw3knd37Vg90H21EOLACvtfcHk0lg1v1mGz1k8RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOlu7bM&md5=686b5b718e2919aaf08e34855cc39ebf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.216820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.216820%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DRobinson%26aufirst%3DJ.%2BE.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DDiBerto%26aufirst%3DJ.%2BF.%26aulast%3DPolepally%26aufirst%3DP.%2BR.%26aulast%3DZjawiony%26aufirst%3DJ.%2BK.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMalanga%26aufirst%3DC.%2BJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520G%2520protein-biased%2520kappa-opioid%2520receptor%2520agonist%2520RB-64%2520is%2520analgesic%2520with%2520a%2520unique%2520spectrum%2520of%2520activities%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D352%26spage%3D98%26epage%3D109%26doi%3D10.1124%2Fjpet.114.216820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dogra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. N.</span></span> <span> </span><span class="NLM_article-title">Biased agonism at kappa opioid receptors: implication in pain and mood disorders</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>763</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2015.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.ejphar.2015.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=26164787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOktLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=763&publication_year=2015&pages=184-190&author=S.+Dograauthor=P.+N.+Yadav&title=Biased+agonism+at+kappa+opioid+receptors%3A+implication+in+pain+and+mood+disorders&doi=10.1016%2Fj.ejphar.2015.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Biased agonism at kappa opioid receptors: Implication in pain and mood disorders</span></div><div class="casAuthors">Dogra, Shalini; Yadav, Prem N.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">763</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">184-190</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The kappa opioid receptor (k receptor) and its endogenous ligand dynorphin have received significant attention due to their involvement in pathophysiol. of mood disorders, drug addiction, psychotic disorders and pain.  Multiple lines of evidences suggest that the k receptor modulates overlapping neurocircuits connecting brainstem monoaminergic nuclei with forebrain limbic structures and thereby regulates neurobiol. effects of stress and psychostimulants.  The emerging concept of "biased agonism" (also known as functional selectivity) for G Protein Coupled Receptor (GPCR) ligands have provided new insights into overall response generated by a ligand, which could be exploited for drug discovery.  According to this concept, every ligand possesses the unique ability (coded in its structure) that dictates distinct signalling pattern, and consequently beneficial or adverse response.  Although still a long way to comprehend the clin. potential of biased GPCR ligands, such ligand could be vital pharmacol. probes.  This article highlights various lines of evidence, which indicates different ligands of k receptor as "biased", and their potential implications in mood and pain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa9u79NzRMt7Vg90H21EOLACvtfcHk0lg1v1mGz1k8RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOktLjN&md5=2aacd81253e158b23d721eaf1b1985c6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DDogra%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26atitle%3DBiased%2520agonism%2520at%2520kappa%2520opioid%2520receptors%253A%2520implication%2520in%2520pain%2520and%2520mood%2520disorders%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D763%26spage%3D184%26epage%3D190%26doi%3D10.1016%2Fj.ejphar.2015.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raehal, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span> <span> </span><span class="NLM_article-title">Morphine Side Effects in -Arrestin 2 Knockout Mice</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1201</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.087254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1124%2Fjpet.105.087254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=15917400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=1195-1201&author=K.+M.+Raehalauthor=J.+K.+Walkerauthor=L.+M.+Bohn&title=Morphine+Side+Effects+in+-Arrestin+2+Knockout+Mice&doi=10.1124%2Fjpet.105.087254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine side effects in β-arrestin 2 knockout mice</span></div><div class="casAuthors">Raehal, Kirsten M.; Walker, Julia K. L.; Bohn, Laura M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1195-1201</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Morphine is a potent analgesic, yet, like most opioid narcotics, it exerts unwanted side effects such as constipation and respiratory suppression, thereby limiting its clin. utility.  Pharmacol. approaches taken to preserve the analgesic properties, while eliminating the unwanted side effects, have met with very limited success.  Here, we provide evidence that altering μ opioid receptor regulation may provide a novel approach to discriminate morphine's beneficial and deleterious effects in vivo.  We have previously reported that mice lacking the G protein-coupled receptor regulatory protein, β-arrestin 2, display profoundly altered morphine responses.  β-Arrestin 2 knockout mice have enhanced and prolonged morphine analgesia with very little morphine tolerance.  In this report, we examine whether the side effects of morphine treatment are also augmented in this animal model.  Surprisingly, the genetic disruption of opioid receptor regulation, while enhancing and prolonging analgesia, dramatically attenuates the respiratory suppression and acute constipation caused by morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGg-s6s4R0F7Vg90H21EOLACvtfcHk0lj2pCff0IdJ3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLw%253D&md5=0d3696e563ae3a6f6ce2cb2570cbb890</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.087254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.087254%26sid%3Dliteratum%253Aachs%26aulast%3DRaehal%26aufirst%3DK.%2BM.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26atitle%3DMorphine%2520Side%2520Effects%2520in%2520-Arrestin%25202%2520Knockout%2520Mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D1195%26epage%3D1201%26doi%3D10.1124%2Fjpet.105.087254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aryal, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dengler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corder, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguère, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Duan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of opioid analgesics with reduced side effects</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>537</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1038/nature19112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnature19112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=27533032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKmsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=185-190&author=A.+Manglikauthor=H.+Linauthor=D.+K.+Aryalauthor=J.+D.+McCorvyauthor=D.+Denglerauthor=G.+Corderauthor=A.+Levitauthor=R.+C.+Klingauthor=V.+Bernatauthor=H.+H%C3%BCbnerauthor=X.-P.+Huangauthor=M.+F.+Sassanoauthor=P.+M.+Gigu%C3%A8reauthor=S.+L%C3%B6berauthor=D.+Da+Duanauthor=G.+Scherrerauthor=B.+K.+Kobilkaauthor=P.+Gmeinerauthor=B.+L.+Rothauthor=B.+K.+Shoichet&title=Structure-based+discovery+of+opioid+analgesics+with+reduced+side+effects&doi=10.1038%2Fnature19112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based discovery of opioid analgesics with reduced side effects</span></div><div class="casAuthors">Manglik, Aashish; Lin, Henry; Aryal, Dipendra K.; McCorvy, John D.; Dengler, Daniela; Corder, Gregory; Levit, Anat; Kling, Ralf C.; Bernat, Viachaslau; Hubner, Harald; Huang, Xi-Ping; Sassano, Maria F.; Giguere, Patrick M.; Lober, Stefan; Da Duan; Scherrer, Gregory; Kobilka, Brian K.; Gmeiner, Peter; Roth, Bryan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7619</span>),
    <span class="NLM_cas:pages">185-190</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Morphine is an alkaloid from the opium poppy used to treat pain.  The potentially lethal side effects of morphine and related opioids-which include fatal respiratory depression-are thought to be mediated by μ-opioid-receptor (μOR) signalling through the β-arrestin pathway or by actions at other receptors.  Conversely, G-protein μOR signalling is thought to confer analgesia.  Here we computationally dock over 3 million mols. against the μOR structure and identify new scaffolds unrelated to known opioids.  Structure-based optimization yields PZM21-a potent Gi activator with exceptional selectivity for μOR and minimal β-arrestin-2 recruitment.  Unlike morphine, PZM21 is more efficacious for the affective component of analgesia vs. the reflexive component and is devoid of both respiratory depression and morphine-like reinforcing activity in mice at equi-analgesic doses.  PZM21 thus serves as both a probe to disentangle μOR signalling and a therapeutic lead that is devoid of many of the side effects of current opioids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiCff2w3U8iLVg90H21EOLACvtfcHk0lj2pCff0IdJ3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKmsbvI&md5=b8bb2d8575dadf4a6dc74d94c26d2c1a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature19112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19112%26sid%3Dliteratum%253Aachs%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DAryal%26aufirst%3DD.%2BK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DDengler%26aufirst%3DD.%26aulast%3DCorder%26aufirst%3DG.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DBernat%26aufirst%3DV.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DGigu%25C3%25A8re%26aufirst%3DP.%2BM.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DDa%2BDuan%26aufirst%3DD.%26aulast%3DScherrer%26aufirst%3DG.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DStructure-based%2520discovery%2520of%2520opioid%2520analgesics%2520with%2520reduced%2520side%2520effects%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D185%26epage%3D190%26doi%3D10.1038%2Fnature19112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conibear, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutcliffe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewey, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, G.</span></span> <span> </span><span class="NLM_article-title">The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">2653</span>– <span class="NLM_lpage">2661</span>, <span class="refDoi"> DOI: 10.1111/bph.14224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1111%2Fbph.14224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29582414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVCmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=2653-2661&author=R.+Hillauthor=A.+Disneyauthor=A.+Conibearauthor=K.+Sutcliffeauthor=W.+Deweyauthor=S.+Husbandsauthor=C.+Baileyauthor=E.+Kellyauthor=G.+Henderson&title=The+novel+%CE%BC-opioid+receptor+agonist+PZM21+depresses+respiration+and+induces+tolerance+to+antinociception&doi=10.1111%2Fbph.14224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception</span></div><div class="casAuthors">Hill, Rob; Disney, Alex; Conibear, Alex; Sutcliffe, Katy; Dewey, William; Husbands, Stephen; Bailey, Chris; Kelly, Eamonn; Henderson, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2653-2661</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PZM21 is a novel μ-opioid receptor ligand that has been reported to induce minimal arrestin recruitment and be devoid of the respiratory depressant effects characteristic of classical μ receptor ligands such as morphine.  We have re-examd. the signalling profile of PZM21 and its ability to depress respiration.  G protein (Gi) activation and arrestin-3 translocation were measured in vitro, using BRET assays, in HEK 293 cells expressing μ receptors.  Respiration (rate and tidal vol.) was measured in awake, freely moving mice by whole-body plethysmog., and antinociception was measured by the hot plate test.  PZM21 (10-9 - 3 × 10-5 M) produced concn.-dependent Gi activation and arrestin-3 translocation.  Comparison with responses evoked by morphine and DAMGO revealed that PZM21 was a low efficacy agonist in both signalling assays.  PZM21 (10-80 mg·kg-1) depressed respiration in a dose-dependent manner.  The respiratory depression was due to a decrease in the rate of breathing not a decrease in tidal vol.  On repeated daily administration of PZM21 (twice daily doses of 40 mg·kg-1), complete tolerance developed to the antinociceptive effect of PZM21 over 3 days but no tolerance developed to its respiratory depressant effect.  These data demonstrate that PZM21 is a low efficacy μ receptor agonist for both G protein and arrestin signalling.  Contrary to a previous report, PZM21 depresses respiration in a manner similar to morphine, the classical opioid receptor agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeVaQW_N9c4LVg90H21EOLACvtfcHk0lj2pCff0IdJ3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVCmt7o%253D&md5=adb5bbba116f6d3df8d860754434af16</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fbph.14224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14224%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DR.%26aulast%3DDisney%26aufirst%3DA.%26aulast%3DConibear%26aufirst%3DA.%26aulast%3DSutcliffe%26aufirst%3DK.%26aulast%3DDewey%26aufirst%3DW.%26aulast%3DHusbands%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DE.%26aulast%3DHenderson%26aufirst%3DG.%26atitle%3DThe%2520novel%2520%25CE%25BC-opioid%2520receptor%2520agonist%2520PZM21%2520depresses%2520respiration%2520and%2520induces%2520tolerance%2520to%2520antinociception%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D2653%26epage%3D2661%26doi%3D10.1111%2Fbph.14224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">18488</span>– <span class="NLM_lpage">18493</span>, <span class="refDoi"> DOI: 10.1073/pnas.1104807108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1073%2Fpnas.1104807108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18488-18493&author=J.+A.+Allenauthor=J.+M.+Yostauthor=V.+Setolaauthor=X.+Chenauthor=M.+F.+Sassanoauthor=M.+Chenauthor=S.+Petersonauthor=P.+N.+Yadavauthor=X.-p.+Huangauthor=B.+Fengauthor=N.+H.+Jensenauthor=X.+Cheauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=M.+G.+Caronauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+-Arrestin-Biased+Dopamine+D2+Ligands+for+Probing+Signal+Transduction+Pathways+Essential+for+Antipsychotic+Efficacy&doi=10.1073%2Fpnas.1104807108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1104807108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1104807108%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DYost%26aufirst%3DJ.%2BM.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DHuang%26aufirst%3DX.-p.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520-Arrestin-Biased%2520Dopamine%2520D2%2520Ligands%2520for%2520Probing%2520Signal%2520Transduction%2520Pathways%2520Essential%2520for%2520Antipsychotic%2520Efficacy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D18488%26epage%3D18493%26doi%3D10.1073%2Fpnas.1104807108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of G protein-biased D2 dopamine receptor partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10601</span>– <span class="NLM_lpage">10618</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10601-10618&author=X.+Chenauthor=J.+D.+McCorvyauthor=M.+G.+Fischerauthor=K.+V.+Butlerauthor=Y.+Shenauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+G+protein-biased+D2+dopamine+receptor+partial+agonists&doi=10.1021%2Facs.jmedchem.6b01208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists</span></div><div class="casAuthors">Chen, Xin; McCorvy, John D.; Fischer, Matthew G.; Butler, Kyle V.; Shen, Yudao; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10601-10618</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased ligands (also known as functionally selective ligands) of G protein-coupled receptors are valuable tools for dissecting the roles of G protein-dependent and independent signaling pathways in health and disease.  Biased ligands have also been increasingly pursued by the biomedical community as promising therapeutics with improved efficacy and reduced side effects compared with unbiased ligands.  The authors previously discovered first-in-class β-arrestin-biased agonists of dopamine D2 receptor (D2R) by extensively exploring multiple regions of aripiprazole, a balanced D2R agonist.  In the authors' continuing efforts to identify biased agonists of D2R, the authors unexpectedly discovered a G protein-biased agonist of D2R, compd. 1 (5-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-methylbenzo[d]thiazole), which is the first G protein-biased D2R agonist from the aripiprazole scaffold.  The authors designed and synthesized novel analogs to explore two regions of 1 and conducted structure-functional selectivity relationship (SFSR) studies.  Here the authors report the discovery of 1, findings from the authors' SFSR studies, and characterization of novel G protein-biased D2R agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeKlhGCqSPxLVg90H21EOLACvtfcHk0liDONVvhirPuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK&md5=81b1435b1ae82438aa3f270f7ee4f853</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DFischer%26aufirst%3DM.%2BG.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520G%2520protein-biased%2520D2%2520dopamine%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10601%26epage%3D10618%26doi%3D10.1021%2Facs.jmedchem.6b01208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmerberg, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulman, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span> <span> </span><span class="NLM_article-title">Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">715</span>, <span class="refDoi"> DOI: 10.1038/npp.2015.196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnpp.2015.196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=26129680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Chu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=704-715&author=S.+M.+Parkauthor=M.+Chenauthor=C.+M.+Schmerbergauthor=R.+S.+Dulmanauthor=R.+M.+Rodriguizauthor=M.+G.+Caronauthor=J.+Jinauthor=W.+C.+Wetsel&title=Effects+of+%CE%B2-Arrestin-Biased+Dopamine+D2+Receptor+Ligands+on+Schizophrenia-Like+Behavior+in+Hypoglutamatergic+Mice&doi=10.1038%2Fnpp.2015.196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice</span></div><div class="casAuthors">Park, Su M.; Chen, Meng; Schmerberg, Claire M.; Dulman, Russell S.; Rodriguiz, Ramona M.; Caron, Marc G.; Jin, Jian; Wetsel, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">704-715</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Current antipsychotic drugs (APDs) show efficacy with pos. symptoms, but are limited in treating neg. or cognitive features of schizophrenia.  Whereas all currently FDA-approved medications target primarily the dopamine D2 receptor (D2R) to inhibit Gi/o-mediated adenylyl cyclase, a recent study has shown that many APDs affect not only Gi/o- but they can also influence β-arrestin- (βArr)-mediated signaling.  The ability of ligands to differentially affect signaling through these pathways is termed functional selectivity.  We have developed ligands that are devoid of D2R-mediated Gi/o protein signaling, but are simultaneously partial agonists for D2R/βArr interactions.  The purpose of this study was to test the effectiveness of UNC9975 or UNC9994 on schizophrenia-like behaviors in phencyclidine-treated or NR1-knockdown hypoglutamatergic mice.  We have found the UNC compds. reduce hyperlocomotion in the open field, restore PPI, improve novel object recognition memory, partially normalize social behavior, decrease conditioned avoidance responding, and elicit a much lower level of catalepsy than haloperidol.  These preclin. results suggest that exploitation of functional selectivity may provide unique opportunities to develop drugs with fewer side effects, greater therapeutic selectivity, and enhanced efficacy for treating schizophrenia and related conditions than medications that are currently available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQuhB8VxuXDbVg90H21EOLACvtfcHk0liDONVvhirPuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Chu7jO&md5=82de207db3a78d50ff86a48cda2d2e28</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.196%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BM.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DSchmerberg%26aufirst%3DC.%2BM.%26aulast%3DDulman%26aufirst%3DR.%2BS.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26atitle%3DEffects%2520of%2520%25CE%25B2-Arrestin-Biased%2520Dopamine%2520D2%2520Receptor%2520Ligands%2520on%2520Schizophrenia-Like%2520Behavior%2520in%2520Hypoglutamatergic%2520Mice%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3D704%26epage%3D715%26doi%3D10.1038%2Fnpp.2015.196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>555</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/nature25758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnature25758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29466326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2018&pages=269-273&author=S.+Wangauthor=T.+Cheauthor=A.+Levitauthor=B.+K.+Shoichetauthor=D.+Wackerauthor=B.+L.+Roth&title=Structure+of+the+D2+dopamine+receptor+bound+to+the+atypical+antipsychotic+drug+risperidone&doi=10.1038%2Fnature25758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span></div><div class="casAuthors">Wang, Sheng; Che, Tao; Levit, Anat; Shoichet, Brian K.; Wacker, Daniel; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">7695</span>),
    <span class="NLM_cas:pages">269-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Dopamine is a neurotransmitter that has been implicated in processes as diverse as reward, addiction, control of coordinated movement, metab. and hormonal secretion.  Correspondingly, dysregulation of the dopaminergic system has been implicated in diseases such as schizophrenia, Parkinson's disease, depression, attention deficit hyperactivity disorder, and nausea and vomiting.  The actions of dopamine are mediated by a family of five G-protein-coupled receptors.  The D2 dopamine receptor (DRD2) is the primary target for both typical and atypical antipsychotic drugs, and for drugs used to treat Parkinson's disease.  Unfortunately, many drugs that target DRD2 cause serious and potentially life-threatening side effects due to promiscuous activities against related receptors.  Accordingly, a mol. understanding of the structure and function of DRD2 could provide a template for the design of safer and more effective medications.  Here we report the crystal structure of DRD2 in complex with the widely prescribed atypical antipsychotic drug risperidone.  The DRD2-risperidone structure reveals an unexpected mode of antipsychotic drug binding to dopamine receptors, and highlights structural determinants that are essential for the actions of risperidone and related drugs at DRD2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeo4Ov49kft7Vg90H21EOLACvtfcHk0liDONVvhirPuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D&md5=2842adc1893293ea8dbf98ae3270a1b2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnature25758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25758%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520of%2520the%2520D2%2520dopamine%2520receptor%2520bound%2520to%2520the%2520atypical%2520antipsychotic%2520drug%2520risperidone%26jtitle%3DNature%26date%3D2018%26volume%3D555%26spage%3D269%26epage%3D273%26doi%3D10.1038%2Fnature25758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urs, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pack, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evron, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E8178</span>– <span class="NLM_lpage">E8186</span>, <span class="refDoi"> DOI: 10.1073/pnas.1614347113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1073%2Fpnas.1614347113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E8178-E8186&author=N.+M.+Ursauthor=S.+M.+Geeauthor=T.+F.+Packauthor=J.+D.+McCorvyauthor=T.+Evronauthor=J.+C.+Snyderauthor=X.+Yangauthor=R.+M.+Rodriguizauthor=E.+Borrelliauthor=W.+C.+Wetselauthor=J.+Jinauthor=B.+L.+Rothauthor=P.+O%E2%80%99Donnellauthor=M.+G.+Caron&title=Distinct+cortical+and+striatal+actions+of+a+%CE%B2-arrestin-biased+dopamine+D2+receptor+ligand+reveal+unique+antipsychotic-like+properties&doi=10.1073%2Fpnas.1614347113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1614347113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1614347113%26sid%3Dliteratum%253Aachs%26aulast%3DUrs%26aufirst%3DN.%2BM.%26aulast%3DGee%26aufirst%3DS.%2BM.%26aulast%3DPack%26aufirst%3DT.%2BF.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DEvron%26aufirst%3DT.%26aulast%3DSnyder%26aufirst%3DJ.%2BC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DBorrelli%26aufirst%3DE.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DP.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DDistinct%2520cortical%2520and%2520striatal%2520actions%2520of%2520a%2520%25CE%25B2-arrestin-biased%2520dopamine%2520D2%2520receptor%2520ligand%2520reveal%2520unique%2520antipsychotic-like%2520properties%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2016%26volume%3D113%26spage%3DE8178%26epage%3DE8186%26doi%3D10.1073%2Fpnas.1614347113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnchembio.2527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29227473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGmur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=126-134&author=J.+D.+McCorvyauthor=K.+V.+Butlerauthor=B.+Kellyauthor=K.+Rechsteinerauthor=J.+Karpiakauthor=R.+M.+Betzauthor=B.+L.+Kormosauthor=B.+K.+Shoichetauthor=R.+O.+Drorauthor=J.+Jinauthor=B.+L.+Roth&title=Structure-inspired+design+of+%CE%B2-arrestin-biased+ligands+for+aminergic+GPCRs&doi=10.1038%2Fnchembio.2527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs</span></div><div class="casAuthors">McCorvy, John D.; Butler, Kyle V.; Kelly, Brendan; Rechsteiner, Katie; Karpiak, Joel; Betz, Robin M.; Kormos, Bethany L.; Shoichet, Brian K.; Dror, Ron O.; Jin, Jian; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-134</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Development of biased ligands targeting G protein-coupled receptors (GPCRs) is a promising approach for current drug discovery.  Although structure-based drug design of biased agonists remains challenging even with an abundance of GPCR crystal structures, the authors present an approach for translating GPCR structural data into β-arrestin-biased ligands for aminergic GPCRs.  The authors identified specific amino acid-ligand contacts at transmembrane helix 5 (TM5) and extracellular loop 2 (EL2) responsible for Gi/o and β-arrestin signaling, resp., and targeted those residues to develop biased ligands.  For these ligands, the authors found that bias is conserved at other aminergic GPCRs that retain similar residues at TM5 and EL2.  The authors' approach provides a template for generating arrestin-biased ligands by modifying predicted ligand interactions that block TM5 interactions and promote EL2 interactions.  This strategy may facilitate the structure-guided design of arrestin-biased ligands at other GPCRs, including polypharmacol. biased ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVs9TaoxiFubVg90H21EOLACvtfcHk0lj3p0nBO_aEFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGmur3I&md5=2725e8487638cc07ce5e6a655fcd29f2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2527%26sid%3Dliteratum%253Aachs%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKelly%26aufirst%3DB.%26aulast%3DRechsteiner%26aufirst%3DK.%26aulast%3DKarpiak%26aufirst%3DJ.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure-inspired%2520design%2520of%2520%25CE%25B2-arrestin-biased%2520ligands%2520for%2520aminergic%2520GPCRs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D126%26epage%3D134%26doi%3D10.1038%2Fnchembio.2527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Zastrow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1301071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fsj.npp.1301071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=16554739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSqtbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=67-77&author=J.+D.+Urbanauthor=G.+A.+Vargasauthor=M.+von+Zastrowauthor=R.+B.+Mailman&title=Aripiprazole+has+functionally+selective+actions+at+dopamine+D2+receptor-mediated+signaling+pathways&doi=10.1038%2Fsj.npp.1301071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways</span></div><div class="casAuthors">Urban, Jonathan D.; Vargas, Gabriel A.; von Zastrow, Mark; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-77</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aripiprazole is a unique atypical antipsychotic drug with an excellent side-effect profile presumed, in part, to be due to lack of typical D2 dopamine receptor antagonist properties.  Whether aripiprazole is a typical D2 partial agonist, or a functionally selective D2 ligand, remains controversial (eg D2-mediated inhibition of adenylate cyclase is system dependent; aripiprazole antagonizes D2 receptor-mediated G-protein-coupled inwardly rectifying potassium channels and guanosine triphosphate nucleotide (GTP)γS coupling).  The current study examd. the D2L receptor binding properties of aripiprazole, as well as the effects of the drug on three downstream D2 receptor-mediated functional effectors: mitogen-activated protein kinase (MAPK) phosphorylation, potentiation of arachidonic acid (AA) release, and D2 receptor internalization.  Unlike quinpirole (a full D2 agonist) or (-)3PPP (S(-)-3-(3-hydroxyphenyl)-N-propylpiperidine hydrochloride, a D2 partial agonist), the apparent D2 affinity of aripiprazole was not decreased significantly by GTP.  Moreover, full or partial agonists are expected to have Hill slopes <1.0, yet that of aripiprazole was significantly >1.0.  Whereas aripiprazole partially activated both the MAPK and AA pathways, its potency vs MAPK phosphorylation was much lower relative to potencies in assays either of AA release or inhibition of cyclic adenosine 3',5'-cyclic monophosphate accumulation.  In addn., unlike typical agonists, neither aripiprazole nor (-)3PPP produced significant internalization of the D2L receptor.  These data are clear evidence that aripiprazole affects D2L-mediated signaling pathways in a differential manner.  The results are consistent with the hypothesis that aripiprazole is a functionally selective D2 ligand rather than a simple partial agonist.  Such data may be useful in understanding the novel clin. actions of this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-qAW7cvG3i7Vg90H21EOLACvtfcHk0lj3p0nBO_aEFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSqtbrJ&md5=20b9edb05787dadb09fb4c778205f0b2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301071%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DG.%2BA.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DAripiprazole%2520has%2520functionally%2520selective%2520actions%2520at%2520dopamine%2520D2%2520receptor-mediated%2520signaling%2520pathways%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D67%26epage%3D77%26doi%3D10.1038%2Fsj.npp.1301071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Functionally selective dopamine D2/D3 receptor agonists comprising an enyne moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5130</span>– <span class="NLM_lpage">5141</span>, <span class="refDoi"> DOI: 10.1021/jm400520c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400520c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5130-5141&author=C.+Hillerauthor=R.+C.+Klingauthor=F.+W.+Heinemannauthor=K.+Meyerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D2%2FD3+receptor+agonists+comprising+an+enyne+moiety&doi=10.1021%2Fjm400520c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</span></div><div class="casAuthors">Hiller, Christine; Kling, Ralf C.; Heinemann, Frank W.; Meyer, Karsten; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5130-5141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonracemic ethynylcyclohexynylamines I and ent-I {R = 1,1'-biphenyl-4-yl, pyrazolo[1,5-a]pyridin-2-yl, pyrazolo[1,5-a]pyridin-3-yl, 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl, benzo[b]thiophene-2-yl, ferrocenyl} were prepd. as dopamine receptor agonists with atypical catechol isosteres; their selectivities for dopamine receptors and for activating receptors through G-protein subunits Go and Gi and the metabolic stability of rac-I (R = 4-PhC6H4) were detd.  The ethynylcyclohexynylamines bound to D2-like receptors with high affinities.  Ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) selectively activated D2slow-promoted Go activation over Gi coupling; the most significant functional bias obsd. was for ent-I {R = 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl} which selectively activated Go over Gi coupling at D2long receptors.  Functional selectivity for β-arrestin recruitment over Gi activation was obsd. for I (R = 1,1'-biphenyl-4-yl) and ent-I (R = benzothiophene-2-yl), while ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) preferred β-arrestin recruitment compared to Go coupling.  The structure of a nonracemic N-(ethynylcyclohexenyl)dinitrobenzamide was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXn2SrS-IBCrVg90H21EOLACvtfcHk0lhkG6LHZn7nKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D&md5=3855de949f505a83ed3aa561ca182e75</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm400520c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400520c%26sid%3Dliteratum%253Aachs%26aulast%3DHiller%26aufirst%3DC.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DHeinemann%26aufirst%3DF.%2BW.%26aulast%3DMeyer%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D2%252FD3%2520receptor%2520agonists%2520comprising%2520an%2520enyne%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5130%26epage%3D5141%26doi%3D10.1021%2Fjm400520c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skultety, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Functionally Selective Dopamine D2, D3 Receptor Partial Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4861</span>– <span class="NLM_lpage">4875</span>, <span class="refDoi"> DOI: 10.1021/jm5004039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5004039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4861-4875&author=D.+M%C3%B6llerauthor=R.+C.+Klingauthor=M.+Skultetyauthor=K.+Leunerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Functionally+Selective+Dopamine+D2%2C+D3+Receptor+Partial+Agonists&doi=10.1021%2Fjm5004039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm5004039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5004039%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DLeuner%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520Selective%2520Dopamine%2520D2%252C%2520D3%2520Receptor%2520Partial%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4861%26epage%3D4875%26doi%3D10.1021%2Fjm5004039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzuneser, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skultety, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzheimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of G protein-biased dopaminergics with a pyrazolo[1,5-a]pyridine substructure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2908</span>– <span class="NLM_lpage">2929</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2908-2929&author=D.+M%C3%B6llerauthor=A.+Banerjeeauthor=T.+C.+Uzuneserauthor=M.+Skultetyauthor=T.+Huthauthor=B.+Plouffeauthor=H.+H%C3%BCbnerauthor=C.+Alzheimerauthor=K.+Friedlandauthor=C.+P.+M%C3%BCllerauthor=M.+Bouvierauthor=P.+Gmeiner&title=Discovery+of+G+protein-biased+dopaminergics+with+a+pyrazolo%5B1%2C5-a%5Dpyridine+substructure&doi=10.1021%2Facs.jmedchem.6b01857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure</span></div><div class="casAuthors">Moller Dorothee; Banerjee Ashutosh; Skultety Marika; Hubner Harald; Gmeiner Peter; Uzuneser Taygun C; Muller Christian P; Huth Tobias; Alzheimer Christian; Plouffe Bianca; Bouvier Michel; Friedland Kristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2908-2929</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors.  Connection of a lipophilic moiety to the arylpiperazine core by an appropriate linker represents a promising concept to increase binding affinity and to fine-tune functional properties.  In particular, incorporation of a pyrazolo[1,5-a]pyridine heterocyclic appendage led to a series of high-affinity dopamine receptor partial agonists.  Comprehensive pharmacological characterization involving BRET biosensors, binding studies, electrophysiology, and complementation-based assays revealed compounds favoring activation of G proteins (preferably Go) over β-arrestin recruitment at dopamine D2 receptors.  The feasibility to design G protein-biased partial agonists as putative novel therapeutics was demonstrated for the representative 2-methoxyphenylpiperazine 16c, which unequivocally displayed antipsychotic activity in vivo.  Moreover, combination of the pyrazolo[1,5-a]pyridine appendage with a 5-hydroxy-N-propyl-2-aminotetraline unit led to balanced or G protein-biased dopaminergic ligands depending on the stereochemistry of the headgroup, illustrating the complex structure-functional selectivity relationships at dopamine D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSsvEaQplNsM25P7XSLhESfW6udTcc2eaPKW4I6x9O2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D&md5=208855de29fed6b821fd6e4a5bfb412f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01857%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DUzuneser%26aufirst%3DT.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DHuth%26aufirst%3DT.%26aulast%3DPlouffe%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DAlzheimer%26aufirst%3DC.%26aulast%3DFriedland%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520G%2520protein-biased%2520dopaminergics%2520with%2520a%2520pyrazolo%255B1%252C5-a%255Dpyridine%2520substructure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2908%26epage%3D2929%26doi%3D10.1021%2Facs.jmedchem.6b01857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herenbrink, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span> <span> </span><span class="NLM_article-title">A structure-activity analysis of biased agonism at the dopamine D2 receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9199</span>– <span class="NLM_lpage">9221</span>, <span class="refDoi"> DOI: 10.1021/jm401318w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401318w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9199-9221&author=J.+Shonbergauthor=C.+K.+Herenbrinkauthor=L.+L%C3%B3pezauthor=A.+Christopoulosauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=J.+R.+Lane&title=A+structure-activity+analysis+of+biased+agonism+at+the+dopamine+D2+receptor&doi=10.1021%2Fjm401318w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A Structure-Activity Analysis of Biased Agonism at the Dopamine D2 Receptor</span></div><div class="casAuthors">Shonberg, Jeremy; Herenbrink, Carmen Klein; Lopez, Laura; Christopoulos, Arthur; Scammells, Peter J.; Capuano, Ben; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9199-9221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased agonism offers an opportunity for the medicinal chemist to discover pathway-selective ligands for GPCRs.  A no. of studies have suggested that biased agonism at the dopamine D2 receptor (D2R) may be advantageous for the treatment of neuropsychiatric disorders, including schizophrenia.  As such, it is of great importance to gain insight into the SAR of biased agonism at this receptor.  The authors have generated SAR based on a novel D2R partial agonist, tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate.  This ligand shares structural similarity to cariprazine, a drug awaiting FDA approval for the treatment of schizophrenia, yet displays a distinct bias toward two different signaling end points.  The authors synthesized a no. of derivs. of tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate with subtle structural modifications, including incorporation of cariprazine fragments.  By combining pharmacol. profiling with anal. methodol. to identify and to quantify bias, the authors have demonstrated that efficacy and biased agonism can be finely tuned by minor structural modifications to the head group contg. the tertiary amine, a tail group that extends away from this moiety, and the orientation and length of a spacer region between these two moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocktbsOBHWB7Vg90H21EOLACvtfcHk0lhkG6LHZn7nKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ&md5=124b940132336819740ec30d2962a3a3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm401318w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401318w%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DHerenbrink%26aufirst%3DC.%2BK.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DA%2520structure-activity%2520analysis%2520of%2520biased%2520agonism%2520at%2520the%2520dopamine%2520D2%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9199%26epage%3D9221%26doi%3D10.1021%2Fjm401318w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, M.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Novel bivalent ligands based on the sumanirole pharmacophore reveal dopamine D2 receptor (D2R) biased agonism</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2890</span>– <span class="NLM_lpage">2907</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlSrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2890-2907&author=A.+Bonifaziauthor=H.+Yanoauthor=M.+P.+Ellenbergerauthor=L.+Mullerauthor=V.+Kumarauthor=M.-F.+Zouauthor=N.+S.+Caiauthor=A.+M.+Guerreroauthor=A.+S.+Woodsauthor=L.+Shiauthor=A.+H.+Newman&title=Novel+bivalent+ligands+based+on+the+sumanirole+pharmacophore+reveal+dopamine+D2+receptor+%28D2R%29+biased+agonism&doi=10.1021%2Facs.jmedchem.6b01875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism</span></div><div class="casAuthors">Bonifazi, Alessandro; Yano, Hideaki; Ellenberger, Michael P.; Muller, Ludovic; Kumar, Vivek; Zou, Mu-Fa; Cai, Ning Sheng; Guerrero, Adrian M.; Woods, Amina S.; Shi, Lei; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2890-2907</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of bivalent ligands has attracted interest as a way to potentially improve the selectivity and/or affinity for a specific receptor subtype.  The ability to bind two distinct receptor binding sites simultaneously can allow the selective activation of specific G-protein dependent or β-arrestin-mediated cascade pathways.  Herein, we developed an extended SAR study using sumanirole (1) as the primary pharmacophore.  We found that substitutions in the N-1- and/or N-5-positions, physiochem. properties of those substituents, and secondary arom. pharmacophores can enhance agonist efficacy for the cAMP inhibition mediated by Gi/o-proteins, while reducing or suppressing potency and efficacy toward β-arrestin recruitment.  Compd. 19 was identified as a new lead for its selective D2 G-protein biased agonism with an EC50 in the subnanomolar range.  Structure-activity correlations were obsd. between substitutions in positions N-1 and/or N-5 of 1 and the capacity of the new bivalent compds. to selectively activate G-proteins vs. β-arrestin recruitment in D2R-BRET functional assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprfScHokUgP7Vg90H21EOLACvtfcHk0lje97UnyEOgNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlSrsb0%253D&md5=24bf22a101756e44fbc8f8345d2c1fe4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01875%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DEllenberger%26aufirst%3DM.%2BP.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DZou%26aufirst%3DM.-F.%26aulast%3DCai%26aufirst%3DN.%2BS.%26aulast%3DGuerrero%26aufirst%3DA.%2BM.%26aulast%3DWoods%26aufirst%3DA.%2BS.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520bivalent%2520ligands%2520based%2520on%2520the%2520sumanirole%2520pharmacophore%2520reveal%2520dopamine%2520D2%2520receptor%2520%2528D2R%2529%2520biased%2520agonism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2890%26epage%3D2907%26doi%3D10.1021%2Facs.jmedchem.6b01875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weïwer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gale, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Bittner, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dordevic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skepner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennehy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faloon, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottrell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scolnick, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holson, E. B.</span></span> <span> </span><span class="NLM_article-title">Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1038</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1021/acschembio.8b00168</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00168" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1038-1047&author=M.+We%C3%AFwerauthor=Q.+Xuauthor=J.+P.+Galeauthor=M.+Lewisauthor=A.+J.+Campbellauthor=F.+A.+Schroederauthor=G.+C.+Van+de+Bittnerauthor=M.+Walkauthor=A.+Amayaauthor=P.+Suauthor=L.+Dordevicauthor=A.+Skepnerauthor=D.+Feiauthor=K.+Dennehyauthor=S.+Nguyenauthor=P.+W.+Faloonauthor=J.+Perezauthor=J.+R.+Cottrellauthor=F.+Liuauthor=M.+Palmerauthor=J.+Q.+Panauthor=J.+M.+Hookerauthor=Y.-L.+Zhangauthor=E.+Scolnickauthor=F.+F.+Wagnerauthor=E.+B.+Holson&title=Functionally+Biased+D2R+Antagonists%3A+Targeting+the+%CE%B2-Arrestin+Pathway+to+Improve+Antipsychotic+Treatment&doi=10.1021%2Facschembio.8b00168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment</span></div><div class="casAuthors">Weiwer, Michel; Xu, Qihong; Gale, Jennifer P.; Lewis, Michael; Campbell, Arthur J.; Schroeder, Frederick A.; Van de Bittner, Genevieve C.; Walk, Michelle; Amaya, Aldo; Su, Ping; Dordevic, Luka; Sacher, Joshua R.; Skepner, Adam; Fei, David; Dennehy, Kelly; Nguyen, Shannon; Faloon, Patrick W.; Perez, Jose; Cottrell, Jeffrey R.; Liu, Fang; Palmer, Michelle; Pan, Jen Q.; Hooker, Jacob M.; Zhang, Yan-Ling; Scolnick, Edward; Wagner, Florence F.; Holson, Edward B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1038-1047</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Schizophrenia is a severe neuropsychiatric disease that lacks completely effective and safe therapies.  As a polygenic disorder, genetic studies have only started to shed light on its complex etiol.  To date, the pos. symptoms of schizophrenia are well-managed by antipsychotic drugs, which primarily target the dopamine D2 receptor (D2R).  However, these antipsychotics are often accompanied by severe side effects, including motoric symptoms.  At D2R, antipsychotic drugs antagonize both G-protein dependent (Gαi/o) signaling and G-protein independent (β-arrestin) signaling.  However, the relevant contributions of the distinct D2R signaling pathways to antipsychotic efficacy and on-target side effects (motoric) are still incompletely understood.  Recent evidence from mouse genetic and pharmacol. studies point to β-arrestin signaling as the major driver of antipsychotic efficacy and suggest that a β-arrestin biased D2R antagonist could achieve an addnl. level of selectivity at D2R, increasing the therapeutic index of next generation antipsychotics.  Here, we characterize BRD5814, a highly brain penetrant β-arrestin biased D2R antagonist.  BRD5814 demonstrated good target engagement via PET imaging, achieving efficacy in an amphetamine-induced hyperlocomotion mouse model with strongly reduced motoric side effects in a rotarod performance test.  This proof of concept study opens the possibility for the development of a new generation of pathway selective antipsychotics at D2R with reduced side effect profiles for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPBrMik6d7a7Vg90H21EOLACvtfcHk0lje97UnyEOgNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOrtbw%253D&md5=51d636dd2a0ebfc83d58a6158a1da40e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00168%26sid%3Dliteratum%253Aachs%26aulast%3DWe%25C3%25AFwer%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DGale%26aufirst%3DJ.%2BP.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DA.%2BJ.%26aulast%3DSchroeder%26aufirst%3DF.%2BA.%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DG.%2BC.%26aulast%3DWalk%26aufirst%3DM.%26aulast%3DAmaya%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DP.%26aulast%3DDordevic%26aufirst%3DL.%26aulast%3DSkepner%26aufirst%3DA.%26aulast%3DFei%26aufirst%3DD.%26aulast%3DDennehy%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DS.%26aulast%3DFaloon%26aufirst%3DP.%2BW.%26aulast%3DPerez%26aufirst%3DJ.%26aulast%3DCottrell%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DPalmer%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DJ.%2BQ.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DY.-L.%26aulast%3DScolnick%26aufirst%3DE.%26aulast%3DWagner%26aufirst%3DF.%2BF.%26aulast%3DHolson%26aufirst%3DE.%2BB.%26atitle%3DFunctionally%2520Biased%2520D2R%2520Antagonists%253A%2520Targeting%2520the%2520%25CE%25B2-Arrestin%2520Pathway%2520to%2520Improve%2520Antipsychotic%2520Treatment%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D1038%26epage%3D1047%26doi%3D10.1021%2Facschembio.8b00168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMarco, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efremov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tierney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volfson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilmette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salafia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, M. D.</span></span> <span> </span><span class="NLM_article-title">Impaired beta-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">674</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02776-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fs41467-017-02776-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29445200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A280%3ADC%252BC1Mrhsl2nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=674&author=D.+L.+Grayauthor=J.+A.+Allenauthor=S.+Menteauthor=R.+E.+O%E2%80%99Connorauthor=G.+J.+DeMarcoauthor=I.+Efremovauthor=P.+Tierneyauthor=D.+Volfsonauthor=J.+Davorenauthor=E.+Guilmetteauthor=M.+Salafiaauthor=R.+Kozakauthor=M.+D.+Ehlers&title=Impaired+beta-arrestin+recruitment+and+reduced+desensitization+by+non-catechol+agonists+of+the+D1+dopamine+receptor&doi=10.1038%2Fs41467-017-02776-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor</span></div><div class="casAuthors">Gray David L; Mente Scot; Efremov Ivan; Davoren Jennifer; Gray David L; Allen John A; Tierney Patrick; Volfson Dmitri; Guilmette Edward; Kozak Rouba; Ehlers Michael D; Allen John A; O'Connor Rebecca E; Salafia Michelle; DeMarco George J; Ehlers Michael D</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">674</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Selective activation of dopamine D1 receptors (D1Rs) has been pursued for 40 years as a therapeutic strategy for neurologic and psychiatric diseases due to the fundamental role of D1Rs in motor function, reward processing, and cognition.  All known D1R-selective agonists are catechols, which are rapidly metabolized and desensitize the D1R after prolonged exposure, reducing agonist response.  As such, drug-like selective D1R agonists have remained elusive.  Here we report a novel series of selective, potent non-catechol D1R agonists with promising in vivo pharmacokinetic properties.  These ligands stimulate adenylyl cyclase signaling and are efficacious in a rodent model of Parkinson's disease after oral administration.  They exhibit distinct binding to the D1R orthosteric site and a novel functional profile including minimal receptor desensitization, reduced recruitment of β-arrestin, and sustained in vivo efficacy.  These results reveal a novel class of D1 agonists with favorable drug-like properties, and define the molecular basis for catechol-specific recruitment of β-arrestin to D1Rs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcShdJOozuyZkBe4jJGKT5N0fW6udTcc2eZwIvus5RQvirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mrhsl2nsQ%253D%253D&md5=2ba64bda304b083647eedff999f3fdcd</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02776-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02776-7%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DD.%2BL.%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DMente%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DDeMarco%26aufirst%3DG.%2BJ.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DTierney%26aufirst%3DP.%26aulast%3DVolfson%26aufirst%3DD.%26aulast%3DDavoren%26aufirst%3DJ.%26aulast%3DGuilmette%26aufirst%3DE.%26aulast%3DSalafia%26aufirst%3DM.%26aulast%3DKozak%26aufirst%3DR.%26aulast%3DEhlers%26aufirst%3DM.%2BD.%26atitle%3DImpaired%2520beta-arrestin%2520recruitment%2520and%2520reduced%2520desensitization%2520by%2520non-catechol%2520agonists%2520of%2520the%2520D1%2520dopamine%2520receptor%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D674%26doi%3D10.1038%2Fs41467-017-02776-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugolenski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rai, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salafia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D.</span></span> <span> </span><span class="NLM_article-title">Discovery and lead optimization of atropisomer D1 agonists with reduced desensitization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11384</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01622</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01622" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitF2qtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11384&author=J.+E.+Davorenauthor=D.+Nasonauthor=J.+Coeauthor=K.+Dlugolenskiauthor=C.+Helalauthor=A.+R.+Harrisauthor=E.+LaChapelleauthor=S.+Liangauthor=Y.+Liuauthor=R.+O%E2%80%99Connorauthor=C.+C.+Orozcoauthor=B.+K.+Raiauthor=M.+Salafiaauthor=B.+Samasauthor=W.+Xuauthor=R.+Kozakauthor=D.+Gray&title=Discovery+and+lead+optimization+of+atropisomer+D1+agonists+with+reduced+desensitization&doi=10.1021%2Facs.jmedchem.8b01622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization</span></div><div class="casAuthors">Davoren, Jennifer E.; Nason, Deane; Coe, Jotham; Dlugolenski, Keith; Helal, Christopher; Harris, Anthony R.; LaChapelle, Erik; Liang, Sidney; Liu, Yue; OConnor, Rebecca; Orozco, Christine C.; Rai, Brajesh K.; Salafia, Michelle; Samas, Brian; Xu, Wenjian; Kozak, Rouba; Gray, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11384-11397</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of D1 subtype-selective agonists with drug-like properties has been an enduring challenge for the greater part of 40 years.  All known D1-selective agonists are catecholamines that bring about receptor desensitization and undergo rapid metab., thus limiting their utility as a therapeutic for chronic illness such as schizophrenia and Parkinson's disease.  Our high-throughput screening efforts on D1 yielded a single non-catecholamine hit PF-4211 (6) that was developed into a series of potent D1 receptor agonist leads with high oral bioavailability and CNS penetration.  An important structural feature of this series is the locked biaryl ring system resulting in atropisomerism.  Disclosed herein is a summary of our hit-to-lead efforts on this series of D1 activators culminating in the discovery of atropisomer 31 (PF-06256142), a potent and selective orthosteric agonist of the D1 receptor that has reduced receptor desensitization relative to dopamine and other catechol-contg. agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2S5u6FmBDoLVg90H21EOLACvtfcHk0lhv8QFIBfUc6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitF2qtrvI&md5=ec84a23922f417fdeb1acd9beb3ad4bf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01622%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DNason%26aufirst%3DD.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DHelal%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DOrozco%26aufirst%3DC.%2BC.%26aulast%3DRai%26aufirst%3DB.%2BK.%26aulast%3DSalafia%26aufirst%3DM.%26aulast%3DSamas%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DKozak%26aufirst%3DR.%26aulast%3DGray%26aufirst%3DD.%26atitle%3DDiscovery%2520and%2520lead%2520optimization%2520of%2520atropisomer%2520D1%2520agonists%2520with%2520reduced%2520desensitization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11384%26doi%3D10.1021%2Facs.jmedchem.8b01622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezard, E.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of L-DOPA-induced dyskinesia</span>. <i>Int. Rev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/b978-0-12-381328-2.00004-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fb978-0-12-381328-2.00004-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=21907084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFWhsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2011&pages=95-122&author=G.+Fisoneauthor=E.+Bezard&title=Molecular+mechanisms+of+L-DOPA-induced+dyskinesia&doi=10.1016%2Fb978-0-12-381328-2.00004-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of L-dopa-induced dyskinesia</span></div><div class="casAuthors">Fisone, Gilberto; Bezard, Erwan</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia</span>),
    <span class="NLM_cas:pages">95-122</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD), a common neurodegenerative disorder caused by the loss of the dopaminergic input to the basal ganglia, is commonly treated with L-DOPA.  Use of this drug, however, is severely limited by the development of dystonic and choreic motor complications, or dyskinesia.  This chapter describes the mol. mechanisms implicated in the emergence and manifestation of L-DOPA-induced dyskinesia (LID).  Particular emphasis is given to the role played in this condition by abnormalities in signal transduction at the level of the medium spiny neurons (MSNs) of the striatum, which are the principal target of L-DOPA.  Recent evidence pointing to pre-synaptic dysregulation is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFEzuMQszILbVg90H21EOLACvtfcHk0lhv8QFIBfUc6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFWhsLzL&md5=4f42b455fa3e5c1a4bb6074a6a928490</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fb978-0-12-381328-2.00004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fb978-0-12-381328-2.00004-3%26sid%3Dliteratum%253Aachs%26aulast%3DFisone%26aufirst%3DG.%26aulast%3DBezard%26aufirst%3DE.%26atitle%3DMolecular%2520mechanisms%2520of%2520L-DOPA-induced%2520dyskinesia%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2011%26volume%3D98%26spage%3D95%26epage%3D122%26doi%3D10.1016%2Fb978-0-12-381328-2.00004-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jenner, P.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of L-DOPA-induced dyskinesia</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.1038/nrn2471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnrn2471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=18714325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSjurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=665-677&author=P.+Jenner&title=Molecular+mechanisms+of+L-DOPA-induced+dyskinesia&doi=10.1038%2Fnrn2471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of L-DOPA-induced dyskinesia</span></div><div class="casAuthors">Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">665-677</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dyskinesia is a treatment-limiting side effect of dopaminergic replacement therapies in Parkinson's disease.  Here Jenner discusses what we know about the mol. causes of dyskinesia induction and expression, highlighting recent findings that suggest that altered glutamatergic transmission might be important.  L-DOPA (L-3,4-dihydroxyphenylalanine) remains the most effective drug for the treatment of Parkinson's disease.  However, chronic use causes dyskinesia, a complex motor phenomenon that consists of two components: the execution of involuntary movements in response to drug administration, and the 'priming' phenomenon that underlies these movements' establishment and persistence.  A reinterpretation of recent data suggests that priming for dyskinesia results from nigral denervation and the loss of striatal dopamine input, which alters glutamatergic synaptic connectivity in the striatum.  The subsequent response of the abnormal basal ganglia to dopaminergic drugs dets. the manner and timing of dyskinesia expression.  The combination of nigral denervation and drug treatment establishes inappropriate signaling between the motor cortex and the striatum, leading to persistent dyskinesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-pdXwQI94e7Vg90H21EOLACvtfcHk0lhv8QFIBfUc6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSjurvP&md5=5dac15ce126371908eef79c093420b67</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnrn2471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2471%26sid%3Dliteratum%253Aachs%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DMolecular%2520mechanisms%2520of%2520L-DOPA-induced%2520dyskinesia%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2008%26volume%3D9%26spage%3D665%26epage%3D677%26doi%3D10.1038%2Fnrn2471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weed, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolverton, W. L.</span></span> <span> </span><span class="NLM_article-title">Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1007/bf02244333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1007%2Fbf02244333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=7862828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaK2cXjtFGksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1993&pages=51-52&author=M.+R.+Weedauthor=K.+E.+Vanoverauthor=W.+L.+Woolverton&title=Reinforcing+effect+of+the+D1+dopamine+agonist+SKF+81297+in+rhesus+monkeys&doi=10.1007%2Fbf02244333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys</span></div><div class="casAuthors">Weed, Michael R.; Vanover, Kimberly E.; Woolverton, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-2</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">Rhesus monkeys with IV catheters were allowed to self-administer cocaine for 1 h/day.  When responding was stable, saline or the D1 dopamine agonist SKF 81297 (SKF; 0.001-0.3 mg/kg/inj) was substituted for cocaine.  At least two doses of SKF maintained responding above saline levels in all monkeys.  The D1 antagonist SCH 39166 (0.001-0.03 mg/kg, IM) was then administered 30 min before sessions of self-administration of the lowest dose of SKF that maintained behavior (0.01 mg/kg/inj).  SKF-maintained responding decreased in a dose-related manner, suggesting antagonism of the reinforcing effect.  These results suggest that stimulation of D1 receptors can initiate a reinforcing effect and further implicate D1 receptors in the reinforcing effects of drugs that increase dopamine neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2g0mdrLmjnbVg90H21EOLACvtfcHk0ljdNZQeNsVVbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjtFGksLc%253D&md5=9f93dfa9b995918ef897ac2fb1a6f3d2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fbf02244333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fbf02244333%26sid%3Dliteratum%253Aachs%26aulast%3DWeed%26aufirst%3DM.%2BR.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DWoolverton%26aufirst%3DW.%2BL.%26atitle%3DReinforcing%2520effect%2520of%2520the%2520D1%2520dopamine%2520agonist%2520SKF%252081297%2520in%2520rhesus%2520monkeys%26jtitle%3DPsychopharmacology%26date%3D1993%26volume%3D113%26spage%3D51%26epage%3D52%26doi%3D10.1007%2Fbf02244333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savasta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatton, B.</span></span> <span> </span><span class="NLM_article-title">Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/0306-4522(86)90010-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2F0306-4522%2886%2990010-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=2946980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaL28XlvVeku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1986&pages=125-137&author=A.+Duboisauthor=M.+Savastaauthor=O.+Curetauthor=B.+Scatton&title=Autoradiographic+distribution+of+the+D1+agonist+%5B3H%5DSKF+38393%2C+in+the+rat+brain+and+spinal+cord.+Comparison+with+the+distribution+of+D2+dopamine+receptors&doi=10.1016%2F0306-4522%2886%2990010-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord.  Comparison with the distribution of D2 dopamine receptors</span></div><div class="casAuthors">Dubois, A.; Savasta, M.; Curet, O.; Scatton, B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-37</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    </div><div class="casAbstract">The regional distribution of the specific D1 agonist 3H-labeled SKF 38393 (I)  [67287-49-4] was studied autoradiog. in the rat central nervous system.  The binding of [3H]SKF 38393 to striatal sections was saturable, stereospecific, reversible, of high affinity (Kd = 9.9 nM) and partly Na+ sensitive; it occurred at a single population of sites and possessed the pharmacol. characteristics of the dopamine-D1 receptor.  The highest levels of [3H]SKF 38393 binding sites were found in the caudate putamen, nucleus accumbens, olfactory tubercle and substantia nigra.  Moderately high concns. of the [3H]ligand were obsd. in the amygdala, endopyriform nucleus, nucleus olfactorius anterior, lateral septum, primary olfactory cortex, cerebellum (mol. layer) and spinal cord.  An intermediate labeling was found in the thalamus, habenula, subthalamic nucleus, hypothalamus, ventral tegmental area, superior colliculus, hippocampus and cerebral cortex.  Moderate levels of [3H]SKF 38393 binding were obsd. in the globus pallidus and arcuate nucleus.  The autoradiog. distribution of [3H]SKF 38393 overlapped with that of [3H]N,n-propylnorapomorphine, a radioligand which labels the D2-dopamine receptors, in a no. of dopamine-rich brain areas but there were several areas which exhibited a high d. of [3H]SKF 38393 binding sites but undetectable concns. of [3H]N,n-propylnorapomorphine.  Moreover, in the spinal cord, the subregional localization of these [3H]ligands clearly differed.  Intrastriatal injection of ibotenic acid caused a large decrease in [3H]SKF 38393 and [3H]N,n-propylnorapomorphine binding in the striatum and provoked a redn. of [3H]SKF 38393 but not [3H]N,n-propylnorapomorphine binding in the substantia nigra confirming the view that nigral D1 but not D2 receptors are located on striatonigral fibers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdV6YLmAEVkLVg90H21EOLACvtfcHk0ljdNZQeNsVVbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XlvVeku78%253D&md5=39e8e4614c8ed62f24d15567dfcd039e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0306-4522%2886%2990010-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-4522%252886%252990010-2%26sid%3Dliteratum%253Aachs%26aulast%3DDubois%26aufirst%3DA.%26aulast%3DSavasta%26aufirst%3DM.%26aulast%3DCuret%26aufirst%3DO.%26aulast%3DScatton%26aufirst%3DB.%26atitle%3DAutoradiographic%2520distribution%2520of%2520the%2520D1%2520agonist%2520%255B3H%255DSKF%252038393%252C%2520in%2520the%2520rat%2520brain%2520and%2520spinal%2520cord.%2520Comparison%2520with%2520the%2520distribution%2520of%2520D2%2520dopamine%2520receptors%26jtitle%3DNeuroscience%26date%3D1986%26volume%3D19%26spage%3D125%26epage%3D137%26doi%3D10.1016%2F0306-4522%2886%2990010-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mottola, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewster, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>262</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1352553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaK38XkvVegu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1992&pages=383-393&author=D.+M.+Mottolaauthor=W.+K.+Brewsterauthor=L.+L.+Cookauthor=D.+E.+Nicholsauthor=R.+B.+Mailman&title=Dihydrexidine%2C+a+novel+full+efficacy+D1+dopamine+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist</span></div><div class="casAuthors">Mottola, David M.; Brewster, William K.; Cook, Larry L.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">383-93</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The present work provides a detailed pharmacol. characterization of dihydrexidine (DHX) (trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine), the first high-potency, full efficacy, bioavailable D1 dopamine receptor agonist.  DHX represents a new conformationally rigid structural class of dopamine receptor ligands.  It competes stereoselectively and potently for D1 binding sites in rat striatal membranes labeled with [3H]SCH23390 with an IC50 of about 10 nM compared to about 30 nM for the prototypical D1 agonist SKF38393.  Like other dopamine agonists, DHX has a shallow competition curve (nH = ca. 0.7) that can be fitted by a two-site model consisting of high-affinity (63%; KD = 3 nM) and low-affinity (37%; KD = 75 nM) sites.  DHX was screened for activity against 40 other binding sites, and was inactive (IC50 >10 μM) against all except D2 dopamine receptors (IC50 = 130 nM) and alpha2 adrenoceptors (IC50 = ca. 230 nM).  Functionally, DHX is a full efficacy dopamine D1 agonist.  In homogenates of rat striatum, DHX or dopamine doubles the rate of cAMP synthesis, whereas SKF38393 only causes a maximal increase of about 50%.  These effects of DHX are blocked by the selective D1 antagonist SCH23390, but are not affected by D2, 5-hydroxytryptamine2, muscarinic, or alpha or beta adrenergic antagonists.  Because DHX is known to cause D2-like behavioral effects at high doses, the nature of its D2 activity was characterized using prolactin release as an endpoint.  DHX and the prototypical D2 agonist quinpirole both caused a significant inhibition of the prolactin release induced by 5-hydroxytryptophan.  These effects of DHX are not due to "indirect" alterations at the presynaptic terminal, because DHX is essentially inactive at inhibiting the dopamine uptake system, and does not cause the release of dopamine.  These data demonstrate the utility of DHX for probing the biochem. and function of D1 dopamine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbI1fnzEG8NrVg90H21EOLACvtfcHk0ljdNZQeNsVVbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvVegu78%253D&md5=e5c0d22fc1fea23285fd0ea711c71598</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMottola%26aufirst%3DD.%2BM.%26aulast%3DBrewster%26aufirst%3DW.%2BK.%26aulast%3DCook%26aufirst%3DL.%2BL.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DDihydrexidine%252C%2520a%2520novel%2520full%2520efficacy%2520D1%2520dopamine%2520receptor%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1992%26volume%3D262%26spage%3D383%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collantes, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 5-bromo-6-methyl imidazopyrazine, 5-bromo and 5-chloro-6-methyl imidazopyridine using electron density surface maps to guide synthetic strategy</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">9063</span>– <span class="NLM_lpage">9066</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2011.08.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.tet.2011.08.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKrtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=9063-9066&author=A.+R.+Harrisauthor=D.+M.+Nasonauthor=E.+M.+Collantesauthor=W.+Xuauthor=Y.+Chiauthor=Z.+Wangauthor=B.+Zhangauthor=Q.+Zhangauthor=D.+L.+Grayauthor=J.+E.+Davoren&title=Synthesis+of+5-bromo-6-methyl+imidazopyrazine%2C+5-bromo+and+5-chloro-6-methyl+imidazopyridine+using+electron+density+surface+maps+to+guide+synthetic+strategy&doi=10.1016%2Fj.tet.2011.08.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 5-bromo-6-methyl imidazopyrazine, 5-bromo and 5-chloro-6-methyl imidazopyridine using electron density surface maps to guide synthetic strategy</span></div><div class="casAuthors">Harris, Anthony R.; Nason, Deane M.; Collantes, Elizabeth M.; Xu, Wenjian; Chi, Yushi; Wang, Zhihan; Zhang, Bingzhi; Zhang, Qingjian; Gray, David L.; Davoren, Jennifer E.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">9063-9066</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Small heteroarom. rings are valuable monomers in drug discovery that can enable rapid access to novel and desirable chem. space.  Installation of a synthetic handle on a heteroarom. core may be difficult if steric and electronic factors are not in alignment with the desired transformation.  Described are practical routes for the construction of 5-bromo-6-Me imidazopyrazine I as well as Me imidazopyridines, e.g., II, developed using electron d. surface maps encoded with ionization potential to guide synthetic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0tXPawFaaHLVg90H21EOLACvtfcHk0lifcs7vEZ5QXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKrtr%252FM&md5=41e1ee9ba97bed2073f82cd186ed7a50</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2011.08.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2011.08.090%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DCollantes%26aufirst%3DE.%2BM.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DChi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DGray%26aufirst%3DD.%2BL.%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26atitle%3DSynthesis%2520of%25205-bromo-6-methyl%2520imidazopyrazine%252C%25205-bromo%2520and%25205-chloro-6-methyl%2520imidazopyridine%2520using%2520electron%2520density%2520surface%2520maps%2520to%2520guide%2520synthetic%2520strategy%26jtitle%3DTetrahedron%26date%3D2011%26volume%3D67%26spage%3D9063%26epage%3D9066%26doi%3D10.1016%2Fj.tet.2011.08.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed cross-coupling reactions of organoboron compounds</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2483</span>, <span class="refDoi"> DOI: 10.1021/cr00039a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds&doi=10.1021%2Fcr00039a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lifcs7vEZ5QXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483%26doi%3D10.1021%2Fcr00039a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bercher, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuerstenau-Sharp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedvik, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielinski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doucette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revankar, C.</span></span> <span> </span><span class="NLM_article-title">A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">798</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1177/1087057109335260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1177%2F1087057109335260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=19531663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCgur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=798-810&author=B.+J.+Hansonauthor=J.+Wetterauthor=M.+R.+Bercherauthor=L.+Koppauthor=M.+Fuerstenau-Sharpauthor=K.+L.+Vedvikauthor=T.+Zielinskiauthor=C.+Doucetteauthor=P.+J.+Whitneyauthor=C.+Revankar&title=A+homogeneous+fluorescent+live-cell+assay+for+measuring+7-transmembrane+receptor+activity+and+agonist+functional+selectivity+through+beta-arrestin+recruitment&doi=10.1177%2F1087057109335260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment</span></div><div class="casAuthors">Hanson, Bonnie J.; Wetter, Justin; Bercher, Mark R.; Kopp, Leisha; Fuerstenau-Sharp, Maya; Vedvik, Kevin L.; Zielinski, Thomas; Doucette, Chris; Whitney, Pamela J.; Revankar, Chetana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">798-810</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Seven-transmembrane (7TM) receptors play an essential role in the regulation of a wide variety of physiol. processes, making them one of the top target classes for pharmaceuticals.  7TM receptor function is mediated and modulated through 2 primary processes: G-protein and beta-arrestin signaling.  Classically, it has been recognized that these 2 processes can interact with one another during 7TM receptor desensitization, but it has more recently been recognized that these 2 processes can also act independently of one another and can activate parallel signaling pathways.  As such, the methods used to interrogate 7TM receptor signaling, both from a biol. and a pharmaceutical perspective, may need to be reevaluated and the question of whether functionally selective compds. (compds. that selectively activate one pathway over another) can be rationally developed must be raised.  Although numerous high-throughput screening (HTS) compatible assays exist for studying second messengers arising from G-protein signaling, far fewer HTS compatible assays exist for studying beta-arrestin recruitment.  The authors report on the Tango 7TM receptor assay technol., a high-throughput homogeneous assay method for monitoring beta-arrestin recruitment that uses a live-cell fluorescent readout.  This assay format is broadly applicable to 7TM receptors, independent of G-protein coupling and, as such, has been used to produce assays for over 70 7TM receptor targets.  The authors also show how flow cytometry can be used to select clones with desired pharmacol. profiles and how an inducible expression system can increase the assay window for targets with high levels of constitutive activity.  Finally, they demonstrate how the Tango system can be used in parallel with assays aimed at second-messenger signaling to enable functional selectivity studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF-iHGhENdULVg90H21EOLACvtfcHk0lifcs7vEZ5QXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCgur3F&md5=80c59bd127327e09101543c98a040e16</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1177%2F1087057109335260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057109335260%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DB.%2BJ.%26aulast%3DWetter%26aufirst%3DJ.%26aulast%3DBercher%26aufirst%3DM.%2BR.%26aulast%3DKopp%26aufirst%3DL.%26aulast%3DFuerstenau-Sharp%26aufirst%3DM.%26aulast%3DVedvik%26aufirst%3DK.%2BL.%26aulast%3DZielinski%26aufirst%3DT.%26aulast%3DDoucette%26aufirst%3DC.%26aulast%3DWhitney%26aufirst%3DP.%2BJ.%26aulast%3DRevankar%26aufirst%3DC.%26atitle%3DA%2520homogeneous%2520fluorescent%2520live-cell%2520assay%2520for%2520measuring%25207-transmembrane%2520receptor%2520activity%2520and%2520agonist%2520functional%2520selectivity%2520through%2520beta-arrestin%2520recruitment%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2009%26volume%3D14%26spage%3D798%26epage%3D810%26doi%3D10.1177%2F1087057109335260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span>; <span class="NLM_string-name">Li, Z.</span>; <span class="NLM_string-name">Cvijic, M. E.</span>; <span class="NLM_string-name">Krause, C.</span>; <span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">Sum, C.
S.</span></span> <span> </span><span class="NLM_article-title">Measurement of Beta-Arrestin Recruitment for GPCR Targets</span>. In  <i>Assay Guidance Manual</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sittampalam, G. S.</span>, <span class="NLM_string-name">Coussens, N. P.</span>, <span class="NLM_string-name">Brimacombe, K.</span>, <span class="NLM_string-name">Grossman, A.</span>, <span class="NLM_string-name">Arkin, M.</span>, <span class="NLM_string-name">Auld, D.</span>, <span class="NLM_string-name">Austin, C.</span>, <span class="NLM_string-name">Baell, J.</span>, <span class="NLM_string-name">Bejcek, B.</span>, <span class="NLM_string-name">Caaveiro, J. M. M.</span>, <span class="NLM_string-name">Chung, T. D. Y.</span>, <span class="NLM_string-name">Dahlin, J. L.</span>; <span class="NLM_string-name">Devanaryan, V.</span>, <span class="NLM_string-name">Foley, T. L.</span>, <span class="NLM_string-name">Glicksman, M.</span>, <span class="NLM_string-name">Hall, M. D.</span>, <span class="NLM_string-name">Haas, J. V.</span>, <span class="NLM_string-name">Inglese, J.</span>, <span class="NLM_string-name">Iversen, P. W.</span>, <span class="NLM_string-name">Kahl, S. D.</span>, <span class="NLM_string-name">Kales, S. C.</span>, <span class="NLM_string-name">Lal-Nag, M.</span>, <span class="NLM_string-name">Li, Z.</span>, <span class="NLM_string-name">McGee, J.</span>, <span class="NLM_string-name">McManus, O.</span>, <span class="NLM_string-name">Riss, T.</span>, <span class="NLM_string-name">Trask, O. J.,  Jr.</span>, <span class="NLM_string-name">Weidner, J. R.</span>, <span class="NLM_string-name">Wildey, M. J.</span>, <span class="NLM_string-name">Xia, M.</span>, <span class="NLM_string-name">Xu, X.</span></span>, Eds.; <span class="NLM_publisher-name">Eli Lilly & Company</span>: <span class="NLM_publisher-loc">Bethesda MD</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=T.+Wang&author=Z.+Li&author=M.+E.+Cvijic&author=C.+Krause&author=L.+Zhang&author=C.%0AS.+Sumauthor=G.+S.+Sittampalam&author=N.+P.+Coussens&author=K.+Brimacombe&author=A.+Grossman&author=M.+Arkin&author=D.+Auld&author=C.+Austin&author=J.+Baell&author=B.+Bejcek&author=J.+M.+M.+Caaveiro&author=T.+D.+Y.+Chung&author=J.+L.+Dahlin&author=V.+Devanaryan&author=T.+L.+Foley&author=M.+Glicksman&author=M.+D.+Hall&author=J.+V.+Haas&author=J.+Inglese&author=P.+W.+Iversen&author=S.+D.+Kahl&author=S.+C.+Kales&author=M.+Lal-Nag&author=Z.+Li&author=J.+McGee&author=O.+McManus&author=T.+Riss&author=O.+J.+Trask&author=J.+R.+Weidner&author=M.+J.+Wildey&author=M.+Xia&author=X.+Xu&title=Assay+Guidance+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26atitle%3DMeasurement%2520of%2520Beta-Arrestin%2520Recruitment%2520for%2520GPCR%2520Targets%26btitle%3DAssay%2520Guidance%2520Manual%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26pub%3DEli%2520Lilly%2520%2526%2520Company%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span> <span> </span><span class="NLM_article-title">Tools for GPCR drug discovery</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1038/aps.2011.173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Faps.2011.173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=22266728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1elu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=372-384&author=R.+Zhangauthor=X.+Xie&title=Tools+for+GPCR+drug+discovery&doi=10.1038%2Faps.2011.173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Tools for GPCR drug discovery</span></div><div class="casAuthors">Zhang, Ru; Xie, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">372-384</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCRs) mediate many important physiol. functions and are considered as one of the most successful therapeutic targets for a broad spectrum of diseases.  The design and implementation of high-throughput GPCR assays that allow the cost-effective screening of large compd. libraries to identify novel drug candidates are crit. in early drug discovery.  Early functional GPCR assays depend primarily on the measurement of G-protein-mediated 2nd messenger generation.  Taking advantage of the continuously deepening understanding of GPCR signal transduction, many G-protein-independent pathways are utilized to detect the activity of GPCRs, and may provide addnl. information on functional selectivity of candidate compds.  With the combination of automated imaging systems and label-free detection systems, such assays are now suitable for high-throughput screening (HTS).  In this review, we summarize the most widely used GPCR assays and recent advances in HTS technologies for GPCR drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8pC8anrKpWLVg90H21EOLACvtfcHk0likTRERtCjGNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1elu7Y%253D&md5=04ca4fed048dbca837d81c02566e6e25</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Faps.2011.173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2011.173%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DTools%2520for%2520GPCR%2520drug%2520discovery%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2012%26volume%3D33%26spage%3D372%26epage%3D384%26doi%3D10.1038%2Faps.2011.173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besnard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constam, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.-P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+C.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0likTRERtCjGNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muniz-Medina, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S.</span></span> <span> </span><span class="NLM_article-title">A simple method for quantifying functional selectivity and agonist bias</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1021/cn200111m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200111m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=193-203&author=T.+Kenakinauthor=C.+Watsonauthor=V.+Muniz-Medinaauthor=A.+Christopoulosauthor=S.+Novick&title=A+simple+method+for+quantifying+functional+selectivity+and+agonist+bias&doi=10.1021%2Fcn200111m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Method for Quantifying Functional Selectivity and Agonist Bias</span></div><div class="casAuthors">Kenakin, Terry; Watson, Christian; Muniz-Medina, Vanessa; Christopoulos, Arthur; Novick, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-203</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of seven-transmembrane (7TM) receptors by agonists does not always lead to uniform activation of all signaling pathways mediated by a given receptor.  Relative to other ligands, many agonists are "biased" toward producing subsets of receptor behaviors.  A hallmark of such "functional selectivity" is cell type dependence; this poses a particular problem for the profiling of agonists in whole cell test systems removed from the therapeutic one(s).  Such response-specific cell-based variability makes it difficult to guide medicinal chem. efforts aimed at identifying and optimizing therapeutically meaningful agonist bias.  For this reason, we present a scale, based on the Black and Leff operational model, that contains the key elements required to describe 7TM agonism, namely, affinity (KA-1) for the receptor and efficacy (τ) in activating a particular signaling pathway.  Utilizing a "transduction coeff." term, log(τ/KA), this scale can statistically evaluate selective agonist effects in a manner that can theor. inform structure-activity studies and/or drug candidate selection matrixes.  The bias of four chemokines for CCR5-mediated inositol phosphate prodn. vs. internalization is quantified to illustrate the practical application of this method.  The independence of this method with respect to receptor d. and the calcn. of statistical ests. of confidence of differences are specifically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxSkELs1bHQLVg90H21EOLACvtfcHk0likTRERtCjGNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN&md5=270841d11f9720caaf3e59a6fe0aee74</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fcn200111m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200111m%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DMuniz-Medina%26aufirst%3DV.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DNovick%26aufirst%3DS.%26atitle%3DA%2520simple%2520method%2520for%2520quantifying%2520functional%2520selectivity%2520and%2520agonist%2520bias%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D193%26epage%3D203%26doi%3D10.1021%2Fcn200111m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hyejin Park, Aarti N. Urs, Joseph Zimmerman, Chuan Liu, Qiu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Nikhil M. Urs</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 385-392. <a href="https://doi.org/10.1021/acsmedchemlett.9b00575" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00575%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Functional%2525E2%252580%252593Selectivity%252BRelationship%252BStudies%252Bof%252BNovel%252BApomorphine%252BAnalogs%252Bto%252BDevelop%252BD1R%25252FD2R%252BBiased%252BLigands%26aulast%3DPark%26aufirst%3DHyejin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D07122019%26date%3D06012020%26date%3D13012020%26date%3D06012020%26volume%3D11%26issue%3D3%26spage%3D385%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael
L. Martini, Caroline Ray, Xufen Yu, Jing Liu, Vladimir M. Pogorelov, William C. Wetsel, Xi-Ping Huang, John D. McCorvy, Marc G. Caron, <span class="NLM_string-name hlFld-ContribAuthor">Jian Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 4160-4182. <a href="https://doi.org/10.1021/acschemneuro.9b00410" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00410%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesigning%252BFunctionally%252BSelective%252BNoncatechol%252BDopamine%252BD1%252BReceptor%252BAgonists%252Bwith%252BPotent%252BIn%252BVivo%252BAntiparkinsonian%252BActivity%26aulast%3DMartini%26aufirst%3DMichael%2BL.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20072019%26date%3D06082019%26date%3D20082019%26date%3D06082019%26volume%3D10%26issue%3D9%26spage%3D4160%26epage%3D4182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bingfa  Sun</span>, <span class="hlFld-ContribAuthor ">Dan  Feng</span>, <span class="hlFld-ContribAuthor ">Matthew Ling-Hon  Chu</span>, <span class="hlFld-ContribAuthor ">Inbar  Fish</span>, <span class="hlFld-ContribAuthor ">Silvia  Lovera</span>, <span class="hlFld-ContribAuthor ">Zara A.  Sands</span>, <span class="hlFld-ContribAuthor ">Sebastian  Kelm</span>, <span class="hlFld-ContribAuthor ">Anne  Valade</span>, <span class="hlFld-ContribAuthor ">Martyn  Wood</span>, <span class="hlFld-ContribAuthor ">Tom  Ceska</span>, <span class="hlFld-ContribAuthor ">Tong Sun  Kobilka</span>, <span class="hlFld-ContribAuthor ">Florence  Lebon</span>, <span class="hlFld-ContribAuthor ">Brian K.  Kobilka</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-021-23519-9" title="DOI URL">https://doi.org/10.1038/s41467-021-23519-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-021-23519-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-021-23519-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DCrystal%252Bstructure%252Bof%252Bdopamine%252BD1%252Breceptor%252Bin%252Bcomplex%252Bwith%252BG%252Bprotein%252Band%252Ba%252Bnon-catechol%252Bagonist%26aulast%3DSun%26aufirst%3DBingfa%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian  Newman-Tancredi</span>, <span class="hlFld-ContribAuthor ">Ronan Y.  Depoortère</span>, <span class="hlFld-ContribAuthor ">Mark S.  Kleven</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Luc  Zimmer</span>. </span><span class="cited-content_cbyCitation_article-title">Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>107 </em>, 107937. <a href="https://doi.org/10.1016/j.pharmthera.2021.107937" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2021.107937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2021.107937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2021.107937%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DTranslating%252Bbiased%252Bagonists%252Bfrom%252Bmolecules%252Bto%252Bmedications%25253A%252BSerotonin%252B5-HT1A%252Breceptor%252Bfunctional%252Bselectivity%252Bfor%252BCNS%252Bdisorders%26aulast%3DNewman-Tancredi%26aufirst%3DAdrian%26date%3D2021%26volume%3D107%26spage%3D107937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharonda S.  Harris</span>, <span class="hlFld-ContribAuthor ">Nikhil M.  Urs</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting β-Arrestins in the Treatment of Psychiatric and Neurological Disorders. </span><span class="cited-content_cbyCitation_journal-name">CNS Drugs</span><span> <strong>2021,</strong> <em>35 </em>
                                    (3)
                                     , 253-264. <a href="https://doi.org/10.1007/s40263-021-00796-y" title="DOI URL">https://doi.org/10.1007/s40263-021-00796-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40263-021-00796-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40263-021-00796-y%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Drugs%26atitle%3DTargeting%252B%2525CE%2525B2-Arrestins%252Bin%252Bthe%252BTreatment%252Bof%252BPsychiatric%252Band%252BNeurological%252BDisorders%26aulast%3DHarris%26aufirst%3DSharonda%2BS.%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D3%26spage%3D253%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael L.  Martini</span>, <span class="hlFld-ContribAuthor ">Sean N.  Neifert</span>, <span class="hlFld-ContribAuthor ">J  Mocco</span>, <span class="hlFld-ContribAuthor ">Fedor  Panov</span>, <span class="hlFld-ContribAuthor ">Winona  Tse</span>, <span class="hlFld-ContribAuthor ">Ruth H.  Walker</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>, <span class="hlFld-ContribAuthor ">Fiona  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development of Experimental Therapeutics for Levodopa-Induced Dyskinesia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Movement Disorders</span><span> <strong>2019,</strong> <em>12 </em>
                                    (3)
                                     , 161-165. <a href="https://doi.org/10.14802/jmd.19029" title="DOI URL">https://doi.org/10.14802/jmd.19029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14802/jmd.19029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14802%2Fjmd.19029%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Movement%2520Disorders%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BExperimental%252BTherapeutics%252Bfor%252BLevodopa-Induced%252BDyskinesia%26aulast%3DMartini%26aufirst%3DMichael%2BL.%26date%3D2019%26volume%3D12%26issue%3D3%26spage%3D161%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel E.  Felsing</span>, <span class="hlFld-ContribAuthor ">Manish K.  Jain</span>, <span class="hlFld-ContribAuthor ">John A.  Allen</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (16)
                                     , 1365-1380. <a href="https://doi.org/10.2174/1568026619666190712210903" title="DOI URL">https://doi.org/10.2174/1568026619666190712210903</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190712210903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190712210903%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252BDopamine%252BD1%252BReceptor%252BLigands%252Bfor%252BNeurotherapeutics%26aulast%3DFelsing%26aufirst%3DDaniel%2BE.%26date%3D2019%26volume%3D19%26issue%3D16%26spage%3D1365%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Four regions of the arylphenoxyaryl scaffold of compound <b>1</b> that were investigated for SFSR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds for Exploring the RHS Heterocyclic Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 125 °C, 48 h; (b) Pd(dppf)Cl<sub>2</sub>, KOAc, B<sub>2</sub>(pin)<sub>2</sub>, dioxane, 80 °C, 18 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O<sub>2</sub>, 120 °C, 25 min.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Full concentration–response curves for representative compounds and control compounds measured using the Glosensor assay for G<sub>S</sub> pathway activation (G<sub>S</sub>-cAMP) and the BRET assay for β-arrestin2 (β-arr2) recruitment as a percentage of the maximal dopamine (DA) response. Dopamine (A) is a potent full agonist of both signaling pathways, while dihydrexidine (B), a known D<sub>1</sub>/D<sub>5</sub> selective full agonist, displays a slight β-arrestin bias (bias factor = 7.5). Compound <b>1</b> (C) is a potent G<sub>S</sub>-biased partial agonist in both pathways, while compound <b>7</b> (D) displays relatively enhanced G<sub>S</sub> bias and full agonism in the G<sub>S</sub> pathway with minimal β-arr2 recruitment. Compound <b>17</b> (E) is a potent full agonist of both signaling pathways and possesses a functional selectivity profile similar to dopamine. Compound <b>46</b> (F) also displays relatively enhanced G<sub>S</sub> bias, with potent full agonism in the G<sub>S</sub> pathway and minimal β-arr2 recruitment. Data points represent the mean concentrations ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds for Exploring the Middle Phenyl Ring Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 125 °C, 48 h; (b) Pd(dppf)Cl<sub>2</sub>, KOAc, B<sub>2</sub>(pin)<sub>2</sub>, dioxane, 80 °C, 18 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O<sub>2</sub>, 120 °C, 25 min.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds for Exploring the Linking Heteroatom Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 125 °C, 48 h; (b) Pd(dppf)Cl<sub>2</sub>, KOAc, B<sub>2</sub>(pin)<sub>2</sub>, dioxane, 80 °C, 18 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O<sub>2</sub>, 120 °C, 25 min; (d) NaH, DMF, 1 h, 80 °C, then 25–0 °C, R-I, 2 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds for Exploring the LHS Heterocyclic Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 125 °C, 48 h; (b) Pd(dppf)Cl<sub>2</sub>, KOAc, B<sub>2</sub>(pin)<sub>2</sub>, dioxane, 80 °C, 18 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O<sub>2</sub>, 120 °C 25 min.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/medium/jm-2019-00351u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mouse pharmacokinetic profile of compound <b>40</b> in the plasma and brain. Compound <b>40</b> was injected into the peritoneum at 50 mg/kg, and concentrations were quantitatively assessed at 0.5, 1, 2, and 4 h after administration. Experiments were carried out in biological triplicates. Data points represent the mean concentrations ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00351/20190404/images/large/jm-2019-00351u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00351&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rask-Andersen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almén, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiöth, H. B.</span></span> <span> </span><span class="NLM_article-title">Trends in the exploitation of novel drug targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1038/nrd3478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnrd3478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=21804595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFKqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=579-590&author=M.+Rask-Andersenauthor=M.+S.+Alm%C3%A9nauthor=H.+B.+Schi%C3%B6th&title=Trends+in+the+exploitation+of+novel+drug+targets&doi=10.1038%2Fnrd3478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in the exploitation of novel drug targets</span></div><div class="casAuthors">Rask-Andersen, Mathias; Almen, Markus Saellman; Schioeth, Helgi B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">579-590</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery and exploitation of new drug targets is a key focus for both the pharmaceutical industry and academic biomedical research.  To provide an insight into trends in the exploitation of new drug targets, we have analyzed the drugs that were approved by the US Food and Drug Administration during the past three decades and examd. the interactions of these drugs with therapeutic targets that are encoded by the human genome, using the DrugBank database and extensive manual curation.  We have identified 435 effect-mediating drug targets in the human genome, which are modulated by 989 unique drugs, through 2,242 drug-target interactions.  We also analyze trends in the introduction of drugs that modulate previously unexploited targets, and discuss the network pharmacol. of the drugs in our data set.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo19FXXFB-PsLVg90H21EOLACvtfcHk0ljdc4TaeSJP3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFKqsLc%253D&md5=9255431a28f2c07759b0f36975711f84</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3478%26sid%3Dliteratum%253Aachs%26aulast%3DRask-Andersen%26aufirst%3DM.%26aulast%3DAlm%25C3%25A9n%26aufirst%3DM.%2BS.%26aulast%3DSchi%25C3%25B6th%26aufirst%3DH.%2BB.%26atitle%3DTrends%2520in%2520the%2520exploitation%2520of%2520novel%2520drug%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D579%26epage%3D590%26doi%3D10.1038%2Fnrd3478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">How Ligands Illuminate GPCR Molecular Pharmacology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.cell.2017.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=28753422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GisLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2017&pages=414-427&author=D.+Wackerauthor=R.+C.+Stevensauthor=B.+L.+Roth&title=How+Ligands+Illuminate+GPCR+Molecular+Pharmacology&doi=10.1016%2Fj.cell.2017.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">How ligands illuminate GPCR molecular pharmacology</span></div><div class="casAuthors">Wacker, Daniel; Stevens, Raymond C.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">414-427</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs), which are modulated by a variety of endogenous and synthetic ligands, represent the largest family of druggable targets in the human genome.  Recent structural and mol. studies have both transformed and expanded classical concepts of receptor pharmacol. and have begun to illuminate the distinct mechanisms by which structurally, chem., and functionally diverse ligands modulate GPCR function.  These mol. insights into ligand engagement and action have enabled new computational methods and accelerated the discovery of novel ligands and tool compds., esp. for understudied and orphan GPCRs.  These advances promise to streamline the development of GPCR-targeted medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCNWK2Zg6HebVg90H21EOLACvtfcHk0liem4l1ITUKaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GisLvF&md5=d4f7f48d757cf3d13a980d2f7f1be138</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DHow%2520Ligands%2520Illuminate%2520GPCR%2520Molecular%2520Pharmacology%26jtitle%3DCell%26date%3D2017%26volume%3D170%26spage%3D414%26epage%3D427%26doi%3D10.1016%2Fj.cell.2017.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span> <span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1124/pr.110.002642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.-M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors&doi=10.1124%2Fpr.110.002642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0liem4l1ITUKaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.-M.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217%26doi%3D10.1124%2Fpr.110.002642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spano, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabucchi, M.</span></span> <span> </span><span class="NLM_article-title">Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system</span>. <i>Adv. Biochem. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=358777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaE1cXmtV2gsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1978&pages=155-165&author=P.+F.+Spanoauthor=S.+Govoniauthor=M.+Trabucchi&title=Studies+on+the+pharmacological+properties+of+dopamine+receptors+in+various+areas+of+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system</span></div><div class="casAuthors">Spano, P. F.; Govoni, S.; Trabucchi, M.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biochemical Psychopharmacology</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">Dopamine</span>),
    <span class="NLM_cas:pages">155-65</span>CODEN:
                <span class="NLM_cas:coden">ABPYBL</span>;
        ISSN:<span class="NLM_cas:issn">0065-2229</span>.
    </div><div class="casAbstract">A review with 4 refs. of studies on the pharmacol. properties of dopamine (I)  [51-61-6] receptors in various areas of the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC0TSNtsLbfLVg90H21EOLACvtfcHk0liem4l1ITUKaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXmtV2gsr0%253D&md5=1dc94041ad8f5201f508d9736220c142</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpano%26aufirst%3DP.%2BF.%26aulast%3DGovoni%26aufirst%3DS.%26aulast%3DTrabucchi%26aufirst%3DM.%26atitle%3DStudies%2520on%2520the%2520pharmacological%2520properties%2520of%2520dopamine%2520receptors%2520in%2520various%2520areas%2520of%2520the%2520central%2520nervous%2520system%26jtitle%3DAdv.%2520Biochem.%2520Psychopharmacol.%26date%3D1978%26volume%3D19%26spage%3D155%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greengard, P.</span></span> <span> </span><span class="NLM_article-title">The neurobiology of dopamine signaling</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1023/a:1013205230142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1023%2Fa%3A1013205230142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=11892993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFSmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=247-269&author=P.+Greengard&title=The+neurobiology+of+dopamine+signaling&doi=10.1023%2Fa%3A1013205230142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The neurobiology of dopamine signaling</span></div><div class="casAuthors">Greengard, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Bioscience Reports</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-269</span>CODEN:
                <span class="NLM_cas:coden">BRPTDT</span>;
        ISSN:<span class="NLM_cas:issn">0144-8463</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">A review with refs.  The biochem. of synaptic transmission, esp. the neurobiol. of dopamine signaling, is discussed.  The elucidation of the principles underlying slow synaptic transmission and the discovery of numerous components of the underlying intracellular signaling pathways have provided a no. of novel therapeutic targets for the treatment of neurol. and psychiatric illnesses assocd. with abnormalities of dopamine signaling.  Levodopa is effective in most patients with Parkinson's disease.  It is converted to dopamine, which then activates dopamine receptors and alleviates the disease symptoms.  Unfortunately, within a short time, many Parkinson's patients become refractory to Levodopa treatment.  This refractoriness is probably the result in part of down-regulation of dopamine receptors.  It should be possible, through the new-found knowledge of the intracellular signaling pathways by which dopamine produces its physiol. effects, to develop various therapeutic substances that activate or inhibit these various intracellular components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK48-i-tJZe7Vg90H21EOLACvtfcHk0liem4l1ITUKaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFSmtLo%253D&md5=1a899c5801216bc46e6d99928f3a1f09</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1023%2Fa%3A1013205230142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252Fa%253A1013205230142%26sid%3Dliteratum%253Aachs%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DThe%2520neurobiology%2520of%2520dopamine%2520signaling%26jtitle%3DBiosci.%2520Rep.%26date%3D2001%26volume%3D21%26spage%3D247%26epage%3D269%26doi%3D10.1023%2Fa%3A1013205230142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotnikova, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marion, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2005.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.cell.2005.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=16051150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFGjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2005&pages=261-273&author=J.-M.+Beaulieuauthor=T.+D.+Sotnikovaauthor=S.+Marionauthor=R.+J.+Lefkowitzauthor=R.+R.+Gainetdinovauthor=M.+G.+Caron&title=An+Akt%2F%CE%B2-Arrestin+2%2FPP2A+Signaling+Complex+Mediates+Dopaminergic+Neurotransmission+and+Behavior&doi=10.1016%2Fj.cell.2005.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Sotnikova, Tatyana D.; Marion, Sebastien; Lefkowitz, Robert J.; Gainetdinov, Raul R.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Dopamine plays an important role in the etiol. of schizophrenia, and D2 class dopamine receptors are the best-established target of antipsychotic drugs.  Here we show that D2 class-receptor-mediated Akt regulation involves the formation of signaling complexes contg. β-arrestin 2, PP2A, and Akt.  β-Arrestin 2 deficiency in mice results in redn. of dopamine-dependent behaviors, loss of Akt regulation by dopamine in the striatum, and disruption of the dopamine-dependent interaction of Akt with its neg. regulator, protein phosphatase 2A.  Importantly, canonical cAMP-mediated dopamine-receptor signaling is not inhibited in the absence of β-arrestin 2.  These results demonstrate that, apart from its classical function in receptor desensitization, β-arrestin 2 also acts as a signaling intermediate through a kinase/phosphatase scaffold.  Furthermore, this function of β-arrestin 2 is important for the expression of dopamine-assocd. behaviors, thus implicating β-arrestin 2 as a pos. mediator of dopaminergic synaptic transmission and a potential pharmacol. target for dopamine-related psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC2L_HMvsJuLVg90H21EOLACvtfcHk0liIehmDipS-9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFGjsLw%253D&md5=841fbd1ab433f4795631118d9de65e4b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.-M.%26aulast%3DSotnikova%26aufirst%3DT.%2BD.%26aulast%3DMarion%26aufirst%3DS.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DAn%2520Akt%252F%25CE%25B2-Arrestin%25202%252FPP2A%2520Signaling%2520Complex%2520Mediates%2520Dopaminergic%2520Neurotransmission%2520and%2520Behavior%26jtitle%3DCell%26date%3D2005%26volume%3D122%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fj.cell.2005.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urs, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigle, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">A Dopamine D1 Receptor-Dependent β-Arrestin Signaling Complex Potentially Regulates Morphine-Induced Psychomotor Activation but not Reward in Mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1038/npp.2010.186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnpp.2010.186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=20980993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=551-558&author=N.+M.+Ursauthor=T.+L.+Daigleauthor=M.+G.+Caron&title=A+Dopamine+D1+Receptor-Dependent+%CE%B2-Arrestin+Signaling+Complex+Potentially+Regulates+Morphine-Induced+Psychomotor+Activation+but+not+Reward+in+Mice&doi=10.1038%2Fnpp.2010.186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A Dopamine D1 Receptor-Dependent β-Arrestin Signaling Complex Potentially Regulates Morphine-Induced Psychomotor Activation but not Reward in Mice</span></div><div class="casAuthors">Urs, Nikhil M.; Daigle, Tanya L.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">551-558</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Morphine is a widely used analgesic in humans that is assocd. with multiple untoward effects, such as addiction and phys. dependence.  In rodent models, morphine also induces locomotor activity.  These effects likely involve functionally selective mechanisms.  Indeed, G protein-coupled receptor desensitization and adaptor protein β-arrestin 2 (βarr2) through its interaction with the μ-opioid receptor regulates the analgesic but not the rewarding properties of morphine.  However, βarr2 is also required for morphine-induced locomotor activity in mice, but the exact cellular and mol. mechanisms that mediate this arrestin-dependent behavior are not understood.  In this study, we show that βarr2 is required for morphine-induced locomotor activity in a dopamine D1 receptor (D1R)-dependent manner and that a βarr2/phospho-ERK (βarr2/pERK) signaling complex may mediate this behavior.  Systemic administration of SL327, an MEK inhibitor, inhibits morphine-induced locomotion in wild-type mice in a dose-dependent manner.  Acute morphine administration to mice promotes the formation of a βarr2/pERK signaling complex.  Morphine-induced locomotor activity and formation of the βarr2/pERK signaling complex is blunted in D1R knockout (D1-KO) mice and is presumably independent of D2 dopamine receptors.  However, D1Rs are not required for morphine-induced reward as D1-KO mice show the same conditioned place preference for morphine as do control mice.  Taken together, these results suggest a potential role for a D1R-dependent βarr2/pERK signaling complex in selectively mediating the locomotor-stimulating but not the rewarding properties of morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEqpxpdYvWw7Vg90H21EOLACvtfcHk0liIehmDipS-9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtQ%253D%253D&md5=54a307ae3ad0968f15c8f23bf3da166d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2010.186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2010.186%26sid%3Dliteratum%253Aachs%26aulast%3DUrs%26aufirst%3DN.%2BM.%26aulast%3DDaigle%26aufirst%3DT.%2BL.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DA%2520Dopamine%2520D1%2520Receptor-Dependent%2520%25CE%25B2-Arrestin%2520Signaling%2520Complex%2520Potentially%2520Regulates%2520Morphine-Induced%2520Psychomotor%2520Activation%2520but%2520not%2520Reward%2520in%2520Mice%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D551%26epage%3D558%26doi%3D10.1038%2Fnpp.2010.186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenoy, S. K.</span></span> <span> </span><span class="NLM_article-title">Transduction of Receptor Signals by -Arrestins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>308</i></span>,  <span class="NLM_fpage">512</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1126/science.1109237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1126%2Fscience.1109237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=15845844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlOjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2005&pages=512-517&author=R.+J.+Lefkowitzauthor=S.+K.+Shenoy&title=Transduction+of+Receptor+Signals+by+-Arrestins&doi=10.1126%2Fscience.1109237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Transduction of Receptor Signals by β-Arrestins</span></div><div class="casAuthors">Lefkowitz, Robert J.; Shenoy, Sudha K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">5721</span>),
    <span class="NLM_cas:pages">512-517</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  The transmission of extracellular signals to the interior of the cell is a function of plasma membrane receptors, of which the seven transmembrane receptor family is by far the largest and most versatile.  Classically, these receptors stimulate heterotrimeric G proteins, which control rates of generation of diffusible second messengers and entry of ions at the plasma membrane.  Recent evidence, however, indicates another previously unappreciated strategy used by the receptors to regulate intracellular signaling pathways.  They direct the recruitment, activation, and scaffolding of cytoplasmic signaling complexes via two multifunctional adaptor and transducer mols., β-arrestins 1 and 2.  This mechanism regulates aspects of cell motility, chemotaxis, apoptosis, and likely other cellular functions through a rapidly expanding list of signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk2fXdqgYhC7Vg90H21EOLACvtfcHk0liIehmDipS-9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlOjtLs%253D&md5=ed070237312d050e5d5ec437b3adc76c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1109237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1109237%26sid%3Dliteratum%253Aachs%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DShenoy%26aufirst%3DS.%2BK.%26atitle%3DTransduction%2520of%2520Receptor%2520Signals%2520by%2520-Arrestins%26jtitle%3DScience%26date%3D2005%26volume%3D308%26spage%3D512%26epage%3D517%26doi%3D10.1126%2Fscience.1109237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Attramadal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arriza, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwatra, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">17882</span>– <span class="NLM_lpage">17890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1517224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaK3sXisV2qt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=17882-17890&author=H.+Attramadalauthor=J.+L.+Arrizaauthor=C.+Aokiauthor=T.+M.+Dawsonauthor=J.+Codinaauthor=M.+M.+Kwatraauthor=S.+H.+Snyderauthor=M.+G.+Caronauthor=R.+J.+Lefkowitz&title=Beta-arrestin2%2C+a+novel+member+of+the+arrestin%2Fbeta-arrestin+gene+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">β-Arrestin2, a novel member of the arrestin/β-arrestin gene family</span></div><div class="casAuthors">Attramadal, Havard; Arriza, Jeffrey L.; Aoki, Chiye; Dawson, Ted M.; Codina, Juan; Kwatra, Madan M.; Snyder, Solomon H.; Caron, Marc G.; Lefkowitz, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">17882-90</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Homologs or agonist-specific desensitization of β-adrenergic receptors (β2AR) is mediated by the β-adrenergic receptor kinase (βARK) which specifically phosphorylates the agonist-occupied form of the receptor.  However, the capacity of βARK-phosphorylated β2AR to stimulate Gs in a reconstituted system is only minimally impaired.  Recently, a protein termed β-arrestin, was cloned from a bovine brain cDNA library and found to quench phosphorylated β2AR-coupling to Gs.  Utilizing a low stringency hybridization technique to screen a rat brain cDNA library, cDNA clones representing two distinct β-arrestin-like genes were isolated.  One of the cDNAs is the rat homolog of bovine β-arrestin (β-arrestin1).  In addn., a cDNA clone encoding a novel, β-arrestin-related protein was isolated which was termed β-arrestin2.  Overall, β-arrestin2 exhibits 78% amino acid identity with β-arrestin1.  The primary structure of these proteins delineates a family of proteins that regulates receptor coupling to G proteins.  The capacity of purified β-arrestin1, β-arrestin2, and arrestin to inhibit the coupling of phosphorylated receptors to their resp. G proteins were assessed in a reconstituted β2AR-Gs system and in a reconstituted rhodopsin-GT system.  β-Arrestin2 was equipotent to β-arrestin1 and specifically inhibited β2AR function.  Conversely, arrestin inhibited rhodopsin coupling to GT, whereas β-arrestin1 and β-arrestin2 were at least 20-fold less potent in this system.  β-Arrestin1 and β-arrestin2 are predominantly localized in neuronal tissues and in the spleen.  However, low mRNA levels can be detected in most peripheral tissues.  In the central nervous system, β-arrestin2 appears to be even more abundant than β-arrestin1.  Immunohistochem. anal. of the tissue distribution of β-arrestin1 and β-arrestin2 in rat brain shows extensive, but heterogeneous, neuronal labeling of the two proteins.  They are found in several neuronal pathways suggesting that they have relatively broad receptor specificity regulating many G protein-coupled receptors.  Furthermore, immunoelectron microscopy shows that the β-arrestins are appropriately situated at postsynaptic sites to act in concert with βARK to regulate G protein-coupled neurotransmitter receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOAuYQ15wDkbVg90H21EOLACvtfcHk0liIehmDipS-9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXisV2qt7w%253D&md5=b6847e8bdbaacd4928da1d5b970af31f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAttramadal%26aufirst%3DH.%26aulast%3DArriza%26aufirst%3DJ.%2BL.%26aulast%3DAoki%26aufirst%3DC.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DCodina%26aufirst%3DJ.%26aulast%3DKwatra%26aufirst%3DM.%2BM.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DBeta-arrestin2%252C%2520a%2520novel%2520member%2520of%2520the%2520arrestin%252Fbeta-arrestin%2520gene%2520family%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D17882%26epage%3D17890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roudabush, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choy, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">Activation and targeting of extracellular signal-regulated kinases by -arrestin scaffolds</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">2449</span>– <span class="NLM_lpage">2454</span>, <span class="refDoi"> DOI: 10.1073/pnas.041604898</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1073%2Fpnas.041604898" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=2449-2454&author=L.+M.+Luttrellauthor=F.+L.+Roudabushauthor=E.+W.+Choyauthor=W.+E.+Millerauthor=M.+E.+Fieldauthor=K.+L.+Pierceauthor=R.+J.+Lefkowitz&title=Activation+and+targeting+of+extracellular+signal-regulated+kinases+by+-arrestin+scaffolds&doi=10.1073%2Fpnas.041604898"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.041604898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.041604898%26sid%3Dliteratum%253Aachs%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26aulast%3DRoudabush%26aufirst%3DF.%2BL.%26aulast%3DChoy%26aufirst%3DE.%2BW.%26aulast%3DMiller%26aufirst%3DW.%2BE.%26aulast%3DField%26aufirst%3DM.%2BE.%26aulast%3DPierce%26aufirst%3DK.%2BL.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DActivation%2520and%2520targeting%2520of%2520extracellular%2520signal-regulated%2520kinases%2520by%2520-arrestin%2520scaffolds%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D2449%26epage%3D2454%26doi%3D10.1073%2Fpnas.041604898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeFea, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalevsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Déry, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N. W.</span></span> <span> </span><span class="NLM_article-title">β-Arrestin-Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">1267</span>– <span class="NLM_lpage">1282</span>, <span class="refDoi"> DOI: 10.1083/jcb.148.6.1267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1083%2Fjcb.148.6.1267" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2000&pages=1267-1282&author=K.+A.+DeFeaauthor=J.+Zalevskyauthor=M.+S.+Thomaauthor=O.+D%C3%A9ryauthor=R.+D.+Mullinsauthor=N.+W.+Bunnett&title=%CE%B2-Arrestin-Dependent+Endocytosis+of+Proteinase-Activated+Receptor+2+Is+Required+for+Intracellular+Targeting+of+Activated+Erk1%2F2&doi=10.1083%2Fjcb.148.6.1267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1083%2Fjcb.148.6.1267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.148.6.1267%26sid%3Dliteratum%253Aachs%26aulast%3DDeFea%26aufirst%3DK.%2BA.%26aulast%3DZalevsky%26aufirst%3DJ.%26aulast%3DThoma%26aufirst%3DM.%2BS.%26aulast%3DD%25C3%25A9ry%26aufirst%3DO.%26aulast%3DMullins%26aufirst%3DR.%2BD.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26atitle%3D%25CE%25B2-Arrestin-Dependent%2520Endocytosis%2520of%2520Proteinase-Activated%2520Receptor%25202%2520Is%2520Required%2520for%2520Intracellular%2520Targeting%2520of%2520Activated%2520Erk1%252F2%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2000%26volume%3D148%26spage%3D1267%26epage%3D1282%26doi%3D10.1083%2Fjcb.148.6.1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laporte, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">beta -Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">1574</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1126/science.290.5496.1574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1126%2Fscience.290.5496.1574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=11090355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotl2ks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=1574-1577&author=P.+H.+McDonaldauthor=C.-W.+Chowauthor=W.+E.+Millerauthor=S.+A.+Laporteauthor=M.+E.+Fieldauthor=F.-T.+Linauthor=R.+J.+Davisauthor=R.+J.+Lefkowitz&title=beta+-Arrestin+2%3A+A+Receptor-Regulated+MAPK+Scaffold+for+the+Activation+of+JNK3&doi=10.1126%2Fscience.290.5496.1574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">β-Arrestin 2: A receptor-regulated MAPK scaffold for the activation of JNK3</span></div><div class="casAuthors">McDonald, Patricia H.; Chow, Chi-Wing; Miller, William E.; Laporte, Stephane A.; Field, Michael E.; Lin, Fang-Tsyr; Davis, Roger J.; Lefkowitz, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">5496</span>),
    <span class="NLM_cas:pages">1574-1577</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">β-Arrestins, originally discovered in the context of heterotrimeric guanine nucleotide binding protein-coupled receptor (GPCR) desensitization, also function in internalization and signaling of these receptors.  We identified c-Jun amino-terminal kinase 3 (JNK3) as a binding partner of β-arrestin 2 using a yeast two-hybrid screen and by coimmunopptn. from mouse brain exts. or cotransfected COS-7 cells.  The upstream JNK activators apoptosis signal-regulating kinase 1 (ASK1) and mitogen-activated protein kinase (MAPK) kinase 4 were also found in complex with β-arrestin 2.  Cellular transfection of β-arrestin 2 caused cytosolic retention of JNK3 and enhanced JNK3 phosphorylation stimulated by ASK1.  Moreover, stimulation of the angiotensin II type 1A receptor activated JNK3 and triggered the colocalization of β-arrestin 2 and active JNK3 to intracellular vesicles.  Thus, β-arrestin 2 acts as a scaffold protein, which brings the spatial distribution and activity of this MAPK module under the control of a GPCR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd3_ayCtQ7gbVg90H21EOLACvtfcHk0ljDSWO4Br9vww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotl2ks7w%253D&md5=1f4b206ba2b12681d75792a8841b7533</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.290.5496.1574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.290.5496.1574%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DP.%2BH.%26aulast%3DChow%26aufirst%3DC.-W.%26aulast%3DMiller%26aufirst%3DW.%2BE.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26aulast%3DField%26aufirst%3DM.%2BE.%26aulast%3DLin%26aufirst%3DF.-T.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3Dbeta%2520-Arrestin%25202%253A%2520A%2520Receptor-Regulated%2520MAPK%2520Scaffold%2520for%2520the%2520Activation%2520of%2520JNK3%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D1574%26epage%3D1577%26doi%3D10.1126%2Fscience.290.5496.1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tohgo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choy, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesty-Palmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laporte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oakley, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span> <span> </span><span class="NLM_article-title">The Stability of the G Protein-coupled Receptor-β-Arrestin Interaction Determines the Mechanism and Functional Consequence of ERK Activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">6258</span>– <span class="NLM_lpage">6267</span>, <span class="refDoi"> DOI: 10.1074/jbc.m212231200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1074%2Fjbc.m212231200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=6258-6267&author=A.+Tohgoauthor=E.+W.+Choyauthor=D.+Gesty-Palmerauthor=K.+L.+Pierceauthor=S.+Laporteauthor=R.+H.+Oakleyauthor=M.+G.+Caronauthor=R.+J.+Lefkowitzauthor=L.+M.+Luttrell&title=The+Stability+of+the+G+Protein-coupled+Receptor-%CE%B2-Arrestin+Interaction+Determines+the+Mechanism+and+Functional+Consequence+of+ERK+Activation&doi=10.1074%2Fjbc.m212231200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m212231200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m212231200%26sid%3Dliteratum%253Aachs%26aulast%3DTohgo%26aufirst%3DA.%26aulast%3DChoy%26aufirst%3DE.%2BW.%26aulast%3DGesty-Palmer%26aufirst%3DD.%26aulast%3DPierce%26aufirst%3DK.%2BL.%26aulast%3DLaporte%26aufirst%3DS.%26aulast%3DOakley%26aufirst%3DR.%2BH.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26atitle%3DThe%2520Stability%2520of%2520the%2520G%2520Protein-coupled%2520Receptor-%25CE%25B2-Arrestin%2520Interaction%2520Determines%2520the%2520Mechanism%2520and%2520Functional%2520Consequence%2520of%2520ERK%2520Activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D6258%26epage%3D6267%26doi%3D10.1074%2Fjbc.m212231200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usui, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olefsky, J. M.</span></span> <span> </span><span class="NLM_article-title">β-Arrestin-mediated Recruitment of the Src Family Kinase Yes Mediates Endothelin-1-stimulated Glucose Transport</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">43663</span>– <span class="NLM_lpage">43667</span>, <span class="refDoi"> DOI: 10.1074/jbc.m105364200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1074%2Fjbc.m105364200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=43663-43667&author=T.+Imamuraauthor=J.+Huangauthor=S.+Dalleauthor=S.+Ugiauthor=I.+Usuiauthor=L.+M.+Luttrellauthor=W.+E.+Millerauthor=R.+J.+Lefkowitzauthor=J.+M.+Olefsky&title=%CE%B2-Arrestin-mediated+Recruitment+of+the+Src+Family+Kinase+Yes+Mediates+Endothelin-1-stimulated+Glucose+Transport&doi=10.1074%2Fjbc.m105364200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m105364200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m105364200%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DDalle%26aufirst%3DS.%26aulast%3DUgi%26aufirst%3DS.%26aulast%3DUsui%26aufirst%3DI.%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26aulast%3DMiller%26aufirst%3DW.%2BE.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26atitle%3D%25CE%25B2-Arrestin-mediated%2520Recruitment%2520of%2520the%2520Src%2520Family%2520Kinase%2520Yes%2520Mediates%2520Endothelin-1-stimulated%2520Glucose%2520Transport%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D43663%26epage%3D43667%26doi%3D10.1074%2Fjbc.m105364200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barlic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelvin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosinger, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVries, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobransky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, S. S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelvin, D. J.</span></span> <span> </span><span class="NLM_article-title">Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCR1</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/79767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2F79767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10973280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVyiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=227-233&author=J.+Barlicauthor=J.+D.+Andrewsauthor=A.+A.+Kelvinauthor=S.+E.+Bosingerauthor=M.+E.+DeVriesauthor=L.+Xuauthor=T.+Dobranskyauthor=R.+D.+Feldmanauthor=S.+S.+G.+Fergusonauthor=D.+J.+Kelvin&title=Regulation+of+tyrosine+kinase+activation+and+granule+release+through+%CE%B2-arrestin+by+CXCR1&doi=10.1038%2F79767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCR1</span></div><div class="casAuthors">Barlic, Jana; Andrews, Joseph D.; Kelvin, Alyson A.; Bosinger, Steven E.; DeVries, Mark E.; Xu, Luoling; Dobransky, Tomas; Feldman, Ross D.; Ferguson, Stephen S. G.; Kelvin, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-233</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Chemoattractant-stimulated granule release from neutrophils, basophils, and eosinophils is crit. for the innate immune response against infectious bacteria.  Interleukin 8 (IL-8) activation of the chemokine receptor CXCR1 was found to stimulate rapid formation of β-arrestin complexes with Hck or c-Fgr.  Formation of β-arrestin-Hck complexes led to Hck activation and trafficking of the complexes to granule-rich regions.  Granulocytes expressing a dominant-neg. β-arrestin-mutant did not release granules or activate tyrosine kinases after IL-8 stimulation.  Thus, β-arrestins regulate chemokine-induced granule exocytosis, indicating a broader role for β-arrestins in the regulation of cellular functions than was previously suspected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqxNWGyd4lArVg90H21EOLACvtfcHk0ljDSWO4Br9vww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVyiur0%253D&md5=b8d91d977678631c028bb3dc9a343e64</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F79767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F79767%26sid%3Dliteratum%253Aachs%26aulast%3DBarlic%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DJ.%2BD.%26aulast%3DKelvin%26aufirst%3DA.%2BA.%26aulast%3DBosinger%26aufirst%3DS.%2BE.%26aulast%3DDeVries%26aufirst%3DM.%2BE.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DDobransky%26aufirst%3DT.%26aulast%3DFeldman%26aufirst%3DR.%2BD.%26aulast%3DFerguson%26aufirst%3DS.%2BS.%2BG.%26aulast%3DKelvin%26aufirst%3DD.%2BJ.%26atitle%3DRegulation%2520of%2520tyrosine%2520kinase%2520activation%2520and%2520granule%2520release%2520through%2520%25CE%25B2-arrestin%2520by%2520CXCR1%26jtitle%3DNat.%2520Immunol.%26date%3D2000%26volume%3D1%26spage%3D227%26epage%3D233%26doi%3D10.1038%2F79767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, S. S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maudsley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Rocca, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakatsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">β-Arrestin-Dependent Formation of β2Adrenergic Receptor-Src Protein Kinase Complexes</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1126/science.283.5402.655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1126%2Fscience.283.5402.655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=9924018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaK1MXot1Kmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1999&pages=655-661&author=L.+M.+Luttrellauthor=S.+S.+G.+Fergusonauthor=Y.+Daakaauthor=W.+E.+Millerauthor=S.+Maudsleyauthor=G.+J.+Della+Roccaauthor=F.-T.+Linauthor=H.+Kawakatsuauthor=K.+Owadaauthor=D.+K.+Luttrellauthor=M.+G.+Caronauthor=R.+J.+Lefkowitz&title=%CE%B2-Arrestin-Dependent+Formation+of+%CE%B22Adrenergic+Receptor-Src+Protein+Kinase+Complexes&doi=10.1126%2Fscience.283.5402.655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">β-Arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes</span></div><div class="casAuthors">Luttrell, L. M.; Ferguson, S. S. G.; Daaka, Y.; Miller, W. E.; Maudsley, S.; Rocca, G. J. Della; Lin, F.-T.; Kawakatsu, H.; Owada, K.; Luttrell, D. K.; Caron, M. G.; Lefkowitz, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">5402</span>),
    <span class="NLM_cas:pages">655-661</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The Ras-dependent activation of mitogen-activated protein (MAP) kinase pathways by many receptors coupled to heterotrimeric guanine nucleotide binding proteins (G proteins) requires the activation of Src family tyrosine kinases.  Stimulation of β2 adrenergic receptors resulted in the assembly of a protein complex contg. activated c-Src and the receptor.  Src recruitment was mediated by β-arrestin, which functions as an adapter protein, binding both c-Src and the agonist-occupied receptor.  β-Arrestin 1 mutants, impaired either in c-Src binding or in the ability to target receptors to clathrin-coated pits, acted as dominant neg. inhibitors of β2 adrenergic receptor-mediated activation of the MAP kinases Erk1 and Erk2.  These data suggest that β-arrestin binding, which terminates receptor-G protein coupling, also initiates a second wave of signal transduction in which the "desensitized" receptor functions as a crit. structural component of a mitogenic signaling complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_2hPyTs99rbVg90H21EOLACvtfcHk0lhdUMTFvPflaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXot1Kmug%253D%253D&md5=3fc55fc9a12ae32562bf0693a0050803</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.283.5402.655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.283.5402.655%26sid%3Dliteratum%253Aachs%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26aulast%3DFerguson%26aufirst%3DS.%2BS.%2BG.%26aulast%3DDaaka%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DW.%2BE.%26aulast%3DMaudsley%26aufirst%3DS.%26aulast%3DDella%2BRocca%26aufirst%3DG.%2BJ.%26aulast%3DLin%26aufirst%3DF.-T.%26aulast%3DKawakatsu%26aufirst%3DH.%26aulast%3DOwada%26aufirst%3DK.%26aulast%3DLuttrell%26aufirst%3DD.%2BK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3D%25CE%25B2-Arrestin-Dependent%2520Formation%2520of%2520%25CE%25B22Adrenergic%2520Receptor-Src%2520Protein%2520Kinase%2520Complexes%26jtitle%3DScience%26date%3D1999%26volume%3D283%26spage%3D655%26epage%3D661%26doi%3D10.1126%2Fscience.283.5402.655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, N.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rea, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, S.</span></span> <span> </span><span class="NLM_article-title">Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">486</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02606-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fs41467-017-02606-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29402888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A280%3ADC%252BC1MvnsFyntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=486&author=H.+Yanoauthor=N.-S.+Caiauthor=M.+Xuauthor=R.+K.+Vermaauthor=W.+Reaauthor=A.+F.+Hoffmanauthor=L.+Shiauthor=J.+A.+Javitchauthor=A.+Bonciauthor=S.+Ferre&title=Gs-+versus+Golf-dependent+functional+selectivity+mediated+by+the+dopamine+D1+receptor&doi=10.1038%2Fs41467-017-02606-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor</span></div><div class="casAuthors">Yano Hideaki; Cai Ning-Sheng; Xu Min; Verma Ravi Kumar; Rea William; Hoffman Alexander F; Shi Lei; Bonci Antonello; Ferre Sergi; Javitch Jonathan A; Javitch Jonathan A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">486</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The two highly homologous subtypes of stimulatory G proteins Gαs (Gs) and Gαolf (Golf) display contrasting expression patterns in the brain.  Golf is predominant in the striatum, while Gs is predominant in the cortex.  Yet, little is known about their functional distinctions.  The dopamine D1 receptor (D1R) couples to Gs/olf and is highly expressed in cortical and striatal areas, making it an important therapeutic target for neuropsychiatric disorders.  Using novel drug screening methods that allow analysis of specific G-protein subtype coupling, we found that, relative to dopamine, dihydrexidine and N-propyl-apomorphine behave as full D1R agonists when coupled to Gs, but as partial D1R agonists when coupled to Golf.  The Gs/Golf-dependent biased agonism by dihydrexidine was consistently observed at the levels of cellular signaling, neuronal function, and behavior.  Our findings of Gs/Golf-dependent functional selectivity in D1R ligands open a new avenue for the treatment of cortex-specific or striatum-specific neuropsychiatric dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMzpsIkzpxmdHxxy173TfNfW6udTcc2eYXHIk3s6sy8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvnsFyntw%253D%253D&md5=4661a051d063c010fd4908a100849bfe</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02606-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02606-w%26sid%3Dliteratum%253Aachs%26aulast%3DYano%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DN.-S.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DVerma%26aufirst%3DR.%2BK.%26aulast%3DRea%26aufirst%3DW.%26aulast%3DHoffman%26aufirst%3DA.%2BF.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DBonci%26aufirst%3DA.%26aulast%3DFerre%26aufirst%3DS.%26atitle%3DGs-%2520versus%2520Golf-dependent%2520functional%2520selectivity%2520mediated%2520by%2520the%2520dopamine%2520D1%2520receptor%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D486%26doi%3D10.1038%2Fs41467-017-02606-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urs, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bido, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigle, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bass, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Targeting β-arrestin2 in the treatment of l-DOPA-induced dyskinesia in Parkinson’s disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E2517</span>– <span class="NLM_lpage">E2526</span>, <span class="refDoi"> DOI: 10.1073/pnas.1502740112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1073%2Fpnas.1502740112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=25918399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFCitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E2517-E2526&author=N.+M.+Ursauthor=S.+Bidoauthor=S.+M.+Petersonauthor=T.+L.+Daigleauthor=C.+E.+Bassauthor=R.+R.+Gainetdinovauthor=E.+Bezardauthor=M.+G.+Caron&title=Targeting+%CE%B2-arrestin2+in+the+treatment+of+l-DOPA-induced+dyskinesia+in+Parkinson%E2%80%99s+disease&doi=10.1073%2Fpnas.1502740112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease</span></div><div class="casAuthors">Urs, Nikhil M.; Bido, Simone; Peterson, Sean M.; Daigle, Tanya L.; Bass, Caroline E.; Gainetdinov, Raul R.; Bezard, Erwan; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">E2517-E2526</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is characterized by severe locomotor deficits and is commonly treated with the dopamine (DA) precursor l-3,4-dihydroxyphenylalanine (l-DOPA), but its prolonged use causes dyskinesias referred to as l-DOPA-induced dyskinesias (LIDs).  Recent studies in animal models of PD have suggested that dyskinesias are assocd. with the overactivation of G protein-mediated signaling through DA receptors.  β-Arrestins desensitize G protein signaling at DA receptors (D1R and D2R) in addn. to activating their own G protein-independent signaling events, which have been shown to mediate locomotion.  Therefore, targeting β-arrestins in PD l-DOPA therapy might prove to be a desirable approach.  Here we show in a bilateral DA-depletion mouse model of Parkinson's symptoms that genetic deletion of β-arrestin2 significantly limits the beneficial locomotor effects while markedly enhancing the dyskinesia-like effects of acute or chronic l-DOPA treatment.  Viral rescue or overexpression of β-arrestin2 in knockout or control mice either reverses or protects against LIDs and its key biochem. markers.  In other more conventional animal models of DA neuron loss and PD, such as 6-hydroxydopamine-treated mice or rats and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated nonhuman primates, β-arrestin2 overexpression significantly reduced dyskinesias while maintaining the therapeutic effect of l-DOPA.  Considerable efforts are being spent in the pharmaceutical industry to identify therapeutic approaches to block LIDs in patients with PD.  Our results point to a potential therapeutic approach, whereby development of either a genetic or pharmacol. intervention to enhance β-arrestin2- or limit G protein-dependent D1/D2R signaling could represent a more mechanistically informed strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0JS5BaOtvPLVg90H21EOLACvtfcHk0lhdUMTFvPflaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFCitro%253D&md5=427748219d0f90165241156fcdc3122e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1502740112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1502740112%26sid%3Dliteratum%253Aachs%26aulast%3DUrs%26aufirst%3DN.%2BM.%26aulast%3DBido%26aufirst%3DS.%26aulast%3DPeterson%26aufirst%3DS.%2BM.%26aulast%3DDaigle%26aufirst%3DT.%2BL.%26aulast%3DBass%26aufirst%3DC.%2BE.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DTargeting%2520%25CE%25B2-arrestin2%2520in%2520the%2520treatment%2520of%2520l-DOPA-induced%2520dyskinesia%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3DE2517%26epage%3DE2526%26doi%3D10.1073%2Fpnas.1502740112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span> <span> </span><span class="NLM_article-title">Biased ligands of G protein-coupled receptors (GPCRs): structure-functional selectivity relationships (SFSRs) and therapeutic potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9841</span>– <span class="NLM_lpage">9878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00435</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9841-9878&author=L.+Tanauthor=W.+Yanauthor=J.+D.+McCorvyauthor=J.+Cheng&title=Biased+ligands+of+G+protein-coupled+receptors+%28GPCRs%29%3A+structure-functional+selectivity+relationships+%28SFSRs%29+and+therapeutic+potential&doi=10.1021%2Facs.jmedchem.8b00435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential</span></div><div class="casAuthors">Tan, Liang; Yan, Wenzhong; McCorvy, John D.; Cheng, Jianjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9841-9878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) signal through both G-protein-dependent and G-protein-independent pathways, and β-arrestin recruitment is the most recognized one of the latter.  Biased ligands selective for either pathway are expected to regulate biol. functions of GPCRs in a more precise way, therefore providing new drug mols. with superior efficacy and/or reduced side effects.  During the past decade, biased ligands have been discovered and developed for many GPCRs, such as the μ opioid receptor, the angiotensin II receptor type 1, the dopamine D2 receptor, and many others.  In this Perspective, recent advances in this field are reviewed by discussing the structure-functional selectivity relationships (SFSRs) of GPCR biased ligands and the therapeutic potential of these mols.  Further understanding of the biol. functions assocd. with each signaling pathway and structural basis for biased signaling will facilitate future drug design in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFjkAvar29LVg90H21EOLACvtfcHk0li2Lt4UjYqvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N&md5=a7bd605b82666357f5a0a209002225e5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DCheng%26aufirst%3DJ.%26atitle%3DBiased%2520ligands%2520of%2520G%2520protein-coupled%2520receptors%2520%2528GPCRs%2529%253A%2520structure-functional%2520selectivity%2520relationships%2520%2528SFSRs%2529%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9841%26epage%3D9878%26doi%3D10.1021%2Facs.jmedchem.8b00435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeWire, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rominger, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graczyk, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitis, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotchev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lark, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span> <span> </span><span class="NLM_article-title">A G Protein-Biased Ligand at the -Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1124/jpet.112.201616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1124%2Fjpet.112.201616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=23300227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVaisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=708-717&author=S.+M.+DeWireauthor=D.+S.+Yamashitaauthor=D.+H.+Romingerauthor=G.+Liuauthor=C.+L.+Cowanauthor=T.+M.+Graczykauthor=X.-T.+Chenauthor=P.+M.+Pitisauthor=D.+Gotchevauthor=C.+Yuanauthor=M.+Koblishauthor=M.+W.+Larkauthor=J.+D.+Violin&title=A+G+Protein-Biased+Ligand+at+the+-Opioid+Receptor+Is+Potently+Analgesic+with+Reduced+Gastrointestinal+and+Respiratory+Dysfunction+Compared+with+Morphine&doi=10.1124%2Fjpet.112.201616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine</span></div><div class="casAuthors">DeWire, Scott M.; Yamashita, Dennis S.; Rominger, David H.; Liu, Guodong; Cowan, Conrad L.; Graczyk, Thomas M.; Chen, Xiao-Tao; Pitis, Philip M.; Gotchev, Dimitar; Yuan, Catherine; Koblish, Michael; Lark, Michael W.; Violin, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">708-717</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The concept of ligand bias at G protein-coupled receptors broadens the possibilities for agonist activities and provides the opportunity to develop safer, more selective therapeutics.  Morphine pharmacol. in β-arrestin-2 knockout mice suggested that a ligand that promotes coupling of the μ-opioid receptor (MOR) to G proteins, but not β-arrestins, would result in higher analgesic efficacy, less gastrointestinal dysfunction, and less respiratory suppression than morphine.  Here we report the discovery of TRV130 ([(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine), a novel MOR G protein-biased ligand.  In cell-based assays, TRV130 elicits robust G protein signaling, with potency and efficacy similar to morphine, but with far less β-arrestin recruitment and receptor internalization.  In mice and rats, TRV130 is potently analgesic while causing less gastrointestinal dysfunction and respiratory suppression than morphine at equianalgesic doses.  TRV130 successfully translates evidence that analgesic and adverse MOR signaling pathways are distinct into a biased ligand with differentiated pharmacol.  These preclin. data suggest that TRV130 may be a safer and more tolerable therapeutic for treating severe pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps3tTP2BOOKrVg90H21EOLACvtfcHk0li2Lt4UjYqvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVaisro%253D&md5=33a685cd1952dd9cb1fb82afe78452af</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.201616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.201616%26sid%3Dliteratum%253Aachs%26aulast%3DDeWire%26aufirst%3DS.%2BM.%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DRominger%26aufirst%3DD.%2BH.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DCowan%26aufirst%3DC.%2BL.%26aulast%3DGraczyk%26aufirst%3DT.%2BM.%26aulast%3DChen%26aufirst%3DX.-T.%26aulast%3DPitis%26aufirst%3DP.%2BM.%26aulast%3DGotchev%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DKoblish%26aufirst%3DM.%26aulast%3DLark%26aufirst%3DM.%2BW.%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26atitle%3DA%2520G%2520Protein-Biased%2520Ligand%2520at%2520the%2520-Opioid%2520Receptor%2520Is%2520Potently%2520Analgesic%2520with%2520Reduced%2520Gastrointestinal%2520and%2520Respiratory%2520Dysfunction%2520Compared%2520with%2520Morphine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D708%26epage%3D717%26doi%3D10.1124%2Fjpet.112.201616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crombie, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soergel, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lark, M. W.</span></span> <span> </span><span class="NLM_article-title">Biased ligands at G-protein-coupled receptors: promise and progress</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.tips.2014.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=24878326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosl2htr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=308-316&author=J.+D.+Violinauthor=A.+L.+Crombieauthor=D.+G.+Soergelauthor=M.+W.+Lark&title=Biased+ligands+at+G-protein-coupled+receptors%3A+promise+and+progress&doi=10.1016%2Fj.tips.2014.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Biased ligands at G-protein-coupled receptors: promise and progress</span></div><div class="casAuthors">Violin, Jonathan D.; Crombie, Aimee L.; Soergel, David G.; Lark, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">308-316</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug discovery targeting G protein-coupled receptors (GPCRs) is no longer limited to seeking agonists or antagonists to stimulate or block cellular responses assocd. with a particular receptor.  GPCRs are now known to support a diversity of pharmacol. profiles, a concept broadly referred to as functional selectivity.  In particular, the concept of ligand bias, whereby a ligand stabilizes subsets of receptor conformations to engender novel pharmacol. profiles, has recently gained increasing prominence.  This review discusses how biased ligands may deliver safer, better tolerated, and more efficacious drugs, and highlights several biased ligands that are in clin. development.  Biased ligands targeting the angiotensin II type 1 receptor and the μ opioid receptor illustrate the translation of the biased ligand concept from basic biol. to clin. drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBma1S1zZ0-7Vg90H21EOLACvtfcHk0li2Lt4UjYqvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosl2htr4%253D&md5=768953e7aa5726d1a47ecbdb068469d8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26aulast%3DCrombie%26aufirst%3DA.%2BL.%26aulast%3DSoergel%26aufirst%3DD.%2BG.%26aulast%3DLark%26aufirst%3DM.%2BW.%26atitle%3DBiased%2520ligands%2520at%2520G-protein-coupled%2520receptors%253A%2520promise%2520and%2520progress%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D308%26epage%3D316%26doi%3D10.1016%2Fj.tips.2014.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.-T.</span></span> <span> </span><span class="NLM_article-title">Enhanced Morphine Analgesia in Mice Lacking -Arrestin 2 </span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">2495</span>– <span class="NLM_lpage">2498</span>, <span class="refDoi"> DOI: 10.1126/science.286.5449.2495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1126%2Fscience.286.5449.2495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10617462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVKg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=2495-2498&author=L.+M.+Bohnauthor=R.+J.+Lefkowitzauthor=R.+R.+Gainetdinovauthor=K.+Peppelauthor=M.+G.+Caronauthor=F.-T.+Lin&title=Enhanced+Morphine+Analgesia+in+Mice+Lacking+-Arrestin+2%E2%80%89&doi=10.1126%2Fscience.286.5449.2495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced morphine analgesia in mice lacking β-arrestin 2</span></div><div class="casAuthors">Bohn, Laura M.; Lefkowitz, Robert J.; Gainetdinov, Raul R.; Peppel, Karsten; Caron, Marc G.; Lin, Fang-Tsyr</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5449</span>),
    <span class="NLM_cas:pages">2495-2498</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ability of morphine to alleviate pain is mediated through a heterotrimeric guanine nucleotide binding protein (G protein)-coupled heptahelical receptor (GPCR), the μ opioid receptor (μOR).  The efficiency of GPCR signaling is tightly regulated and ultimately limited by the coordinated phosphorylation of the receptors by specific GPCR kinases and the subsequent interaction of the phosphorylated receptors with β-arrestin 1 and β-arrestin 2.  Functional deletion of the β-arrestin 2 gene in mice resulted in remarkable potentiation and prolongation of the analgesic effect of morphine, suggesting that μOR desensitization was impaired.  These results provide evidence in vivo for the physiol. importance of β-arrestin 2 in regulating the function of a specific GPCR, the μOR.  Moreover, they suggest that inhibition of β-arrestin 2 function might lead to enhanced analgesic effectiveness of morphine and provide potential new avenues for the study and treatment of pain, narcotic tolerance, and dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSeiDXvYdnz7Vg90H21EOLACvtfcHk0lii_L7IfXLtkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVKg&md5=95f67b133e86422f385d1a7f8165d772</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5449.2495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5449.2495%26sid%3Dliteratum%253Aachs%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DPeppel%26aufirst%3DK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLin%26aufirst%3DF.-T.%26atitle%3DEnhanced%2520Morphine%2520Analgesia%2520in%2520Mice%2520Lacking%2520-Arrestin%25202%25E2%2580%2589%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D2495%26epage%3D2498%26doi%3D10.1126%2Fscience.286.5449.2495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgenweck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span> <span> </span><span class="NLM_article-title">Bias factor and therapeutic window correlate to predict safer opioid analgesics</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">1165</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.10.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.cell.2017.10.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29149605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOhs7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2017&pages=1165-1175&author=C.+L.+Schmidauthor=N.+M.+Kennedyauthor=N.+C.+Rossauthor=K.+M.+Lovellauthor=Z.+Yueauthor=J.+Morgenweckauthor=M.+D.+Cameronauthor=T.+D.+Bannisterauthor=L.+M.+Bohn&title=Bias+factor+and+therapeutic+window+correlate+to+predict+safer+opioid+analgesics&doi=10.1016%2Fj.cell.2017.10.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics</span></div><div class="casAuthors">Schmid, Cullen L.; Kennedy, Nicole M.; Ross, Nicolette C.; Lovell, Kimberly M.; Yue, Zhizhou; Morgenweck, Jenny; Cameron, Michael D.; Bannister, Thomas D.; Bohn, Laura M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1165-1175.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Biased agonism has been proposed as a means to sep. desirable and adverse drug responses downstream of G protein-coupled receptor (GPCR) targets.  Herein, we describe structural features of a series of mu-opioid-receptor (MOR)-selective agonists that preferentially activate receptors to couple to G proteins or to recruit βarrestin proteins.  By comparing relative bias for MOR-mediated signaling in each pathway, we demonstrate a strong correlation between the respiratory suppression/antinociception therapeutic window in a series of compds. spanning a wide range of signaling bias.  We find that β-arrestin-biased compds., such as fentanyl, are more likely to induce respiratory suppression at weak analgesic doses, while G protein signaling bias broadens the therapeutic window, allowing for antinociception in the absence of respiratory suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfthQaadgklLVg90H21EOLACvtfcHk0lii_L7IfXLtkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOhs7vE&md5=6d3f21c03fb40bc83adbe62c3ea331fc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.10.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.10.035%26sid%3Dliteratum%253Aachs%26aulast%3DSchmid%26aufirst%3DC.%2BL.%26aulast%3DKennedy%26aufirst%3DN.%2BM.%26aulast%3DRoss%26aufirst%3DN.%2BC.%26aulast%3DLovell%26aufirst%3DK.%2BM.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3DMorgenweck%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DBannister%26aufirst%3DT.%2BD.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26atitle%3DBias%2520factor%2520and%2520therapeutic%2520window%2520correlate%2520to%2520predict%2520safer%2520opioid%2520analgesics%26jtitle%3DCell%26date%3D2017%26volume%3D171%26spage%3D1165%26epage%3D1175%26doi%3D10.1016%2Fj.cell.2017.10.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiBerto, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polepally, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zjawiony, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malanga, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">The G protein-biased kappa-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.216820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1124%2Fjpet.114.216820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=25320048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOlu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2015&pages=98-109&author=K.+L.+Whiteauthor=J.+E.+Robinsonauthor=H.+Zhuauthor=J.+F.+DiBertoauthor=P.+R.+Polepallyauthor=J.+K.+Zjawionyauthor=D.+E.+Nicholsauthor=C.+J.+Malangaauthor=B.+L.+Roth&title=The+G+protein-biased+kappa-opioid+receptor+agonist+RB-64+is+analgesic+with+a+unique+spectrum+of+activities+in+vivo&doi=10.1124%2Fjpet.114.216820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo</span></div><div class="casAuthors">White, Kate L.; Robinson, J. Elliott; Zhu, Hu; DiBerto, Jeffrey F.; Polepally, Prabhakar R.; Zjawiony, Jordan K.; Nichols, David E.; Malanga, C. J.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-109, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The hypothesis that functionally selective G protein-coupled receptor (GPCR) agonists may have enhanced therapeutic benefits has revitalized interest for many GPCR targets.  In particular, although κ-opioid receptor (KOR) agonists are analgesic with a low risk of dependence and abuse, their use is limited by a propensity to induce sedation, motor incoordination, hallucinations, and dysphoria-like states.  Several labs. have produced a body of work suggesting that G protein-biased KOR agonists might be analgesic with fewer side effects.  Although that has been an intriguing hypothesis, suitable KOR-selective and G protein-biased agonists have not been available to test this idea.  Here we provide data using a G protein-biased agonist, RB-64 (22-thiocyanatosalvinorin A), which suggests that KOR-mediated G protein signaling induces analgesia and aversion, whereas β-arrestin-2 signaling may be assocd. with motor incoordination.  Addnl., unlike unbiased KOR agonists, the G protein-biased ligand RB-64 does not induce sedation and does not have anhedonia-like actions, suggesting that a mechanism other than G protein signaling mediates these effects.  Our findings provide the first evidence for a highly selective and G protein-biased tool compd. for which many, but not all, of the neg. side effects of KOR agonists can be minimized by creating G protein-biased KOR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGporsYw3knd37Vg90H21EOLACvtfcHk0lii_L7IfXLtkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOlu7bM&md5=686b5b718e2919aaf08e34855cc39ebf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.216820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.216820%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DRobinson%26aufirst%3DJ.%2BE.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DDiBerto%26aufirst%3DJ.%2BF.%26aulast%3DPolepally%26aufirst%3DP.%2BR.%26aulast%3DZjawiony%26aufirst%3DJ.%2BK.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMalanga%26aufirst%3DC.%2BJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520G%2520protein-biased%2520kappa-opioid%2520receptor%2520agonist%2520RB-64%2520is%2520analgesic%2520with%2520a%2520unique%2520spectrum%2520of%2520activities%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D352%26spage%3D98%26epage%3D109%26doi%3D10.1124%2Fjpet.114.216820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dogra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. N.</span></span> <span> </span><span class="NLM_article-title">Biased agonism at kappa opioid receptors: implication in pain and mood disorders</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>763</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2015.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.ejphar.2015.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=26164787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOktLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=763&publication_year=2015&pages=184-190&author=S.+Dograauthor=P.+N.+Yadav&title=Biased+agonism+at+kappa+opioid+receptors%3A+implication+in+pain+and+mood+disorders&doi=10.1016%2Fj.ejphar.2015.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Biased agonism at kappa opioid receptors: Implication in pain and mood disorders</span></div><div class="casAuthors">Dogra, Shalini; Yadav, Prem N.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">763</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">184-190</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The kappa opioid receptor (k receptor) and its endogenous ligand dynorphin have received significant attention due to their involvement in pathophysiol. of mood disorders, drug addiction, psychotic disorders and pain.  Multiple lines of evidences suggest that the k receptor modulates overlapping neurocircuits connecting brainstem monoaminergic nuclei with forebrain limbic structures and thereby regulates neurobiol. effects of stress and psychostimulants.  The emerging concept of "biased agonism" (also known as functional selectivity) for G Protein Coupled Receptor (GPCR) ligands have provided new insights into overall response generated by a ligand, which could be exploited for drug discovery.  According to this concept, every ligand possesses the unique ability (coded in its structure) that dictates distinct signalling pattern, and consequently beneficial or adverse response.  Although still a long way to comprehend the clin. potential of biased GPCR ligands, such ligand could be vital pharmacol. probes.  This article highlights various lines of evidence, which indicates different ligands of k receptor as "biased", and their potential implications in mood and pain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa9u79NzRMt7Vg90H21EOLACvtfcHk0lhznIT1lC9wpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOktLjN&md5=2aacd81253e158b23d721eaf1b1985c6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DDogra%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26atitle%3DBiased%2520agonism%2520at%2520kappa%2520opioid%2520receptors%253A%2520implication%2520in%2520pain%2520and%2520mood%2520disorders%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D763%26spage%3D184%26epage%3D190%26doi%3D10.1016%2Fj.ejphar.2015.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raehal, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span> <span> </span><span class="NLM_article-title">Morphine Side Effects in -Arrestin 2 Knockout Mice</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1201</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.087254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1124%2Fjpet.105.087254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=15917400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=1195-1201&author=K.+M.+Raehalauthor=J.+K.+Walkerauthor=L.+M.+Bohn&title=Morphine+Side+Effects+in+-Arrestin+2+Knockout+Mice&doi=10.1124%2Fjpet.105.087254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine side effects in β-arrestin 2 knockout mice</span></div><div class="casAuthors">Raehal, Kirsten M.; Walker, Julia K. L.; Bohn, Laura M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1195-1201</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Morphine is a potent analgesic, yet, like most opioid narcotics, it exerts unwanted side effects such as constipation and respiratory suppression, thereby limiting its clin. utility.  Pharmacol. approaches taken to preserve the analgesic properties, while eliminating the unwanted side effects, have met with very limited success.  Here, we provide evidence that altering μ opioid receptor regulation may provide a novel approach to discriminate morphine's beneficial and deleterious effects in vivo.  We have previously reported that mice lacking the G protein-coupled receptor regulatory protein, β-arrestin 2, display profoundly altered morphine responses.  β-Arrestin 2 knockout mice have enhanced and prolonged morphine analgesia with very little morphine tolerance.  In this report, we examine whether the side effects of morphine treatment are also augmented in this animal model.  Surprisingly, the genetic disruption of opioid receptor regulation, while enhancing and prolonging analgesia, dramatically attenuates the respiratory suppression and acute constipation caused by morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGg-s6s4R0F7Vg90H21EOLACvtfcHk0lhznIT1lC9wpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLw%253D&md5=0d3696e563ae3a6f6ce2cb2570cbb890</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.087254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.087254%26sid%3Dliteratum%253Aachs%26aulast%3DRaehal%26aufirst%3DK.%2BM.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26atitle%3DMorphine%2520Side%2520Effects%2520in%2520-Arrestin%25202%2520Knockout%2520Mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D1195%26epage%3D1201%26doi%3D10.1124%2Fjpet.105.087254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aryal, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dengler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corder, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguère, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Duan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of opioid analgesics with reduced side effects</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>537</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1038/nature19112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnature19112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=27533032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKmsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=185-190&author=A.+Manglikauthor=H.+Linauthor=D.+K.+Aryalauthor=J.+D.+McCorvyauthor=D.+Denglerauthor=G.+Corderauthor=A.+Levitauthor=R.+C.+Klingauthor=V.+Bernatauthor=H.+H%C3%BCbnerauthor=X.-P.+Huangauthor=M.+F.+Sassanoauthor=P.+M.+Gigu%C3%A8reauthor=S.+L%C3%B6berauthor=D.+Da+Duanauthor=G.+Scherrerauthor=B.+K.+Kobilkaauthor=P.+Gmeinerauthor=B.+L.+Rothauthor=B.+K.+Shoichet&title=Structure-based+discovery+of+opioid+analgesics+with+reduced+side+effects&doi=10.1038%2Fnature19112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based discovery of opioid analgesics with reduced side effects</span></div><div class="casAuthors">Manglik, Aashish; Lin, Henry; Aryal, Dipendra K.; McCorvy, John D.; Dengler, Daniela; Corder, Gregory; Levit, Anat; Kling, Ralf C.; Bernat, Viachaslau; Hubner, Harald; Huang, Xi-Ping; Sassano, Maria F.; Giguere, Patrick M.; Lober, Stefan; Da Duan; Scherrer, Gregory; Kobilka, Brian K.; Gmeiner, Peter; Roth, Bryan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7619</span>),
    <span class="NLM_cas:pages">185-190</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Morphine is an alkaloid from the opium poppy used to treat pain.  The potentially lethal side effects of morphine and related opioids-which include fatal respiratory depression-are thought to be mediated by μ-opioid-receptor (μOR) signalling through the β-arrestin pathway or by actions at other receptors.  Conversely, G-protein μOR signalling is thought to confer analgesia.  Here we computationally dock over 3 million mols. against the μOR structure and identify new scaffolds unrelated to known opioids.  Structure-based optimization yields PZM21-a potent Gi activator with exceptional selectivity for μOR and minimal β-arrestin-2 recruitment.  Unlike morphine, PZM21 is more efficacious for the affective component of analgesia vs. the reflexive component and is devoid of both respiratory depression and morphine-like reinforcing activity in mice at equi-analgesic doses.  PZM21 thus serves as both a probe to disentangle μOR signalling and a therapeutic lead that is devoid of many of the side effects of current opioids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiCff2w3U8iLVg90H21EOLACvtfcHk0lhznIT1lC9wpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKmsbvI&md5=b8bb2d8575dadf4a6dc74d94c26d2c1a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature19112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19112%26sid%3Dliteratum%253Aachs%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DAryal%26aufirst%3DD.%2BK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DDengler%26aufirst%3DD.%26aulast%3DCorder%26aufirst%3DG.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DBernat%26aufirst%3DV.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DGigu%25C3%25A8re%26aufirst%3DP.%2BM.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DDa%2BDuan%26aufirst%3DD.%26aulast%3DScherrer%26aufirst%3DG.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DStructure-based%2520discovery%2520of%2520opioid%2520analgesics%2520with%2520reduced%2520side%2520effects%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D185%26epage%3D190%26doi%3D10.1038%2Fnature19112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conibear, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutcliffe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewey, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, G.</span></span> <span> </span><span class="NLM_article-title">The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">2653</span>– <span class="NLM_lpage">2661</span>, <span class="refDoi"> DOI: 10.1111/bph.14224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1111%2Fbph.14224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29582414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVCmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=2653-2661&author=R.+Hillauthor=A.+Disneyauthor=A.+Conibearauthor=K.+Sutcliffeauthor=W.+Deweyauthor=S.+Husbandsauthor=C.+Baileyauthor=E.+Kellyauthor=G.+Henderson&title=The+novel+%CE%BC-opioid+receptor+agonist+PZM21+depresses+respiration+and+induces+tolerance+to+antinociception&doi=10.1111%2Fbph.14224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception</span></div><div class="casAuthors">Hill, Rob; Disney, Alex; Conibear, Alex; Sutcliffe, Katy; Dewey, William; Husbands, Stephen; Bailey, Chris; Kelly, Eamonn; Henderson, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2653-2661</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PZM21 is a novel μ-opioid receptor ligand that has been reported to induce minimal arrestin recruitment and be devoid of the respiratory depressant effects characteristic of classical μ receptor ligands such as morphine.  We have re-examd. the signalling profile of PZM21 and its ability to depress respiration.  G protein (Gi) activation and arrestin-3 translocation were measured in vitro, using BRET assays, in HEK 293 cells expressing μ receptors.  Respiration (rate and tidal vol.) was measured in awake, freely moving mice by whole-body plethysmog., and antinociception was measured by the hot plate test.  PZM21 (10-9 - 3 × 10-5 M) produced concn.-dependent Gi activation and arrestin-3 translocation.  Comparison with responses evoked by morphine and DAMGO revealed that PZM21 was a low efficacy agonist in both signalling assays.  PZM21 (10-80 mg·kg-1) depressed respiration in a dose-dependent manner.  The respiratory depression was due to a decrease in the rate of breathing not a decrease in tidal vol.  On repeated daily administration of PZM21 (twice daily doses of 40 mg·kg-1), complete tolerance developed to the antinociceptive effect of PZM21 over 3 days but no tolerance developed to its respiratory depressant effect.  These data demonstrate that PZM21 is a low efficacy μ receptor agonist for both G protein and arrestin signalling.  Contrary to a previous report, PZM21 depresses respiration in a manner similar to morphine, the classical opioid receptor agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeVaQW_N9c4LVg90H21EOLACvtfcHk0lhVknePIcuiXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVCmt7o%253D&md5=adb5bbba116f6d3df8d860754434af16</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fbph.14224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14224%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DR.%26aulast%3DDisney%26aufirst%3DA.%26aulast%3DConibear%26aufirst%3DA.%26aulast%3DSutcliffe%26aufirst%3DK.%26aulast%3DDewey%26aufirst%3DW.%26aulast%3DHusbands%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DE.%26aulast%3DHenderson%26aufirst%3DG.%26atitle%3DThe%2520novel%2520%25CE%25BC-opioid%2520receptor%2520agonist%2520PZM21%2520depresses%2520respiration%2520and%2520induces%2520tolerance%2520to%2520antinociception%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D2653%26epage%3D2661%26doi%3D10.1111%2Fbph.14224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">18488</span>– <span class="NLM_lpage">18493</span>, <span class="refDoi"> DOI: 10.1073/pnas.1104807108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1073%2Fpnas.1104807108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18488-18493&author=J.+A.+Allenauthor=J.+M.+Yostauthor=V.+Setolaauthor=X.+Chenauthor=M.+F.+Sassanoauthor=M.+Chenauthor=S.+Petersonauthor=P.+N.+Yadavauthor=X.-p.+Huangauthor=B.+Fengauthor=N.+H.+Jensenauthor=X.+Cheauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=M.+G.+Caronauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+-Arrestin-Biased+Dopamine+D2+Ligands+for+Probing+Signal+Transduction+Pathways+Essential+for+Antipsychotic+Efficacy&doi=10.1073%2Fpnas.1104807108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1104807108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1104807108%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DYost%26aufirst%3DJ.%2BM.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DHuang%26aufirst%3DX.-p.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520-Arrestin-Biased%2520Dopamine%2520D2%2520Ligands%2520for%2520Probing%2520Signal%2520Transduction%2520Pathways%2520Essential%2520for%2520Antipsychotic%2520Efficacy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D18488%26epage%3D18493%26doi%3D10.1073%2Fpnas.1104807108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of G protein-biased D2 dopamine receptor partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10601</span>– <span class="NLM_lpage">10618</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10601-10618&author=X.+Chenauthor=J.+D.+McCorvyauthor=M.+G.+Fischerauthor=K.+V.+Butlerauthor=Y.+Shenauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+G+protein-biased+D2+dopamine+receptor+partial+agonists&doi=10.1021%2Facs.jmedchem.6b01208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists</span></div><div class="casAuthors">Chen, Xin; McCorvy, John D.; Fischer, Matthew G.; Butler, Kyle V.; Shen, Yudao; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10601-10618</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased ligands (also known as functionally selective ligands) of G protein-coupled receptors are valuable tools for dissecting the roles of G protein-dependent and independent signaling pathways in health and disease.  Biased ligands have also been increasingly pursued by the biomedical community as promising therapeutics with improved efficacy and reduced side effects compared with unbiased ligands.  The authors previously discovered first-in-class β-arrestin-biased agonists of dopamine D2 receptor (D2R) by extensively exploring multiple regions of aripiprazole, a balanced D2R agonist.  In the authors' continuing efforts to identify biased agonists of D2R, the authors unexpectedly discovered a G protein-biased agonist of D2R, compd. 1 (5-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-methylbenzo[d]thiazole), which is the first G protein-biased D2R agonist from the aripiprazole scaffold.  The authors designed and synthesized novel analogs to explore two regions of 1 and conducted structure-functional selectivity relationship (SFSR) studies.  Here the authors report the discovery of 1, findings from the authors' SFSR studies, and characterization of novel G protein-biased D2R agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeKlhGCqSPxLVg90H21EOLACvtfcHk0lhVknePIcuiXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK&md5=81b1435b1ae82438aa3f270f7ee4f853</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DFischer%26aufirst%3DM.%2BG.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520G%2520protein-biased%2520D2%2520dopamine%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10601%26epage%3D10618%26doi%3D10.1021%2Facs.jmedchem.6b01208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmerberg, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulman, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span> <span> </span><span class="NLM_article-title">Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">715</span>, <span class="refDoi"> DOI: 10.1038/npp.2015.196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnpp.2015.196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=26129680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Chu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=704-715&author=S.+M.+Parkauthor=M.+Chenauthor=C.+M.+Schmerbergauthor=R.+S.+Dulmanauthor=R.+M.+Rodriguizauthor=M.+G.+Caronauthor=J.+Jinauthor=W.+C.+Wetsel&title=Effects+of+%CE%B2-Arrestin-Biased+Dopamine+D2+Receptor+Ligands+on+Schizophrenia-Like+Behavior+in+Hypoglutamatergic+Mice&doi=10.1038%2Fnpp.2015.196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice</span></div><div class="casAuthors">Park, Su M.; Chen, Meng; Schmerberg, Claire M.; Dulman, Russell S.; Rodriguiz, Ramona M.; Caron, Marc G.; Jin, Jian; Wetsel, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">704-715</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Current antipsychotic drugs (APDs) show efficacy with pos. symptoms, but are limited in treating neg. or cognitive features of schizophrenia.  Whereas all currently FDA-approved medications target primarily the dopamine D2 receptor (D2R) to inhibit Gi/o-mediated adenylyl cyclase, a recent study has shown that many APDs affect not only Gi/o- but they can also influence β-arrestin- (βArr)-mediated signaling.  The ability of ligands to differentially affect signaling through these pathways is termed functional selectivity.  We have developed ligands that are devoid of D2R-mediated Gi/o protein signaling, but are simultaneously partial agonists for D2R/βArr interactions.  The purpose of this study was to test the effectiveness of UNC9975 or UNC9994 on schizophrenia-like behaviors in phencyclidine-treated or NR1-knockdown hypoglutamatergic mice.  We have found the UNC compds. reduce hyperlocomotion in the open field, restore PPI, improve novel object recognition memory, partially normalize social behavior, decrease conditioned avoidance responding, and elicit a much lower level of catalepsy than haloperidol.  These preclin. results suggest that exploitation of functional selectivity may provide unique opportunities to develop drugs with fewer side effects, greater therapeutic selectivity, and enhanced efficacy for treating schizophrenia and related conditions than medications that are currently available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQuhB8VxuXDbVg90H21EOLACvtfcHk0lg697Es9PNzpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Chu7jO&md5=82de207db3a78d50ff86a48cda2d2e28</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.196%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BM.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DSchmerberg%26aufirst%3DC.%2BM.%26aulast%3DDulman%26aufirst%3DR.%2BS.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26atitle%3DEffects%2520of%2520%25CE%25B2-Arrestin-Biased%2520Dopamine%2520D2%2520Receptor%2520Ligands%2520on%2520Schizophrenia-Like%2520Behavior%2520in%2520Hypoglutamatergic%2520Mice%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3D704%26epage%3D715%26doi%3D10.1038%2Fnpp.2015.196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>555</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/nature25758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnature25758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29466326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2018&pages=269-273&author=S.+Wangauthor=T.+Cheauthor=A.+Levitauthor=B.+K.+Shoichetauthor=D.+Wackerauthor=B.+L.+Roth&title=Structure+of+the+D2+dopamine+receptor+bound+to+the+atypical+antipsychotic+drug+risperidone&doi=10.1038%2Fnature25758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span></div><div class="casAuthors">Wang, Sheng; Che, Tao; Levit, Anat; Shoichet, Brian K.; Wacker, Daniel; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">7695</span>),
    <span class="NLM_cas:pages">269-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Dopamine is a neurotransmitter that has been implicated in processes as diverse as reward, addiction, control of coordinated movement, metab. and hormonal secretion.  Correspondingly, dysregulation of the dopaminergic system has been implicated in diseases such as schizophrenia, Parkinson's disease, depression, attention deficit hyperactivity disorder, and nausea and vomiting.  The actions of dopamine are mediated by a family of five G-protein-coupled receptors.  The D2 dopamine receptor (DRD2) is the primary target for both typical and atypical antipsychotic drugs, and for drugs used to treat Parkinson's disease.  Unfortunately, many drugs that target DRD2 cause serious and potentially life-threatening side effects due to promiscuous activities against related receptors.  Accordingly, a mol. understanding of the structure and function of DRD2 could provide a template for the design of safer and more effective medications.  Here we report the crystal structure of DRD2 in complex with the widely prescribed atypical antipsychotic drug risperidone.  The DRD2-risperidone structure reveals an unexpected mode of antipsychotic drug binding to dopamine receptors, and highlights structural determinants that are essential for the actions of risperidone and related drugs at DRD2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeo4Ov49kft7Vg90H21EOLACvtfcHk0lg697Es9PNzpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D&md5=2842adc1893293ea8dbf98ae3270a1b2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnature25758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25758%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520of%2520the%2520D2%2520dopamine%2520receptor%2520bound%2520to%2520the%2520atypical%2520antipsychotic%2520drug%2520risperidone%26jtitle%3DNature%26date%3D2018%26volume%3D555%26spage%3D269%26epage%3D273%26doi%3D10.1038%2Fnature25758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urs, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pack, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evron, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E8178</span>– <span class="NLM_lpage">E8186</span>, <span class="refDoi"> DOI: 10.1073/pnas.1614347113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1073%2Fpnas.1614347113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E8178-E8186&author=N.+M.+Ursauthor=S.+M.+Geeauthor=T.+F.+Packauthor=J.+D.+McCorvyauthor=T.+Evronauthor=J.+C.+Snyderauthor=X.+Yangauthor=R.+M.+Rodriguizauthor=E.+Borrelliauthor=W.+C.+Wetselauthor=J.+Jinauthor=B.+L.+Rothauthor=P.+O%E2%80%99Donnellauthor=M.+G.+Caron&title=Distinct+cortical+and+striatal+actions+of+a+%CE%B2-arrestin-biased+dopamine+D2+receptor+ligand+reveal+unique+antipsychotic-like+properties&doi=10.1073%2Fpnas.1614347113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1614347113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1614347113%26sid%3Dliteratum%253Aachs%26aulast%3DUrs%26aufirst%3DN.%2BM.%26aulast%3DGee%26aufirst%3DS.%2BM.%26aulast%3DPack%26aufirst%3DT.%2BF.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DEvron%26aufirst%3DT.%26aulast%3DSnyder%26aufirst%3DJ.%2BC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DBorrelli%26aufirst%3DE.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DP.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DDistinct%2520cortical%2520and%2520striatal%2520actions%2520of%2520a%2520%25CE%25B2-arrestin-biased%2520dopamine%2520D2%2520receptor%2520ligand%2520reveal%2520unique%2520antipsychotic-like%2520properties%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2016%26volume%3D113%26spage%3DE8178%26epage%3DE8186%26doi%3D10.1073%2Fpnas.1614347113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnchembio.2527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29227473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGmur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=126-134&author=J.+D.+McCorvyauthor=K.+V.+Butlerauthor=B.+Kellyauthor=K.+Rechsteinerauthor=J.+Karpiakauthor=R.+M.+Betzauthor=B.+L.+Kormosauthor=B.+K.+Shoichetauthor=R.+O.+Drorauthor=J.+Jinauthor=B.+L.+Roth&title=Structure-inspired+design+of+%CE%B2-arrestin-biased+ligands+for+aminergic+GPCRs&doi=10.1038%2Fnchembio.2527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs</span></div><div class="casAuthors">McCorvy, John D.; Butler, Kyle V.; Kelly, Brendan; Rechsteiner, Katie; Karpiak, Joel; Betz, Robin M.; Kormos, Bethany L.; Shoichet, Brian K.; Dror, Ron O.; Jin, Jian; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-134</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Development of biased ligands targeting G protein-coupled receptors (GPCRs) is a promising approach for current drug discovery.  Although structure-based drug design of biased agonists remains challenging even with an abundance of GPCR crystal structures, the authors present an approach for translating GPCR structural data into β-arrestin-biased ligands for aminergic GPCRs.  The authors identified specific amino acid-ligand contacts at transmembrane helix 5 (TM5) and extracellular loop 2 (EL2) responsible for Gi/o and β-arrestin signaling, resp., and targeted those residues to develop biased ligands.  For these ligands, the authors found that bias is conserved at other aminergic GPCRs that retain similar residues at TM5 and EL2.  The authors' approach provides a template for generating arrestin-biased ligands by modifying predicted ligand interactions that block TM5 interactions and promote EL2 interactions.  This strategy may facilitate the structure-guided design of arrestin-biased ligands at other GPCRs, including polypharmacol. biased ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVs9TaoxiFubVg90H21EOLACvtfcHk0lg697Es9PNzpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGmur3I&md5=2725e8487638cc07ce5e6a655fcd29f2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2527%26sid%3Dliteratum%253Aachs%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKelly%26aufirst%3DB.%26aulast%3DRechsteiner%26aufirst%3DK.%26aulast%3DKarpiak%26aufirst%3DJ.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure-inspired%2520design%2520of%2520%25CE%25B2-arrestin-biased%2520ligands%2520for%2520aminergic%2520GPCRs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D126%26epage%3D134%26doi%3D10.1038%2Fnchembio.2527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Zastrow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1301071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fsj.npp.1301071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=16554739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSqtbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=67-77&author=J.+D.+Urbanauthor=G.+A.+Vargasauthor=M.+von+Zastrowauthor=R.+B.+Mailman&title=Aripiprazole+has+functionally+selective+actions+at+dopamine+D2+receptor-mediated+signaling+pathways&doi=10.1038%2Fsj.npp.1301071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways</span></div><div class="casAuthors">Urban, Jonathan D.; Vargas, Gabriel A.; von Zastrow, Mark; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-77</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aripiprazole is a unique atypical antipsychotic drug with an excellent side-effect profile presumed, in part, to be due to lack of typical D2 dopamine receptor antagonist properties.  Whether aripiprazole is a typical D2 partial agonist, or a functionally selective D2 ligand, remains controversial (eg D2-mediated inhibition of adenylate cyclase is system dependent; aripiprazole antagonizes D2 receptor-mediated G-protein-coupled inwardly rectifying potassium channels and guanosine triphosphate nucleotide (GTP)γS coupling).  The current study examd. the D2L receptor binding properties of aripiprazole, as well as the effects of the drug on three downstream D2 receptor-mediated functional effectors: mitogen-activated protein kinase (MAPK) phosphorylation, potentiation of arachidonic acid (AA) release, and D2 receptor internalization.  Unlike quinpirole (a full D2 agonist) or (-)3PPP (S(-)-3-(3-hydroxyphenyl)-N-propylpiperidine hydrochloride, a D2 partial agonist), the apparent D2 affinity of aripiprazole was not decreased significantly by GTP.  Moreover, full or partial agonists are expected to have Hill slopes <1.0, yet that of aripiprazole was significantly >1.0.  Whereas aripiprazole partially activated both the MAPK and AA pathways, its potency vs MAPK phosphorylation was much lower relative to potencies in assays either of AA release or inhibition of cyclic adenosine 3',5'-cyclic monophosphate accumulation.  In addn., unlike typical agonists, neither aripiprazole nor (-)3PPP produced significant internalization of the D2L receptor.  These data are clear evidence that aripiprazole affects D2L-mediated signaling pathways in a differential manner.  The results are consistent with the hypothesis that aripiprazole is a functionally selective D2 ligand rather than a simple partial agonist.  Such data may be useful in understanding the novel clin. actions of this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-qAW7cvG3i7Vg90H21EOLACvtfcHk0lifWTUjkEmAjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSqtbrJ&md5=20b9edb05787dadb09fb4c778205f0b2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301071%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DG.%2BA.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DAripiprazole%2520has%2520functionally%2520selective%2520actions%2520at%2520dopamine%2520D2%2520receptor-mediated%2520signaling%2520pathways%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D67%26epage%3D77%26doi%3D10.1038%2Fsj.npp.1301071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Functionally selective dopamine D2/D3 receptor agonists comprising an enyne moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5130</span>– <span class="NLM_lpage">5141</span>, <span class="refDoi"> DOI: 10.1021/jm400520c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400520c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5130-5141&author=C.+Hillerauthor=R.+C.+Klingauthor=F.+W.+Heinemannauthor=K.+Meyerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D2%2FD3+receptor+agonists+comprising+an+enyne+moiety&doi=10.1021%2Fjm400520c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</span></div><div class="casAuthors">Hiller, Christine; Kling, Ralf C.; Heinemann, Frank W.; Meyer, Karsten; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5130-5141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonracemic ethynylcyclohexynylamines I and ent-I {R = 1,1'-biphenyl-4-yl, pyrazolo[1,5-a]pyridin-2-yl, pyrazolo[1,5-a]pyridin-3-yl, 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl, benzo[b]thiophene-2-yl, ferrocenyl} were prepd. as dopamine receptor agonists with atypical catechol isosteres; their selectivities for dopamine receptors and for activating receptors through G-protein subunits Go and Gi and the metabolic stability of rac-I (R = 4-PhC6H4) were detd.  The ethynylcyclohexynylamines bound to D2-like receptors with high affinities.  Ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) selectively activated D2slow-promoted Go activation over Gi coupling; the most significant functional bias obsd. was for ent-I {R = 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl} which selectively activated Go over Gi coupling at D2long receptors.  Functional selectivity for β-arrestin recruitment over Gi activation was obsd. for I (R = 1,1'-biphenyl-4-yl) and ent-I (R = benzothiophene-2-yl), while ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) preferred β-arrestin recruitment compared to Go coupling.  The structure of a nonracemic N-(ethynylcyclohexenyl)dinitrobenzamide was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXn2SrS-IBCrVg90H21EOLACvtfcHk0lifWTUjkEmAjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D&md5=3855de949f505a83ed3aa561ca182e75</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm400520c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400520c%26sid%3Dliteratum%253Aachs%26aulast%3DHiller%26aufirst%3DC.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DHeinemann%26aufirst%3DF.%2BW.%26aulast%3DMeyer%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D2%252FD3%2520receptor%2520agonists%2520comprising%2520an%2520enyne%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5130%26epage%3D5141%26doi%3D10.1021%2Fjm400520c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skultety, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Functionally Selective Dopamine D2, D3 Receptor Partial Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4861</span>– <span class="NLM_lpage">4875</span>, <span class="refDoi"> DOI: 10.1021/jm5004039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5004039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4861-4875&author=D.+M%C3%B6llerauthor=R.+C.+Klingauthor=M.+Skultetyauthor=K.+Leunerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Functionally+Selective+Dopamine+D2%2C+D3+Receptor+Partial+Agonists&doi=10.1021%2Fjm5004039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm5004039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5004039%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DLeuner%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520Selective%2520Dopamine%2520D2%252C%2520D3%2520Receptor%2520Partial%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4861%26epage%3D4875%26doi%3D10.1021%2Fjm5004039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzuneser, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skultety, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzheimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of G protein-biased dopaminergics with a pyrazolo[1,5-a]pyridine substructure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2908</span>– <span class="NLM_lpage">2929</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2908-2929&author=D.+M%C3%B6llerauthor=A.+Banerjeeauthor=T.+C.+Uzuneserauthor=M.+Skultetyauthor=T.+Huthauthor=B.+Plouffeauthor=H.+H%C3%BCbnerauthor=C.+Alzheimerauthor=K.+Friedlandauthor=C.+P.+M%C3%BCllerauthor=M.+Bouvierauthor=P.+Gmeiner&title=Discovery+of+G+protein-biased+dopaminergics+with+a+pyrazolo%5B1%2C5-a%5Dpyridine+substructure&doi=10.1021%2Facs.jmedchem.6b01857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure</span></div><div class="casAuthors">Moller Dorothee; Banerjee Ashutosh; Skultety Marika; Hubner Harald; Gmeiner Peter; Uzuneser Taygun C; Muller Christian P; Huth Tobias; Alzheimer Christian; Plouffe Bianca; Bouvier Michel; Friedland Kristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2908-2929</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors.  Connection of a lipophilic moiety to the arylpiperazine core by an appropriate linker represents a promising concept to increase binding affinity and to fine-tune functional properties.  In particular, incorporation of a pyrazolo[1,5-a]pyridine heterocyclic appendage led to a series of high-affinity dopamine receptor partial agonists.  Comprehensive pharmacological characterization involving BRET biosensors, binding studies, electrophysiology, and complementation-based assays revealed compounds favoring activation of G proteins (preferably Go) over β-arrestin recruitment at dopamine D2 receptors.  The feasibility to design G protein-biased partial agonists as putative novel therapeutics was demonstrated for the representative 2-methoxyphenylpiperazine 16c, which unequivocally displayed antipsychotic activity in vivo.  Moreover, combination of the pyrazolo[1,5-a]pyridine appendage with a 5-hydroxy-N-propyl-2-aminotetraline unit led to balanced or G protein-biased dopaminergic ligands depending on the stereochemistry of the headgroup, illustrating the complex structure-functional selectivity relationships at dopamine D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSsvEaQplNsM25P7XSLhESfW6udTcc2eaMSF7vGuzBhrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D&md5=208855de29fed6b821fd6e4a5bfb412f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01857%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DUzuneser%26aufirst%3DT.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DHuth%26aufirst%3DT.%26aulast%3DPlouffe%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DAlzheimer%26aufirst%3DC.%26aulast%3DFriedland%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520G%2520protein-biased%2520dopaminergics%2520with%2520a%2520pyrazolo%255B1%252C5-a%255Dpyridine%2520substructure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2908%26epage%3D2929%26doi%3D10.1021%2Facs.jmedchem.6b01857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herenbrink, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span> <span> </span><span class="NLM_article-title">A structure-activity analysis of biased agonism at the dopamine D2 receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9199</span>– <span class="NLM_lpage">9221</span>, <span class="refDoi"> DOI: 10.1021/jm401318w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401318w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9199-9221&author=J.+Shonbergauthor=C.+K.+Herenbrinkauthor=L.+L%C3%B3pezauthor=A.+Christopoulosauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=J.+R.+Lane&title=A+structure-activity+analysis+of+biased+agonism+at+the+dopamine+D2+receptor&doi=10.1021%2Fjm401318w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A Structure-Activity Analysis of Biased Agonism at the Dopamine D2 Receptor</span></div><div class="casAuthors">Shonberg, Jeremy; Herenbrink, Carmen Klein; Lopez, Laura; Christopoulos, Arthur; Scammells, Peter J.; Capuano, Ben; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9199-9221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased agonism offers an opportunity for the medicinal chemist to discover pathway-selective ligands for GPCRs.  A no. of studies have suggested that biased agonism at the dopamine D2 receptor (D2R) may be advantageous for the treatment of neuropsychiatric disorders, including schizophrenia.  As such, it is of great importance to gain insight into the SAR of biased agonism at this receptor.  The authors have generated SAR based on a novel D2R partial agonist, tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate.  This ligand shares structural similarity to cariprazine, a drug awaiting FDA approval for the treatment of schizophrenia, yet displays a distinct bias toward two different signaling end points.  The authors synthesized a no. of derivs. of tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate with subtle structural modifications, including incorporation of cariprazine fragments.  By combining pharmacol. profiling with anal. methodol. to identify and to quantify bias, the authors have demonstrated that efficacy and biased agonism can be finely tuned by minor structural modifications to the head group contg. the tertiary amine, a tail group that extends away from this moiety, and the orientation and length of a spacer region between these two moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocktbsOBHWB7Vg90H21EOLACvtfcHk0lhouALP-C8nGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ&md5=124b940132336819740ec30d2962a3a3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm401318w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401318w%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DHerenbrink%26aufirst%3DC.%2BK.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DA%2520structure-activity%2520analysis%2520of%2520biased%2520agonism%2520at%2520the%2520dopamine%2520D2%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9199%26epage%3D9221%26doi%3D10.1021%2Fjm401318w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, M.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Novel bivalent ligands based on the sumanirole pharmacophore reveal dopamine D2 receptor (D2R) biased agonism</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2890</span>– <span class="NLM_lpage">2907</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlSrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2890-2907&author=A.+Bonifaziauthor=H.+Yanoauthor=M.+P.+Ellenbergerauthor=L.+Mullerauthor=V.+Kumarauthor=M.-F.+Zouauthor=N.+S.+Caiauthor=A.+M.+Guerreroauthor=A.+S.+Woodsauthor=L.+Shiauthor=A.+H.+Newman&title=Novel+bivalent+ligands+based+on+the+sumanirole+pharmacophore+reveal+dopamine+D2+receptor+%28D2R%29+biased+agonism&doi=10.1021%2Facs.jmedchem.6b01875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism</span></div><div class="casAuthors">Bonifazi, Alessandro; Yano, Hideaki; Ellenberger, Michael P.; Muller, Ludovic; Kumar, Vivek; Zou, Mu-Fa; Cai, Ning Sheng; Guerrero, Adrian M.; Woods, Amina S.; Shi, Lei; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2890-2907</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of bivalent ligands has attracted interest as a way to potentially improve the selectivity and/or affinity for a specific receptor subtype.  The ability to bind two distinct receptor binding sites simultaneously can allow the selective activation of specific G-protein dependent or β-arrestin-mediated cascade pathways.  Herein, we developed an extended SAR study using sumanirole (1) as the primary pharmacophore.  We found that substitutions in the N-1- and/or N-5-positions, physiochem. properties of those substituents, and secondary arom. pharmacophores can enhance agonist efficacy for the cAMP inhibition mediated by Gi/o-proteins, while reducing or suppressing potency and efficacy toward β-arrestin recruitment.  Compd. 19 was identified as a new lead for its selective D2 G-protein biased agonism with an EC50 in the subnanomolar range.  Structure-activity correlations were obsd. between substitutions in positions N-1 and/or N-5 of 1 and the capacity of the new bivalent compds. to selectively activate G-proteins vs. β-arrestin recruitment in D2R-BRET functional assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprfScHokUgP7Vg90H21EOLACvtfcHk0lhouALP-C8nGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlSrsb0%253D&md5=24bf22a101756e44fbc8f8345d2c1fe4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01875%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DEllenberger%26aufirst%3DM.%2BP.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DZou%26aufirst%3DM.-F.%26aulast%3DCai%26aufirst%3DN.%2BS.%26aulast%3DGuerrero%26aufirst%3DA.%2BM.%26aulast%3DWoods%26aufirst%3DA.%2BS.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520bivalent%2520ligands%2520based%2520on%2520the%2520sumanirole%2520pharmacophore%2520reveal%2520dopamine%2520D2%2520receptor%2520%2528D2R%2529%2520biased%2520agonism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2890%26epage%3D2907%26doi%3D10.1021%2Facs.jmedchem.6b01875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weïwer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gale, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Bittner, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dordevic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skepner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennehy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faloon, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottrell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scolnick, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holson, E. B.</span></span> <span> </span><span class="NLM_article-title">Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1038</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1021/acschembio.8b00168</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00168" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1038-1047&author=M.+We%C3%AFwerauthor=Q.+Xuauthor=J.+P.+Galeauthor=M.+Lewisauthor=A.+J.+Campbellauthor=F.+A.+Schroederauthor=G.+C.+Van+de+Bittnerauthor=M.+Walkauthor=A.+Amayaauthor=P.+Suauthor=L.+Dordevicauthor=A.+Skepnerauthor=D.+Feiauthor=K.+Dennehyauthor=S.+Nguyenauthor=P.+W.+Faloonauthor=J.+Perezauthor=J.+R.+Cottrellauthor=F.+Liuauthor=M.+Palmerauthor=J.+Q.+Panauthor=J.+M.+Hookerauthor=Y.-L.+Zhangauthor=E.+Scolnickauthor=F.+F.+Wagnerauthor=E.+B.+Holson&title=Functionally+Biased+D2R+Antagonists%3A+Targeting+the+%CE%B2-Arrestin+Pathway+to+Improve+Antipsychotic+Treatment&doi=10.1021%2Facschembio.8b00168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment</span></div><div class="casAuthors">Weiwer, Michel; Xu, Qihong; Gale, Jennifer P.; Lewis, Michael; Campbell, Arthur J.; Schroeder, Frederick A.; Van de Bittner, Genevieve C.; Walk, Michelle; Amaya, Aldo; Su, Ping; Dordevic, Luka; Sacher, Joshua R.; Skepner, Adam; Fei, David; Dennehy, Kelly; Nguyen, Shannon; Faloon, Patrick W.; Perez, Jose; Cottrell, Jeffrey R.; Liu, Fang; Palmer, Michelle; Pan, Jen Q.; Hooker, Jacob M.; Zhang, Yan-Ling; Scolnick, Edward; Wagner, Florence F.; Holson, Edward B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1038-1047</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Schizophrenia is a severe neuropsychiatric disease that lacks completely effective and safe therapies.  As a polygenic disorder, genetic studies have only started to shed light on its complex etiol.  To date, the pos. symptoms of schizophrenia are well-managed by antipsychotic drugs, which primarily target the dopamine D2 receptor (D2R).  However, these antipsychotics are often accompanied by severe side effects, including motoric symptoms.  At D2R, antipsychotic drugs antagonize both G-protein dependent (Gαi/o) signaling and G-protein independent (β-arrestin) signaling.  However, the relevant contributions of the distinct D2R signaling pathways to antipsychotic efficacy and on-target side effects (motoric) are still incompletely understood.  Recent evidence from mouse genetic and pharmacol. studies point to β-arrestin signaling as the major driver of antipsychotic efficacy and suggest that a β-arrestin biased D2R antagonist could achieve an addnl. level of selectivity at D2R, increasing the therapeutic index of next generation antipsychotics.  Here, we characterize BRD5814, a highly brain penetrant β-arrestin biased D2R antagonist.  BRD5814 demonstrated good target engagement via PET imaging, achieving efficacy in an amphetamine-induced hyperlocomotion mouse model with strongly reduced motoric side effects in a rotarod performance test.  This proof of concept study opens the possibility for the development of a new generation of pathway selective antipsychotics at D2R with reduced side effect profiles for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPBrMik6d7a7Vg90H21EOLACvtfcHk0lhrnmH_7pzzsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOrtbw%253D&md5=51d636dd2a0ebfc83d58a6158a1da40e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00168%26sid%3Dliteratum%253Aachs%26aulast%3DWe%25C3%25AFwer%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DGale%26aufirst%3DJ.%2BP.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DA.%2BJ.%26aulast%3DSchroeder%26aufirst%3DF.%2BA.%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DG.%2BC.%26aulast%3DWalk%26aufirst%3DM.%26aulast%3DAmaya%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DP.%26aulast%3DDordevic%26aufirst%3DL.%26aulast%3DSkepner%26aufirst%3DA.%26aulast%3DFei%26aufirst%3DD.%26aulast%3DDennehy%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DS.%26aulast%3DFaloon%26aufirst%3DP.%2BW.%26aulast%3DPerez%26aufirst%3DJ.%26aulast%3DCottrell%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DPalmer%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DJ.%2BQ.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DY.-L.%26aulast%3DScolnick%26aufirst%3DE.%26aulast%3DWagner%26aufirst%3DF.%2BF.%26aulast%3DHolson%26aufirst%3DE.%2BB.%26atitle%3DFunctionally%2520Biased%2520D2R%2520Antagonists%253A%2520Targeting%2520the%2520%25CE%25B2-Arrestin%2520Pathway%2520to%2520Improve%2520Antipsychotic%2520Treatment%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D1038%26epage%3D1047%26doi%3D10.1021%2Facschembio.8b00168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMarco, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efremov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tierney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volfson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilmette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salafia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, M. D.</span></span> <span> </span><span class="NLM_article-title">Impaired beta-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">674</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02776-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fs41467-017-02776-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=29445200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A280%3ADC%252BC1Mrhsl2nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=674&author=D.+L.+Grayauthor=J.+A.+Allenauthor=S.+Menteauthor=R.+E.+O%E2%80%99Connorauthor=G.+J.+DeMarcoauthor=I.+Efremovauthor=P.+Tierneyauthor=D.+Volfsonauthor=J.+Davorenauthor=E.+Guilmetteauthor=M.+Salafiaauthor=R.+Kozakauthor=M.+D.+Ehlers&title=Impaired+beta-arrestin+recruitment+and+reduced+desensitization+by+non-catechol+agonists+of+the+D1+dopamine+receptor&doi=10.1038%2Fs41467-017-02776-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor</span></div><div class="casAuthors">Gray David L; Mente Scot; Efremov Ivan; Davoren Jennifer; Gray David L; Allen John A; Tierney Patrick; Volfson Dmitri; Guilmette Edward; Kozak Rouba; Ehlers Michael D; Allen John A; O'Connor Rebecca E; Salafia Michelle; DeMarco George J; Ehlers Michael D</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">674</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Selective activation of dopamine D1 receptors (D1Rs) has been pursued for 40 years as a therapeutic strategy for neurologic and psychiatric diseases due to the fundamental role of D1Rs in motor function, reward processing, and cognition.  All known D1R-selective agonists are catechols, which are rapidly metabolized and desensitize the D1R after prolonged exposure, reducing agonist response.  As such, drug-like selective D1R agonists have remained elusive.  Here we report a novel series of selective, potent non-catechol D1R agonists with promising in vivo pharmacokinetic properties.  These ligands stimulate adenylyl cyclase signaling and are efficacious in a rodent model of Parkinson's disease after oral administration.  They exhibit distinct binding to the D1R orthosteric site and a novel functional profile including minimal receptor desensitization, reduced recruitment of β-arrestin, and sustained in vivo efficacy.  These results reveal a novel class of D1 agonists with favorable drug-like properties, and define the molecular basis for catechol-specific recruitment of β-arrestin to D1Rs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcShdJOozuyZkBe4jJGKT5N0fW6udTcc2eZry5gBywTCj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mrhsl2nsQ%253D%253D&md5=2ba64bda304b083647eedff999f3fdcd</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02776-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02776-7%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DD.%2BL.%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DMente%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DDeMarco%26aufirst%3DG.%2BJ.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DTierney%26aufirst%3DP.%26aulast%3DVolfson%26aufirst%3DD.%26aulast%3DDavoren%26aufirst%3DJ.%26aulast%3DGuilmette%26aufirst%3DE.%26aulast%3DSalafia%26aufirst%3DM.%26aulast%3DKozak%26aufirst%3DR.%26aulast%3DEhlers%26aufirst%3DM.%2BD.%26atitle%3DImpaired%2520beta-arrestin%2520recruitment%2520and%2520reduced%2520desensitization%2520by%2520non-catechol%2520agonists%2520of%2520the%2520D1%2520dopamine%2520receptor%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D674%26doi%3D10.1038%2Fs41467-017-02776-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugolenski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rai, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salafia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D.</span></span> <span> </span><span class="NLM_article-title">Discovery and lead optimization of atropisomer D1 agonists with reduced desensitization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11384</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01622</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01622" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitF2qtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11384&author=J.+E.+Davorenauthor=D.+Nasonauthor=J.+Coeauthor=K.+Dlugolenskiauthor=C.+Helalauthor=A.+R.+Harrisauthor=E.+LaChapelleauthor=S.+Liangauthor=Y.+Liuauthor=R.+O%E2%80%99Connorauthor=C.+C.+Orozcoauthor=B.+K.+Raiauthor=M.+Salafiaauthor=B.+Samasauthor=W.+Xuauthor=R.+Kozakauthor=D.+Gray&title=Discovery+and+lead+optimization+of+atropisomer+D1+agonists+with+reduced+desensitization&doi=10.1021%2Facs.jmedchem.8b01622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization</span></div><div class="casAuthors">Davoren, Jennifer E.; Nason, Deane; Coe, Jotham; Dlugolenski, Keith; Helal, Christopher; Harris, Anthony R.; LaChapelle, Erik; Liang, Sidney; Liu, Yue; OConnor, Rebecca; Orozco, Christine C.; Rai, Brajesh K.; Salafia, Michelle; Samas, Brian; Xu, Wenjian; Kozak, Rouba; Gray, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11384-11397</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of D1 subtype-selective agonists with drug-like properties has been an enduring challenge for the greater part of 40 years.  All known D1-selective agonists are catecholamines that bring about receptor desensitization and undergo rapid metab., thus limiting their utility as a therapeutic for chronic illness such as schizophrenia and Parkinson's disease.  Our high-throughput screening efforts on D1 yielded a single non-catecholamine hit PF-4211 (6) that was developed into a series of potent D1 receptor agonist leads with high oral bioavailability and CNS penetration.  An important structural feature of this series is the locked biaryl ring system resulting in atropisomerism.  Disclosed herein is a summary of our hit-to-lead efforts on this series of D1 activators culminating in the discovery of atropisomer 31 (PF-06256142), a potent and selective orthosteric agonist of the D1 receptor that has reduced receptor desensitization relative to dopamine and other catechol-contg. agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2S5u6FmBDoLVg90H21EOLACvtfcHk0lhrnmH_7pzzsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitF2qtrvI&md5=ec84a23922f417fdeb1acd9beb3ad4bf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01622%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DNason%26aufirst%3DD.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DHelal%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DOrozco%26aufirst%3DC.%2BC.%26aulast%3DRai%26aufirst%3DB.%2BK.%26aulast%3DSalafia%26aufirst%3DM.%26aulast%3DSamas%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DKozak%26aufirst%3DR.%26aulast%3DGray%26aufirst%3DD.%26atitle%3DDiscovery%2520and%2520lead%2520optimization%2520of%2520atropisomer%2520D1%2520agonists%2520with%2520reduced%2520desensitization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11384%26doi%3D10.1021%2Facs.jmedchem.8b01622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezard, E.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of L-DOPA-induced dyskinesia</span>. <i>Int. Rev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/b978-0-12-381328-2.00004-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fb978-0-12-381328-2.00004-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=21907084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFWhsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2011&pages=95-122&author=G.+Fisoneauthor=E.+Bezard&title=Molecular+mechanisms+of+L-DOPA-induced+dyskinesia&doi=10.1016%2Fb978-0-12-381328-2.00004-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of L-dopa-induced dyskinesia</span></div><div class="casAuthors">Fisone, Gilberto; Bezard, Erwan</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia</span>),
    <span class="NLM_cas:pages">95-122</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD), a common neurodegenerative disorder caused by the loss of the dopaminergic input to the basal ganglia, is commonly treated with L-DOPA.  Use of this drug, however, is severely limited by the development of dystonic and choreic motor complications, or dyskinesia.  This chapter describes the mol. mechanisms implicated in the emergence and manifestation of L-DOPA-induced dyskinesia (LID).  Particular emphasis is given to the role played in this condition by abnormalities in signal transduction at the level of the medium spiny neurons (MSNs) of the striatum, which are the principal target of L-DOPA.  Recent evidence pointing to pre-synaptic dysregulation is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFEzuMQszILbVg90H21EOLACvtfcHk0ljJGnrKyFIkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFWhsLzL&md5=4f42b455fa3e5c1a4bb6074a6a928490</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fb978-0-12-381328-2.00004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fb978-0-12-381328-2.00004-3%26sid%3Dliteratum%253Aachs%26aulast%3DFisone%26aufirst%3DG.%26aulast%3DBezard%26aufirst%3DE.%26atitle%3DMolecular%2520mechanisms%2520of%2520L-DOPA-induced%2520dyskinesia%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2011%26volume%3D98%26spage%3D95%26epage%3D122%26doi%3D10.1016%2Fb978-0-12-381328-2.00004-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jenner, P.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of L-DOPA-induced dyskinesia</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.1038/nrn2471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnrn2471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=18714325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSjurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=665-677&author=P.+Jenner&title=Molecular+mechanisms+of+L-DOPA-induced+dyskinesia&doi=10.1038%2Fnrn2471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of L-DOPA-induced dyskinesia</span></div><div class="casAuthors">Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">665-677</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dyskinesia is a treatment-limiting side effect of dopaminergic replacement therapies in Parkinson's disease.  Here Jenner discusses what we know about the mol. causes of dyskinesia induction and expression, highlighting recent findings that suggest that altered glutamatergic transmission might be important.  L-DOPA (L-3,4-dihydroxyphenylalanine) remains the most effective drug for the treatment of Parkinson's disease.  However, chronic use causes dyskinesia, a complex motor phenomenon that consists of two components: the execution of involuntary movements in response to drug administration, and the 'priming' phenomenon that underlies these movements' establishment and persistence.  A reinterpretation of recent data suggests that priming for dyskinesia results from nigral denervation and the loss of striatal dopamine input, which alters glutamatergic synaptic connectivity in the striatum.  The subsequent response of the abnormal basal ganglia to dopaminergic drugs dets. the manner and timing of dyskinesia expression.  The combination of nigral denervation and drug treatment establishes inappropriate signaling between the motor cortex and the striatum, leading to persistent dyskinesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-pdXwQI94e7Vg90H21EOLACvtfcHk0ljJGnrKyFIkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSjurvP&md5=5dac15ce126371908eef79c093420b67</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnrn2471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2471%26sid%3Dliteratum%253Aachs%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DMolecular%2520mechanisms%2520of%2520L-DOPA-induced%2520dyskinesia%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2008%26volume%3D9%26spage%3D665%26epage%3D677%26doi%3D10.1038%2Fnrn2471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weed, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolverton, W. L.</span></span> <span> </span><span class="NLM_article-title">Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1007/bf02244333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1007%2Fbf02244333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=7862828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaK2cXjtFGksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1993&pages=51-52&author=M.+R.+Weedauthor=K.+E.+Vanoverauthor=W.+L.+Woolverton&title=Reinforcing+effect+of+the+D1+dopamine+agonist+SKF+81297+in+rhesus+monkeys&doi=10.1007%2Fbf02244333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys</span></div><div class="casAuthors">Weed, Michael R.; Vanover, Kimberly E.; Woolverton, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-2</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">Rhesus monkeys with IV catheters were allowed to self-administer cocaine for 1 h/day.  When responding was stable, saline or the D1 dopamine agonist SKF 81297 (SKF; 0.001-0.3 mg/kg/inj) was substituted for cocaine.  At least two doses of SKF maintained responding above saline levels in all monkeys.  The D1 antagonist SCH 39166 (0.001-0.03 mg/kg, IM) was then administered 30 min before sessions of self-administration of the lowest dose of SKF that maintained behavior (0.01 mg/kg/inj).  SKF-maintained responding decreased in a dose-related manner, suggesting antagonism of the reinforcing effect.  These results suggest that stimulation of D1 receptors can initiate a reinforcing effect and further implicate D1 receptors in the reinforcing effects of drugs that increase dopamine neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2g0mdrLmjnbVg90H21EOLACvtfcHk0ljJGnrKyFIkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjtFGksLc%253D&md5=9f93dfa9b995918ef897ac2fb1a6f3d2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fbf02244333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fbf02244333%26sid%3Dliteratum%253Aachs%26aulast%3DWeed%26aufirst%3DM.%2BR.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DWoolverton%26aufirst%3DW.%2BL.%26atitle%3DReinforcing%2520effect%2520of%2520the%2520D1%2520dopamine%2520agonist%2520SKF%252081297%2520in%2520rhesus%2520monkeys%26jtitle%3DPsychopharmacology%26date%3D1993%26volume%3D113%26spage%3D51%26epage%3D52%26doi%3D10.1007%2Fbf02244333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savasta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatton, B.</span></span> <span> </span><span class="NLM_article-title">Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/0306-4522(86)90010-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2F0306-4522%2886%2990010-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=2946980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaL28XlvVeku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1986&pages=125-137&author=A.+Duboisauthor=M.+Savastaauthor=O.+Curetauthor=B.+Scatton&title=Autoradiographic+distribution+of+the+D1+agonist+%5B3H%5DSKF+38393%2C+in+the+rat+brain+and+spinal+cord.+Comparison+with+the+distribution+of+D2+dopamine+receptors&doi=10.1016%2F0306-4522%2886%2990010-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord.  Comparison with the distribution of D2 dopamine receptors</span></div><div class="casAuthors">Dubois, A.; Savasta, M.; Curet, O.; Scatton, B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-37</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    </div><div class="casAbstract">The regional distribution of the specific D1 agonist 3H-labeled SKF 38393 (I)  [67287-49-4] was studied autoradiog. in the rat central nervous system.  The binding of [3H]SKF 38393 to striatal sections was saturable, stereospecific, reversible, of high affinity (Kd = 9.9 nM) and partly Na+ sensitive; it occurred at a single population of sites and possessed the pharmacol. characteristics of the dopamine-D1 receptor.  The highest levels of [3H]SKF 38393 binding sites were found in the caudate putamen, nucleus accumbens, olfactory tubercle and substantia nigra.  Moderately high concns. of the [3H]ligand were obsd. in the amygdala, endopyriform nucleus, nucleus olfactorius anterior, lateral septum, primary olfactory cortex, cerebellum (mol. layer) and spinal cord.  An intermediate labeling was found in the thalamus, habenula, subthalamic nucleus, hypothalamus, ventral tegmental area, superior colliculus, hippocampus and cerebral cortex.  Moderate levels of [3H]SKF 38393 binding were obsd. in the globus pallidus and arcuate nucleus.  The autoradiog. distribution of [3H]SKF 38393 overlapped with that of [3H]N,n-propylnorapomorphine, a radioligand which labels the D2-dopamine receptors, in a no. of dopamine-rich brain areas but there were several areas which exhibited a high d. of [3H]SKF 38393 binding sites but undetectable concns. of [3H]N,n-propylnorapomorphine.  Moreover, in the spinal cord, the subregional localization of these [3H]ligands clearly differed.  Intrastriatal injection of ibotenic acid caused a large decrease in [3H]SKF 38393 and [3H]N,n-propylnorapomorphine binding in the striatum and provoked a redn. of [3H]SKF 38393 but not [3H]N,n-propylnorapomorphine binding in the substantia nigra confirming the view that nigral D1 but not D2 receptors are located on striatonigral fibers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdV6YLmAEVkLVg90H21EOLACvtfcHk0ljJGnrKyFIkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XlvVeku78%253D&md5=39e8e4614c8ed62f24d15567dfcd039e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0306-4522%2886%2990010-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-4522%252886%252990010-2%26sid%3Dliteratum%253Aachs%26aulast%3DDubois%26aufirst%3DA.%26aulast%3DSavasta%26aufirst%3DM.%26aulast%3DCuret%26aufirst%3DO.%26aulast%3DScatton%26aufirst%3DB.%26atitle%3DAutoradiographic%2520distribution%2520of%2520the%2520D1%2520agonist%2520%255B3H%255DSKF%252038393%252C%2520in%2520the%2520rat%2520brain%2520and%2520spinal%2520cord.%2520Comparison%2520with%2520the%2520distribution%2520of%2520D2%2520dopamine%2520receptors%26jtitle%3DNeuroscience%26date%3D1986%26volume%3D19%26spage%3D125%26epage%3D137%26doi%3D10.1016%2F0306-4522%2886%2990010-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mottola, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewster, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>262</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1352553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaK38XkvVegu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1992&pages=383-393&author=D.+M.+Mottolaauthor=W.+K.+Brewsterauthor=L.+L.+Cookauthor=D.+E.+Nicholsauthor=R.+B.+Mailman&title=Dihydrexidine%2C+a+novel+full+efficacy+D1+dopamine+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist</span></div><div class="casAuthors">Mottola, David M.; Brewster, William K.; Cook, Larry L.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">383-93</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The present work provides a detailed pharmacol. characterization of dihydrexidine (DHX) (trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine), the first high-potency, full efficacy, bioavailable D1 dopamine receptor agonist.  DHX represents a new conformationally rigid structural class of dopamine receptor ligands.  It competes stereoselectively and potently for D1 binding sites in rat striatal membranes labeled with [3H]SCH23390 with an IC50 of about 10 nM compared to about 30 nM for the prototypical D1 agonist SKF38393.  Like other dopamine agonists, DHX has a shallow competition curve (nH = ca. 0.7) that can be fitted by a two-site model consisting of high-affinity (63%; KD = 3 nM) and low-affinity (37%; KD = 75 nM) sites.  DHX was screened for activity against 40 other binding sites, and was inactive (IC50 >10 μM) against all except D2 dopamine receptors (IC50 = 130 nM) and alpha2 adrenoceptors (IC50 = ca. 230 nM).  Functionally, DHX is a full efficacy dopamine D1 agonist.  In homogenates of rat striatum, DHX or dopamine doubles the rate of cAMP synthesis, whereas SKF38393 only causes a maximal increase of about 50%.  These effects of DHX are blocked by the selective D1 antagonist SCH23390, but are not affected by D2, 5-hydroxytryptamine2, muscarinic, or alpha or beta adrenergic antagonists.  Because DHX is known to cause D2-like behavioral effects at high doses, the nature of its D2 activity was characterized using prolactin release as an endpoint.  DHX and the prototypical D2 agonist quinpirole both caused a significant inhibition of the prolactin release induced by 5-hydroxytryptophan.  These effects of DHX are not due to "indirect" alterations at the presynaptic terminal, because DHX is essentially inactive at inhibiting the dopamine uptake system, and does not cause the release of dopamine.  These data demonstrate the utility of DHX for probing the biochem. and function of D1 dopamine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbI1fnzEG8NrVg90H21EOLACvtfcHk0ljkoUsE8jz7uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvVegu78%253D&md5=e5c0d22fc1fea23285fd0ea711c71598</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMottola%26aufirst%3DD.%2BM.%26aulast%3DBrewster%26aufirst%3DW.%2BK.%26aulast%3DCook%26aufirst%3DL.%2BL.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DDihydrexidine%252C%2520a%2520novel%2520full%2520efficacy%2520D1%2520dopamine%2520receptor%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1992%26volume%3D262%26spage%3D383%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collantes, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 5-bromo-6-methyl imidazopyrazine, 5-bromo and 5-chloro-6-methyl imidazopyridine using electron density surface maps to guide synthetic strategy</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">9063</span>– <span class="NLM_lpage">9066</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2011.08.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1016%2Fj.tet.2011.08.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKrtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=9063-9066&author=A.+R.+Harrisauthor=D.+M.+Nasonauthor=E.+M.+Collantesauthor=W.+Xuauthor=Y.+Chiauthor=Z.+Wangauthor=B.+Zhangauthor=Q.+Zhangauthor=D.+L.+Grayauthor=J.+E.+Davoren&title=Synthesis+of+5-bromo-6-methyl+imidazopyrazine%2C+5-bromo+and+5-chloro-6-methyl+imidazopyridine+using+electron+density+surface+maps+to+guide+synthetic+strategy&doi=10.1016%2Fj.tet.2011.08.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 5-bromo-6-methyl imidazopyrazine, 5-bromo and 5-chloro-6-methyl imidazopyridine using electron density surface maps to guide synthetic strategy</span></div><div class="casAuthors">Harris, Anthony R.; Nason, Deane M.; Collantes, Elizabeth M.; Xu, Wenjian; Chi, Yushi; Wang, Zhihan; Zhang, Bingzhi; Zhang, Qingjian; Gray, David L.; Davoren, Jennifer E.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">9063-9066</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Small heteroarom. rings are valuable monomers in drug discovery that can enable rapid access to novel and desirable chem. space.  Installation of a synthetic handle on a heteroarom. core may be difficult if steric and electronic factors are not in alignment with the desired transformation.  Described are practical routes for the construction of 5-bromo-6-Me imidazopyrazine I as well as Me imidazopyridines, e.g., II, developed using electron d. surface maps encoded with ionization potential to guide synthetic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0tXPawFaaHLVg90H21EOLACvtfcHk0ljkoUsE8jz7uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKrtr%252FM&md5=41e1ee9ba97bed2073f82cd186ed7a50</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2011.08.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2011.08.090%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DCollantes%26aufirst%3DE.%2BM.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DChi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DGray%26aufirst%3DD.%2BL.%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26atitle%3DSynthesis%2520of%25205-bromo-6-methyl%2520imidazopyrazine%252C%25205-bromo%2520and%25205-chloro-6-methyl%2520imidazopyridine%2520using%2520electron%2520density%2520surface%2520maps%2520to%2520guide%2520synthetic%2520strategy%26jtitle%3DTetrahedron%26date%3D2011%26volume%3D67%26spage%3D9063%26epage%3D9066%26doi%3D10.1016%2Fj.tet.2011.08.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed cross-coupling reactions of organoboron compounds</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2483</span>, <span class="refDoi"> DOI: 10.1021/cr00039a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds&doi=10.1021%2Fcr00039a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0ljkoUsE8jz7uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483%26doi%3D10.1021%2Fcr00039a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bercher, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuerstenau-Sharp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedvik, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielinski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doucette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revankar, C.</span></span> <span> </span><span class="NLM_article-title">A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">798</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1177/1087057109335260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1177%2F1087057109335260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=19531663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCgur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=798-810&author=B.+J.+Hansonauthor=J.+Wetterauthor=M.+R.+Bercherauthor=L.+Koppauthor=M.+Fuerstenau-Sharpauthor=K.+L.+Vedvikauthor=T.+Zielinskiauthor=C.+Doucetteauthor=P.+J.+Whitneyauthor=C.+Revankar&title=A+homogeneous+fluorescent+live-cell+assay+for+measuring+7-transmembrane+receptor+activity+and+agonist+functional+selectivity+through+beta-arrestin+recruitment&doi=10.1177%2F1087057109335260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment</span></div><div class="casAuthors">Hanson, Bonnie J.; Wetter, Justin; Bercher, Mark R.; Kopp, Leisha; Fuerstenau-Sharp, Maya; Vedvik, Kevin L.; Zielinski, Thomas; Doucette, Chris; Whitney, Pamela J.; Revankar, Chetana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">798-810</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Seven-transmembrane (7TM) receptors play an essential role in the regulation of a wide variety of physiol. processes, making them one of the top target classes for pharmaceuticals.  7TM receptor function is mediated and modulated through 2 primary processes: G-protein and beta-arrestin signaling.  Classically, it has been recognized that these 2 processes can interact with one another during 7TM receptor desensitization, but it has more recently been recognized that these 2 processes can also act independently of one another and can activate parallel signaling pathways.  As such, the methods used to interrogate 7TM receptor signaling, both from a biol. and a pharmaceutical perspective, may need to be reevaluated and the question of whether functionally selective compds. (compds. that selectively activate one pathway over another) can be rationally developed must be raised.  Although numerous high-throughput screening (HTS) compatible assays exist for studying second messengers arising from G-protein signaling, far fewer HTS compatible assays exist for studying beta-arrestin recruitment.  The authors report on the Tango 7TM receptor assay technol., a high-throughput homogeneous assay method for monitoring beta-arrestin recruitment that uses a live-cell fluorescent readout.  This assay format is broadly applicable to 7TM receptors, independent of G-protein coupling and, as such, has been used to produce assays for over 70 7TM receptor targets.  The authors also show how flow cytometry can be used to select clones with desired pharmacol. profiles and how an inducible expression system can increase the assay window for targets with high levels of constitutive activity.  Finally, they demonstrate how the Tango system can be used in parallel with assays aimed at second-messenger signaling to enable functional selectivity studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF-iHGhENdULVg90H21EOLACvtfcHk0linUNDgtYwBsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCgur3F&md5=80c59bd127327e09101543c98a040e16</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1177%2F1087057109335260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057109335260%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DB.%2BJ.%26aulast%3DWetter%26aufirst%3DJ.%26aulast%3DBercher%26aufirst%3DM.%2BR.%26aulast%3DKopp%26aufirst%3DL.%26aulast%3DFuerstenau-Sharp%26aufirst%3DM.%26aulast%3DVedvik%26aufirst%3DK.%2BL.%26aulast%3DZielinski%26aufirst%3DT.%26aulast%3DDoucette%26aufirst%3DC.%26aulast%3DWhitney%26aufirst%3DP.%2BJ.%26aulast%3DRevankar%26aufirst%3DC.%26atitle%3DA%2520homogeneous%2520fluorescent%2520live-cell%2520assay%2520for%2520measuring%25207-transmembrane%2520receptor%2520activity%2520and%2520agonist%2520functional%2520selectivity%2520through%2520beta-arrestin%2520recruitment%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2009%26volume%3D14%26spage%3D798%26epage%3D810%26doi%3D10.1177%2F1087057109335260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span>; <span class="NLM_string-name">Li, Z.</span>; <span class="NLM_string-name">Cvijic, M. E.</span>; <span class="NLM_string-name">Krause, C.</span>; <span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">Sum, C.
S.</span></span> <span> </span><span class="NLM_article-title">Measurement of Beta-Arrestin Recruitment for GPCR Targets</span>. In  <i>Assay Guidance Manual</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sittampalam, G. S.</span>, <span class="NLM_string-name">Coussens, N. P.</span>, <span class="NLM_string-name">Brimacombe, K.</span>, <span class="NLM_string-name">Grossman, A.</span>, <span class="NLM_string-name">Arkin, M.</span>, <span class="NLM_string-name">Auld, D.</span>, <span class="NLM_string-name">Austin, C.</span>, <span class="NLM_string-name">Baell, J.</span>, <span class="NLM_string-name">Bejcek, B.</span>, <span class="NLM_string-name">Caaveiro, J. M. M.</span>, <span class="NLM_string-name">Chung, T. D. Y.</span>, <span class="NLM_string-name">Dahlin, J. L.</span>; <span class="NLM_string-name">Devanaryan, V.</span>, <span class="NLM_string-name">Foley, T. L.</span>, <span class="NLM_string-name">Glicksman, M.</span>, <span class="NLM_string-name">Hall, M. D.</span>, <span class="NLM_string-name">Haas, J. V.</span>, <span class="NLM_string-name">Inglese, J.</span>, <span class="NLM_string-name">Iversen, P. W.</span>, <span class="NLM_string-name">Kahl, S. D.</span>, <span class="NLM_string-name">Kales, S. C.</span>, <span class="NLM_string-name">Lal-Nag, M.</span>, <span class="NLM_string-name">Li, Z.</span>, <span class="NLM_string-name">McGee, J.</span>, <span class="NLM_string-name">McManus, O.</span>, <span class="NLM_string-name">Riss, T.</span>, <span class="NLM_string-name">Trask, O. J.,  Jr.</span>, <span class="NLM_string-name">Weidner, J. R.</span>, <span class="NLM_string-name">Wildey, M. J.</span>, <span class="NLM_string-name">Xia, M.</span>, <span class="NLM_string-name">Xu, X.</span></span>, Eds.; <span class="NLM_publisher-name">Eli Lilly & Company</span>: <span class="NLM_publisher-loc">Bethesda MD</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=T.+Wang&author=Z.+Li&author=M.+E.+Cvijic&author=C.+Krause&author=L.+Zhang&author=C.%0AS.+Sumauthor=G.+S.+Sittampalam&author=N.+P.+Coussens&author=K.+Brimacombe&author=A.+Grossman&author=M.+Arkin&author=D.+Auld&author=C.+Austin&author=J.+Baell&author=B.+Bejcek&author=J.+M.+M.+Caaveiro&author=T.+D.+Y.+Chung&author=J.+L.+Dahlin&author=V.+Devanaryan&author=T.+L.+Foley&author=M.+Glicksman&author=M.+D.+Hall&author=J.+V.+Haas&author=J.+Inglese&author=P.+W.+Iversen&author=S.+D.+Kahl&author=S.+C.+Kales&author=M.+Lal-Nag&author=Z.+Li&author=J.+McGee&author=O.+McManus&author=T.+Riss&author=O.+J.+Trask&author=J.+R.+Weidner&author=M.+J.+Wildey&author=M.+Xia&author=X.+Xu&title=Assay+Guidance+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26atitle%3DMeasurement%2520of%2520Beta-Arrestin%2520Recruitment%2520for%2520GPCR%2520Targets%26btitle%3DAssay%2520Guidance%2520Manual%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26pub%3DEli%2520Lilly%2520%2526%2520Company%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span> <span> </span><span class="NLM_article-title">Tools for GPCR drug discovery</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1038/aps.2011.173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Faps.2011.173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=22266728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1elu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=372-384&author=R.+Zhangauthor=X.+Xie&title=Tools+for+GPCR+drug+discovery&doi=10.1038%2Faps.2011.173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Tools for GPCR drug discovery</span></div><div class="casAuthors">Zhang, Ru; Xie, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">372-384</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCRs) mediate many important physiol. functions and are considered as one of the most successful therapeutic targets for a broad spectrum of diseases.  The design and implementation of high-throughput GPCR assays that allow the cost-effective screening of large compd. libraries to identify novel drug candidates are crit. in early drug discovery.  Early functional GPCR assays depend primarily on the measurement of G-protein-mediated 2nd messenger generation.  Taking advantage of the continuously deepening understanding of GPCR signal transduction, many G-protein-independent pathways are utilized to detect the activity of GPCRs, and may provide addnl. information on functional selectivity of candidate compds.  With the combination of automated imaging systems and label-free detection systems, such assays are now suitable for high-throughput screening (HTS).  In this review, we summarize the most widely used GPCR assays and recent advances in HTS technologies for GPCR drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8pC8anrKpWLVg90H21EOLACvtfcHk0linUNDgtYwBsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1elu7Y%253D&md5=04ca4fed048dbca837d81c02566e6e25</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Faps.2011.173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2011.173%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DTools%2520for%2520GPCR%2520drug%2520discovery%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2012%26volume%3D33%26spage%3D372%26epage%3D384%26doi%3D10.1038%2Faps.2011.173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besnard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constam, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.-P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+C.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0linUNDgtYwBsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muniz-Medina, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S.</span></span> <span> </span><span class="NLM_article-title">A simple method for quantifying functional selectivity and agonist bias</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1021/cn200111m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200111m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=193-203&author=T.+Kenakinauthor=C.+Watsonauthor=V.+Muniz-Medinaauthor=A.+Christopoulosauthor=S.+Novick&title=A+simple+method+for+quantifying+functional+selectivity+and+agonist+bias&doi=10.1021%2Fcn200111m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Method for Quantifying Functional Selectivity and Agonist Bias</span></div><div class="casAuthors">Kenakin, Terry; Watson, Christian; Muniz-Medina, Vanessa; Christopoulos, Arthur; Novick, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-203</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of seven-transmembrane (7TM) receptors by agonists does not always lead to uniform activation of all signaling pathways mediated by a given receptor.  Relative to other ligands, many agonists are "biased" toward producing subsets of receptor behaviors.  A hallmark of such "functional selectivity" is cell type dependence; this poses a particular problem for the profiling of agonists in whole cell test systems removed from the therapeutic one(s).  Such response-specific cell-based variability makes it difficult to guide medicinal chem. efforts aimed at identifying and optimizing therapeutically meaningful agonist bias.  For this reason, we present a scale, based on the Black and Leff operational model, that contains the key elements required to describe 7TM agonism, namely, affinity (KA-1) for the receptor and efficacy (τ) in activating a particular signaling pathway.  Utilizing a "transduction coeff." term, log(τ/KA), this scale can statistically evaluate selective agonist effects in a manner that can theor. inform structure-activity studies and/or drug candidate selection matrixes.  The bias of four chemokines for CCR5-mediated inositol phosphate prodn. vs. internalization is quantified to illustrate the practical application of this method.  The independence of this method with respect to receptor d. and the calcn. of statistical ests. of confidence of differences are specifically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxSkELs1bHQLVg90H21EOLACvtfcHk0lhp8fHPYSDt0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN&md5=270841d11f9720caaf3e59a6fe0aee74</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fcn200111m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200111m%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DMuniz-Medina%26aufirst%3DV.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DNovick%26aufirst%3DS.%26atitle%3DA%2520simple%2520method%2520for%2520quantifying%2520functional%2520selectivity%2520and%2520agonist%2520bias%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D193%26epage%3D203%26doi%3D10.1021%2Fcn200111m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00351">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50777"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00351">10.1021/acs.jmedchem.9b00351</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H NMR spectra of compounds <b>40</b> and <b>41</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00351/suppl_file/jm9b00351_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00351/suppl_file/jm9b00351_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00351/suppl_file/jm9b00351_si_001.pdf">jm9b00351_si_001.pdf (212.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00351/suppl_file/jm9b00351_si_002.csv">jm9b00351_si_002.csv (4.77 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00351&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00351%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00351" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b20c0966223c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
